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Abstract
Abstract
The findings of the first reported guest centric encapsulation study are presented within. The 
guests were of interest as petrol and diesel (fuel) additives, with the focus on 2 -ethylhexyl 
nitrate (2-EHN), di-tert-butyl peroxide (DTBP), aniline, A-methylaniline (NMA) and N,N- 
dimethylaniline (NNDMA).
Complexation with 2-EHN and DTBP was achieved with the novel calix[4]arene derivative, 
5, 11, 17, 23-tetra-tert-butyl, 25, 27-bis(oxyethylphenylurea), 26, 28-dihydroxycalix[4]arene, 
CA(III). This was confirmed in solution by the use of NMR techniques.
The multi-step procedure to yield a tetrol cavitand, with recent updates to the procedures are 
fully described. A new carceplex system with aniline encapsulated, carceplex ’ aniline (4, 24- 
5, 5’- 6 , 10- 11, 11’- 12, 16- 17, 17’- 18, 22- 23, 23’- 4 ’, 24’- 6 ’, 10’- 12’, 16’- 18’, 22’- 
dodecamethylenedioxy, 2, 8 , 14, 20, 2’, 8 ’, 14’, 20’-octapentyl-bis-calix[4]arene ’ aniline) 
was produced in a pioneering pressure tube encapsulation following unsuccessful attempts 
under reflux conditions.
A pyrogallol[4]arene with pentyl pendant group (2, 8 , 14, 20-tetrapentylpyrogallol[4]arene) 
PA(I) was synthesised and successfully employed for self-assembled complex formation with 
aniline, NMA and NNDMA. These complexes were found to be stable in polar and apolar 
media at 313 K over a duration of 2 months. The complexes were o f stoichiometry 10:1 
(aniline : PA(I)), 12:1 (NMA : PA(I)), and 4:1 (NNDMA : PA(I)). Significant variation was 
observed when complexes were analysed by TGA in air up to 800 °C compared to control. 
PA(I) aniline and PA(I) NMA displayed solubilities in apolar media making them suitable 
for analysis in test engines as fuel additives.
The first report of a (two-step) carcerand synthesised from pyrogallol[4]arene, PA(I) with the 
introduction of methylene dioxy spanning and bridging groups, yielding the novel carcerand 
4, 24- 5, 4 ’- 6 , 5’- 10, 11’- 12, 16- 17, 16’- 18, 17’- 22, 23’- 23, 24’- 6 ’, 10’- 18’, 22’- 
dodecamethylenedioxy, 2, 8 , 14, 20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis-calix[4]arene is also 
presented.
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Navisation o f the text
Navigation of the text
It is possible to read this thesis in two alternative orders. There are the following distinct 
pathways through the research with the traditional progression numbered before titles and the 
alternate is lettered in parenthesis before the title text. The lettering refers to the discrete 
research pathway, thus:
A. Complexation
B. Carceplex
C. Hemicarcerand
D. Self-assembly complexation
E. Pyrogallolarene based carcerand
F. Cyclodextrin inclusion complex
If no marker is offered the section is considered relevant to all pathways and puts the work 
into context. Although section F stands almost completely separate from the other sections as 
it does relate to the calixarene structure, as such unmarked passages may not be relevant.
For greater understanding and background the reader following thread E  should first read 
thread B although it is not essential.
The two indicators provide the reader with alternative approaches to the text but may serve to 
assist in understanding (the progression of) the research and follow it more attentively. The 
six markers are indicative o f the interweaved ‘umbrellas’ under which the research was 
performed.
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L Introduction
1. Introduction
1.1 Aims
The aim o f the research was to design, develop and produce container molecules able to 
retain fuel additives (guests) by supramolecular bonds. The idea of this was to create a 
supermolecule which could afford protection to the additive, without being covalently joined 
to the additive so as not to alter the mode of action when employed. The subsequent desired 
effect was to produce a supermolecule with a time delayed action within the combustion 
cycle, when used in a fuel (petrol or diesel) to improve its combustion characteristics. As 
such the surrounding or supramolecularly bound host would be destroyed by combustion 
prior to the additive. Before releasing the additive to allow for the time-delayed effect, which 
lets the fuel additive to become active on the combustion characteristics o f the fuel at a point 
in time after the ‘free’ fuel additives have been active.
1.2 Supramolecular chemistry
Supramolecular chemistry is the study of the non-covalent bond; it is the section o f chemistry 
which is concerned with intermolecular forces, dynamic interactions and complexes.
Chemistry has until recently been the study of the covalent bond (sharing o f valence electrons 
between atoms) and focussed mainly on their formation and breaking to produce desired 
molecules for later purposes. Such processes are well understood and form the basis of 
molecular chemistry. In supramolecular chemistry, the array o f supramolecular bonds are 
studied with their fascinating dynamic formations, breakings, strengths and abilities to 
conglomerate molecules or atoms to from supermolecules. Supermolecules subsequently can 
have distinct characteristics from their constituent atoms, molecules or species; they can be a 
dramatic example of ‘the whole being greater than the sum of its constituent parts’ -Aristotle.
Supramolecular chemistry has been described as ‘chemistry beyond the covalent bond’,^  it is 
the world of intermolecular forces. Supramolecular chemistry is therefore involved in ion-ion 
interactions, ion-dipole interactions, dipole-dipole interactions, hydrogen bonding, van der
1
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Waals interactions, tc-tt interactions and others. The origins of supramolecular chemistry can 
be traced back to 1894 when Emil Fischer proposed the ‘lock and key mechanism’ for 
enzyme substrate interactions.^ Supramolecular chemistry however did not emerge as a 
branch o f chemistry in its own right until the 1970’s. However supramolecular chemistry is 
only said to have ‘arrived’ in 1987 when three heavyweights in the field; Donald J. Cram, 
Jean-Marie Lehn and Charles J. Pederson were jointly awarded the Nobel Prize in Chemistry 
for their endeavours.^ The structures of supermolecules are usually held together by non- 
covalent bonds, which can be broken and reformed; a number of intermolecular bonds 
working together can be capable o f forming bonds which are as strong as or even stronger 
than a covalent bond. With its background, inspiration and origins in the biological world, 
supramolecular chemistry has since evolved into a study of chemistry where molecular hosts 
can be tailor made for a purpose.
Supramolecular chemistry marks man’s first footsteps into the chemistry o f biomimicry and 
could be said to be approaching its 45* anniversary with the term being introduced to the 
language in 1969."  ^The complex chemistry which occurs constantly inside living organisms is 
intensely governed by the principles of supramolecular chemistry. Life itself is only made 
possible by the complex molecular interactions which occur constantly throughout living 
organisms. The most prevalent o f these is that of enzyme chemistry in which the 
complementarity and selectivity or specificity of enzymes for substrates leaves the 
supramolecular chemist in awe and drives us forward as the examples of the advanced 
possibilities of science become increasingly well understood. Supramolecular chemistry 
seeks to manipulate molecules and the laws o f interactions towards the will o f man. The 
relative primitivity o f the science from synthesised organic hosts to date however does have 
some advantages over the highly evolved biological examples. For instance, an enzyme will 
have a highly specific temperature and pH operating range, outside of which it will likely be 
denatured and become redundant. As the molecules which can be manipulated in the 
laboratory remain relatively simple, the operating parameters of the interactions observed 
remains wide, which often makes them more useful. Developments in organic synthesis lag 
behind those of the ‘molecular machinery’ inside cells which produce the complex structures 
required. Also homeostasis controlled environments, required in biology are not common 
outside of the realms of living organisms.
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1.3 The research approaches
1.3.1 (A) Dynamic interactions
Dynamic interactions are the staple for the supramolecular chemist, especially when 
concerned with the thermodynamics of a system. The usual approach for the production of a 
dynamic system is guest centric; the host is designed to fit the guest with complementarity 
built-in for the guest molecule. This accommodates a ‘pocket’ present in the host; the 
interaction centre functionalised into the host designed for a specific guest. Though 
specificity is rarely achieved, selectivity for one guest over a range of others can be 
established and quantified by the careful study o f thermodynamics. As such it is possible to 
understand the binding properties of the host for the guest and make realistic predictions of 
the efficacy from the model systems studied. Established successes with this approach have 
been advanced for the selective extraction o f polluting species from water systems employing 
macrocycles derived from calixarenes,^'^ calixpyrroles^ and resorcarenes.^ Often from initial 
studies of interaction, suitable host-guest systems can be identified to serve purpose in the 
real-world. The macrocycle may subsequently be polymerised^ or mounted onto a solid 
support such as silica^ or diatomite or other naturally occurring m a t e r i a l . I n  some cases the 
functionalisation which was performed to introduce selectivity onto the macrocycle is used to 
functionalise silica. In all cases this is performed in order to achieve a material capable of 
selective extraction of an ionic species or organic pollutant from water or oil. However to 
date there is no record of an attempt to employ this technology for the purpose o f fuel 
additives. Organic compounds and neutral molecules have been identified to selectively 
interact with host groups. Examples of these include herbicides^^ and pharmaceuticals,^^ 
though the greatest success has been achieved with ionic species.^’^ ’^^ '^^ ^
1.3.2 (B.C.D.E) Encapsulation
Inversely the encapsulation approach is historically host centric, a host system is designed 
and then analysed with a vast array of guest molecules to establish carceplexes or 
hemicarceplexes, with the guest trapped within but not attached to the host. To an extent 
complementarity can be introduced, however the void within a capsule may be altered in
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ternis of size but is to date always a hydrophobic, non-polar cavity. As such selectivity is 
introduced mainly in terms of templation {vide infra), size or symmetry. Polar molecules or 
molecules presenting polar moieties are unsuitable for stable occupation o f the cavity.
1.4 The research plan
1.4.1 (A) Dynamic approach
The synthesis of organic ligands holds an intriguing and complex challenge, requiring 
information to be gained about the guest to greater understand the challenge at hand. This 
information relates to the guest’s spéciation which can be established by partition 
experiments, to determine whether or not the guest is in a monomeric state in solution. 
Conductivity measurements are performed to provide information as to whether the guest is 
in an ionic state in solution. The enthalpy of solution may also be determined in a chosen 
solvent but it is not possible to determine the Gibbs energy if the solvent and guest form a 
solvate. Once this information has been gathered and a greater understanding of the guest in 
solution has been obtained, a design for the features required in the ligand can then begin to 
be formed.
Employment of NMR studies with small molecules makes it possible to identify which 
groups interact readily with the guest molecules. By viewing the pure NMR spectrum and 
comparing this to one where the guest is present in excess a peak shift along the x axis of 
>0.1 ppm should be visible if  a significant interaction has occurred. Interactions below this 
level of intensity are decided to be too weak to be of interest. In this way it becomes possible 
to discover which functional groups to add to a ligand in order to develop one which interacts 
with the guest. Once the data have been compiled and understood it is then possible to design 
a ligand based on one o f the major groups of synthetic ligands (calixarenes, calixpyrroles 
etc.) with functional groups introduced based on evidence o f interaction from the small 
molecule (neutral or ionic species) by NMR studies. A ligand may then be synthesised and 
characterised, and the interaction between it and the guest can be studied. This is initially 
performed by NMR complexation studies where deviations in spectra indicate interactions 
(as above). Following characterisation an interacting proton can be identified by tracing peak
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shifts and integration changes. If  an interaction has been identified it can then be studied by 
conductometric titrations (if ionic species are involved), UV-VIS spectrophotometric 
titrations and calorimetry. These techniques allow for the elucidation o f the stoichiometry of 
the complex to be established, along with thermodynamic parameters.
1.4.2 (B.C) Encapsulation approach
The encapsulation approach requires the organic guest to be imprisoned within a macrocyclic 
compound (host) such as a carceplex.^^ The carceplex or hemicarceplex acts as a cage inside 
which the guest remains imprisoned, intact and unchanged. Carcerand and hemicarcerand are 
the guest absent terms for the same structures. Guests inside hemicarceplexes can be liberated 
at high temperatures without harm to either host or guest. Hemicarceplexes are gated; they 
contain ‘portals’ through which guests may pass. For a guest to be liberated from a carceplex 
the destruction of the host is required due to the confinements o f the host. Due to the nature 
of the encapsulation stage, which requires heating, the cetane improvers detailed within are 
not suitable as heating may cause fire and explosion r e s p e c t i v e l y F o r  the formation of a 
carceplex, the guest must be present during the synthesis as the cage is formed around the 
guest which is used as a template. This process also requires the application of heat. In the 
case of the hemicarceplex the cage is gated and can be formed around a template molecule, 
which can be optimal for formation of the host. The template molecule may then be liberated 
and exchanged for a desired guest, by the application o f the guest as solvent (or in a suitable 
solvent, such as NMP, vide infra) at high temperatures.^^ This occurs only if the guest is 
small enough to occupy the space inside o f the hemicarceplex and then, only if  the process is 
thermodynamically favourable.
1.4.3 (D) Self-assembled capsules
The production o f a self-assembled system requires a host molecule to be designed 
possessing complementarity, either to self for a uni-molecular capsule or to partner(s) which 
may be copies of the host. In this way the guest becomes encapsulated by the host system and 
held in place by the formation of supramolecular (usually hydrogen) bonds which hold the
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host(s) in place with the formation of a ‘seam’. The host system then does not allow for the 
liberation of the guest unless the ‘seam’ is disrupted. This may be accomplished by 
interrupting the hydrogen bonding, for example with the addition of a polar entity. The 
general procedure requires the reflux o f the host in either the guest as solvent or guest in a 
suitable solvent, followed by a suitable work-up procedure, such as the slow evaporation of 
the solvent over time. If self-assembly is preferable then the anticipated supermolecule will 
be yielded, containing the desired encapsulated guest (and solvent if present). These systems 
may require the collaboration of a suitable solvent to assist in the formation o f the seam, 
lending their properties to the formation of the bridge between the large host molecules for 
the formation of the ‘seam’.
1.5 The internal combustion engine and its fuels
Prior to establishing the various fuel additives and specifically the properties o f those studied 
within, it is important to understand how they are employed and also the fuels and the 
engines they are used in. Petrol and diesel internal combustion engines operate upon two 
opposing principles for combusting their specific fuels. Both engines operate a four stroke 
cycle, which are colloquially known as: ‘suck, squeeze, bang, blow’. Suck, intake stroke: air 
(and fuel, some engines) are introduced into the cylinder, piston descending. Squeeze, 
compression stroke: the air(-fuel mixture) is compressed as the piston ascends (fuel 
introduced if not already present). Bang, ignition stroke: the air-fuel mixture is ignited 
forcing the piston downwards and producing the torque which turns the crankshaft. Blow, 
exhaust stroke: the exhaust gasses are expelled by the piston moving upwards.
It is the processes of compression and ignition which vary between the two principles o f the 
internal combustion engine. These lead to required differences in the fuels.
For a petrol engine the fuel must be stable under compression and resistant against auto­
ignition. In a petrol engine the desired source of ignition is a spark-plug. Auto-ignition 
without the induced spark or separate to the combustion front it produces is referred to as 
‘knock’ or engine run-on and can be fatal to an engine. As such much o f the research and 
comparisons of petrol fuels is concerned with the fuel’s stability under compression. A fuel
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which is more stable under compression can allow a modem engine to adjust the quantity of 
fuel introduced and the ignition timing to produce a more efficient and powerful bum. The 
quality o f a fuel is often conveyed to the public by its octane rating, RON (Research Octane 
Number). The RON number relates to the amount of compression the fuel can withstand 
before it detonates. The higher the RON the greater amount o f compression it can withstand. 
These figures are quoted at the pump and range in the UK between ‘95 RON Premium 
Unleaded’ to ‘102 RON BP Ultimate 102’ available at a few garages and designed for race 
and track-day use in performance vehicles The fuel with the highest RON which is widely 
available is TESCO’s ‘Momentum 99’; fuels with RONs greater than 97 are considered 
‘Super Unleaded’ and are for performance vehicles only. Most vehicles will receive no 
benefits in terms of power and economy from mnning on super (instead of premium) 
unleaded. However, often ‘super’ fuels often contain additional (quantities) o f cleaning 
additives which may reduce (or eliminate) the build-up o f deposits in the engine, 
subsequently allowing optimal combustion efficiency over the duration of its operation. The 
RON number is a comparison of the performance of a fuel in a test engine with a variable 
compression ratio against mixtures of iso-octane : «-heptane, so for a 95 RON premium 
unleaded the results are comparable to a mixture of 95:5 iso-octane : «-heptane (v/v) (Fig. 1).
Iso-octaneHexane
Figure 1 The structures of hexane and iso-octane
The diesel (compression-ignition) engine requires compression of the air and fuel to cause 
ignition, in modem diesel engines the air is compressed and the diesel fuel injected directly 
into a cavity in the piston as vapour which is ignited by the heat from the compressed air. 
Subsequently the properties of a diesel fuel require auto-ignition and as such are opposing to 
the properties o f a petrol fuel. The measure o f the quality o f a diesel fuel, especially a 
performance fuel as conveyed to the public, is in terms o f the cetane number. The cetane 
number is measured versus the reference to the properties o f a cetane : methylnaphthalene 
ratio in the same way as a RON number is determined from «-hexane : iso-octane. However
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the requirements are quite different to a petrol (where the highest RON is desirable) as a 
diesel fuel must detonate, due to the way it runs on compression-ignition. Consequently a 
higher cetane number does not constitute a better diesel fuel. Boerlage and van Dyck showed 
the relationship between the cetane : methylnaphthalene ratio and ignition delays, where a 
higher cetane number gives a shorter ignition delay.^^ Shorter ignition delay has finite 
benefits, beyond which it becomes detrimental to efficient ignition and can lead to 
combustion occurring in the fuel delivery system, leading to possible damage and a loss in 
torque.
On sale in the UK, general diesel has a cetane number of 49-51, with super diesels such as BP 
Ultimate Diesel having a cetane number o f 55. Super diesels are a far more recent invention 
than super petrols, where 5 star leaded petrol was the forerunner to today’s super-unleadeds. 
In the past diesel fuel was mainly used to drive heavy machinery and generators but in recent 
times with the increases in fuel prices and the substantial increases in economy offered by the 
compression-ignition engine this trend has shifted. These factors have led engine 
manufacturers to produce recent refinements to the diesel engine to reduce the unpleasant 
noises and vast particulate emissions with which they were associated. Audi’s recent diesel 
domination at Le Mans has been testament to these improvements, which have cumulatively 
led to the recent change in trend which has seen diesel sales overtake petrol sales at both the 
pump and the showroom.^^ This has occurred even in the face o f the premium paid for both, 
due to the increased heat o f combustion requiring stronger engines and fuel price rises linked 
to the dramatic increase in demand.
1.6 Detonation
The key trait of a fuel for use inside an internal combustion engine is ‘detonation’ which is an 
occurrence when the fuel ignites spontaneously as a consequence o f the temperatures and 
pressures o f the internal combustion engine. It has been shown above how this is desired in a 
diesel engine and how it is a key characteristic o f a fuel. There are many mechanical causes 
for ‘detonation’, ‘knock’ or ‘pinking’ which have been well understood for some time^^ but 
are outside of the scope of this work. Regarding the molecular chemistry, a number o f causes 
have been identified. An increase in the tendency o f a fuel to knock has been linked to longer
8
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hydrocarbon chains and increasing cyclic hydrocarbon ring size, whereas branched chains 
and ‘increased molecular centralisation’ have been found to decrease knock?^’^  ^ A general 
definition of this was provided by Lovell al. as: an increase in aniline equivalent {vide 
infra) from a more compact special arrangement of the structural formula o f the molecule.^^ 
Tieszen and Stamps^® performed some research on the detonation characteristics o f some 
hydrocarbons, focussing on Cg chain lengths. Their findings were that detonation sensitivity 
follows the series (in order of decreasing detonation likelihood):
Saturated ring > straight chain alkane > branched chain alkane
Alkane > alkene > alkyne
They concluded that the introduction o f either oxygen or nitrogen into a molecule 
significantly reduces detonation sensitivity.^^ The branching and increased centralisation of 
iso-octane compared to «-hexane led to their implementation as standards for compression 
analysis, the two molecules are visualised as ball-stick and CPK models in Figure 2.
The detonation characteristics define how a molecule may be affected by extremes of 
temperature and pressure within an engine, at the extremes during the compression stroke the 
forces are such that the initiation o f detonation may occur. Sufficient energy is required in the 
system to produce auto-ignition initiation, specifically the reaction between the hydrocarbon 
and oxygen which generates free radicals.^^ This is followed by propagation o f the radicals, 
converting one into another, followed by a branching step which creates an excess o f radicals 
and finally termination, the conversion of free radicals into non-radical products.
Introduction
\
(a) (b)
Figure 2 Energy minimised molecular models o f (a) «-hexane and (b) iso-octane, ball-stick 
above, CPK below
A convenient way to measure the detonation characteristics of a fuel or isolated fuel 
constituent is the aniline point, where direct correlation has been found with the octane- 
rating?^’^  ^The aniline point has been defined as the ‘lowest temperature at which equal 
volumes o f aniline and the sample become completely soluble’. A s  such it has been a 
convenient method to assess the combustion characteristics o f oil refined fuel, prospective 
additives and isolated constituents.
1.7 Fuel additives
1.7.1 Petrol additives, Tetraethyl lead
It is futile to consider fuel additives without mentioning tetraethyl lead (Fig. 3), the presence 
of which in petrol is now highly regulated in the UK,^^ due to its high toxicity,^'^’^  ^ effect on 
developing children^^ and incompatibility with catalytic converters.^^ The lead content of 
fuels provided a means o f distribution of lead into the air, dust, soil, drinking-water and food 
crops, these factors caused a worldwide problem.^^ Lead is particularly dangerous to the 
developing foetus, able to cross the placenta and penetrate the blood brain barrier, affecting
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the development of the unborn infant leaving permanent untreatable damage, from 
concentrations as low as 5 pg/dl.^^
Tetraethyl lead
Figure 3 The chemical structure of tetraethyl lead (TEL)
However, due to tetraethyl lead’s incredible ability to alter the detonation characteristics o f a 
petrol fuel at concentrations as low as 1 in 1 0 0 ,0 0 0 ,^  ^ companies were reluctant to remove it 
from their fuels. Tetraethyl lead as a fuel additive was first reported by Thomas Midgley and 
his colleague T. A. Boyd at General Motors in 1922.^^ Midgley and Boyd studied the effects 
on the detonation characteristics following the addition of other materials into fuels. The 
remarkable properties o f the addition o f tetraethyl lead to the fuel were subsequently 
discovered, as only 0.04 % tetraethyl lead (TEL) by volume was required to suppress 
detonation, compared to 25 % of benzene in ke rosene . These  astonishing results produced a 
pronounced response from the motor fuels industry and leaded petrol soon became 
commonplace. However, after six men died following the exposure to ‘loony gas’ (TEL) and 
a further twenty-nine men being hospitalised from exposure to tetraethyl lead in 1924,"^  ^
Midgley was forced to issue a statement on the health hazards of the substance the next 
year.^^ Regardless of the health implications of their discovery it was still being hailed as a 
‘flash of genius’ as late as 1962."^  ^ In 1991 EU legislation drove the necessity for all cars sold 
from then on to be fitted with a catalytic converter to reduce emissions, following the 
increasing market trends which signalled the death knell for leaded fuels within the 
jurisdiction.'^^’'^  ^ The main issue following its withdrawal from market was in the valve seats 
of vehicles designed to run on leaded petrol. The soft valve seats fitted were lubricated by the 
lead in the petrol; running unleaded fuel in such an engine would eventually lead to burnt 
valves, stopping the engine. Enthusiasts maintaining and regularly using cars with engines
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designed to run on leaded petrol have since been forced to either introduce a lead replacement 
(such as Castrol Valvemaster) to their fuel tanks following each fill or upgrade the valve 
seats.
1.7.2 (B.C.D.F) Petrol additives, organic species
Since the move away from leaded petrols the search has been on for alternative fuel additives 
to replicate the performance o f tetraethyl lead, a forerunner of which has been MTBE 
(methyl-^er^-6 utyl ether). However controversy around the employment of this in motor-fuels 
is also present as it is regarded as a possible carcinogen'^'^ and can be readily absorbed into 
water supplies as the result of a fuel spill, for such reasons its use is regulated."^^ The 
restrictions based on the fuel industry since the removal of lead from fuels has reduced the 
possibilities for fuel additives. Many petrol suppliers will not add inorganics into their fuels, 
and it is these species especially which have been found to exhibit the greatest responses.
Alcohols including bio-ethanol have been employed as gasoline additives; indeed it is the 
high content of alcohols in TESCO’s momentum 99 which boosts its rating to 99 RON."^^ The 
effect of alcohols in a petrol fuel is in line with the addition o f oxygenates, where oxygenated 
fuel blends have been found to produce better anti-knock performance than hydrocarbons of 
the same octane r a n g e . T h e  use of ethanol as a fuel additive or fuel constituent shows 
numerous advantages specifically: increased engine performance and reduced pollutive 
exhaust emissions (CO and HC)."^ ’^^  ^ Blends o f up to 25 % ethanol have been used in 
unleaded petrol without compromising engine f unc t i on . Wi t h  these advantages ethanol has 
become a sought-after petrol constituent, however its employment is somewhat contentious 
as the production o f bio-ethanol draws valuable arable land away from the production o f food 
stocks, especially in developing countries, such as Brazil.
Costagliola et a l boast o f great reductions in exhaust emissions o f benzene and 1, 3- 
butadiene (classified carcinogens) due to increasing volumes (to 85 %) o f ethanol in fuel 
blends but failed to link the reasoning to their overall reduction in the fuel blend.^^
Phenol and alkylated phenols have been employed as fuel additives since at least 1966,^^ 
although little information is available as to the dosage and properties, due to the closed
12
L Introduction
competitive nature of the industry. Its mode o f action and efficacy will be in-line with the 
other oxygenates and aromatics.
Aniline was proposed as a fuel additive to compensate for the void left from the phase-out of 
leaded petrol; however, although it was able to increase the octane number o f the fuel, its use 
resulted in the formation of a gum-like residue in the carburettor and suction systems of 
engines.^"^ The introduction of a blend of oxygenates into the fuel mixture was discovered to 
be the cure to these problems.^"^ Additional to these problems aniline, iV-methylaniline and 
A,A-dimethylaniline have been found to poison three-way catalysts and consequently reduce 
the effectiveness o f catalytic converters.^^ A-methylaniline (NMA) has been found not only 
to be an anti-knock additive, improving compression stabilities but also to increase engine 
power.^^ Furthermore it is claimed that an addition of 1.5 % (by volume) of NMA to petrol 
produces a RON increase o f 6  units (when used in conjunction with MBTE).^^ Other claims 
include: reduced fuel consumption, improved stability of quality o f petrol, reduced carbon 
formation in the combustion chamber, corrosion protection and reduction of the quantity of 
toxic hydrocarbons and carbon monoxide in exhaust g a s e s . L i t t l e  information is freely 
available on the subject due again to the closed nature of the fuel industry. What is known is 
that aniline and substituted aniline possess good compression characteristics and provide a 
cleaning action inside the combustion chamber, either leading to or assisting in increased 
lubricity.^ ’^^ ^
NH. 'NH
Aniline A-Methylaniline
(NMA)
OH
A,WDirnethylanilme
(NNDMA)
Phenol
Figure 4 The structures o f the petrol additives studied
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1.7.3 (A) Diesel additives
The cetane improvers (CIs) studied within, namely, 2-ethylhexylnitrate (2-EHN) and àx-tert- 
butyl peroxide (DTBP) (Fig. 5) improve the combustion characteristics o f a diesel fuel to 
which they are added and consequently raise the cetane number.
■ O  O -
2-EHN DTBP
Figure 5 The chemical structures of the cetane improvers studied
The main parameters which are used to measure the combustion efficiency o f a diesel fuel 
blend are the content in the exhaust gases of carbon monoxide, CO; nitric oxide and nitrogen 
dioxide, NOx; unbumt hydrocarbon content, HC; and particulate matter content, PM.
When 2-EHN or DTBP are combusted, they release oxygen radicals, which begin or assist in 
the auto-ignition process, leading to the term ‘ignition improvers’.^ ®’^  ^ Subsequently they are 
able to improve the combustion characteristics of a diesel fuel even at low doses (0.5 %, 
v/v).^^’^  ^ Leading to exhaust temperature reduction, NOx reduction (especially remarkable in 
the case of 2-EHN due to the additional nitrogen content o f the fuel), HC reduction, smoke 
opacity reduction and CO reductions have also been i d e n t i f i e d . 2 - E H N  has displayed 
slightly improved efficacy compared to DTBP. This is due to the additional oxygen which it 
is able to release, however DTBP is non-toxic, less explosive and does not negatively affect 
the physicochemical properties of the fuel and combines well with other additives.
Ethanol has also been studied as a diesel fuel constituent, the results showed a decrease in 
particulate matter and also in CO from the exhaust gases, with no change to NOx and 
contradicting results regarding the unbumt HC content o f the exhaust gases.^^ The long-term 
implications of an ethanol enriched diesel on the durability of the engine remains untested 
and a drop in performance in-line with the reduced energy content o f the fuel is expected.
14
L_________________________________________________________________________Introduction
Requiring additional study is the possible interaction of a fuel additive with the oil of the 
engine, no-harm tests are required with a variety of lubricants to ensure that the fuel additive 
is not causing changes in the lubricity o f the oil, oxidising the oil or altering the viscosity.^^ 
The use o f metals as diesel fuel additives continues to be a topic of interest with shown 
properties including the use of platinum (and cerium) for PM reduction,^^ manganese for 
reducing the freezing point,^° which along with nickel has been found to reduce the viscosity 
of bio-diesel7^ Fatty acid methyl esters (FAMEs), constituents of bio-diesel, have been found 
to improve lubricity in a diesel fuel blend at volumes as low as 1 subsequently the move 
towards the addition of bio-diesel into the fuel blend has shown advantages. Further 
information is also available in bibliography ( 1 ).
Having discussed some issues related to the oil industry in the next section a brief 
introduction on relevant receptors within the field of supramolecular chemistry is given.
1.8 (F) Cyclodextrin
Cyclodextrin (CD) is the term given to a group o f naturally occurring macrocycles composed 
of repeating glucose sub-units, the prefix of which denoting how many (in parenthesis): a-CD 
(6 ), p-CD (7) and y-CD (8 ), Figure 6 . Cyclodextrins are the product o f the action of 
cyclomaltodextrin glucotransferase (enzyme) on starch and as a result the products (CDs) are 
non-toxic. Subsequently they provide important roles in agriculture, food and 
pharmacology.^^ The unique structures of CDs have been known for many years, indeed they 
were the original receptor molecule and their binding properties with organic molecules have 
been extensively investigated.^^ The key features o f all CDs is the presence o f the 
hydrophobic cavity and the hydrophilic outer structure. Consequently they have been 
demonstrated to be both soluble in water and able to accommodate within the cavity a 
hydrophobic compound, thus the supermolecule containing the hydrophobic guest is often 
soluble in water.^"^
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OH
HO
J i l l
OH
n =  6-8 
n = 6: a-CD  
n = 7 :  P-CD 
n = 8: y-CD
1,4 linked a-D-glucopyranose 
Figure 6  The chemical structure of cyclodextrins
1.9 (A) Calixpyrroles
Calixpyrroles are ligands which possess properties that allow for anion and neutral species 
binding/^ The first recorded calixpyrrole synthesis was by von Baeyer in 1886 with the 
condensation o f pyrrole and acetone (Scheme 1)7^’^  ^By using other ketones for the formation 
of the bridge such as 4 ' -hydroxyacetophenone it is possible to synthesise a calixpyrrole 
derivative which can be further functionalised (an example of which is given in section 
3.1.5).
o
Pyrrole Acetone
Methanol
Calix[4]pyrrole
Scheme 1 Synthesis of calix[4]pyrrole
Calixpyrroles are versatile receptors and subsequently have found diverse applications, most 
notable of which are as: ion-selective electrodes and optical sensors.^^’^  ^ Although 
calixpyrroles are known ditopic receptors^ most of their applications have been as anion
receptors.79
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1.10 (A) Calixarenes
Calixarenes gain their name from ‘calyx’ (cup-like, also derived to chalice) and arene 
(aromatic); calixarenes are therefore cup-like molecules which contain aromatic groups. This 
however only holds true for calix[4] and calix[5]arenes as the cup-like structure is lost for 
calixarenes larger than calix[5]arene but the nomenclature remains the same. Calixarenes are 
synthesised from /jora-functionalised phenol and formaldehyde, with heating under basic 
conditions (Scheme 2).^°
OH
/ 7-R-phenol
o
Base
Heat
Formaldehyde
OH
j9 -R-Calix[4 ]arene
Scheme 2 Synthesis o f calixarene where R is often tert-h\xXy\ and n is normally 4 but can be
up to 2 0 75,:
The usefulness of calixarenes in supramolecular chemistry has been demonstrated by 
innumerable authors and is due to the convenience of which it may be functionalised to form 
diverse derivatives capable of forming strong and thermodynamically quantifiable complexes 
with ionic and neutral species.^^
Additions can be made to the structure of the calixarene at either the upper (wide) rim or 
lower (narrow) rim. The synthesis of calixarenes is usually performed from ^er^-butylphenol 
and formaldehyde, to produce the commercially available, ‘parent’,/>-/er^-butylcalix[4]arene. 
Subsequently functionalisation o f the upper rim first requires the removal of the tert-buty\ 
group, followed by subsequent addition(s).^^ The lower rim however may be functionalised 
directly by nucleophilic substitution, some notable functional additions include: amides,^^ 
ketones,^^ esters,^^ amines^^ and thiophosphate^^ groups. The addition of such groups imparts 
varying molecular recognition properties onto the calixarene host, leading to selectivity, 
quantifiable by detailed thermodynamic studies. Fascinatingly it is possible to control the
17
Introduction
reactions so as to produce partially functionalised derivatives, which may then be further 
functionalised with an alternative group, or compared to fully substituted counterparts.^^’^ ’^^ ^
Rebek detailed a calix[4]arene functionalised in the upper-rim with urea, producing a new 
receptor molecule capable of dimerising through homo-interactions with the urea groups 
forming a ‘seam’ held together by hydrogen b o n d s . T h i s  interaction was able to self- 
assemble in solution, forming capsules around suitable guests. The work was continued to 
join two calixarenes at a single position on each, so as to introduce a flexible linker between 
two calixarene hemispheres, yielding a uni-molecular container capable o f forming dynamic 
capsules.^^ (Hemi)carcerands and (hemic)carceplexes formed from calix[4]arene have also 
been reported, using similar methods to those detailed by Rebek.^^
Rebek describes the cavity within a calixarene as resembling the great pyramid o f Giza 
(albeit in fantastic miniature !),^  ^ as opposed to the cone described by Gutsche.^^ It is the 
author’s opinion that the two are considering different aspects o f the calixarene. The cone 
conformation describes the overall structure of the molecule, with its symmetry, curvature 
and tapering, whereas, Rebek has described just the cavity, a more specific centre, which 
nonetheless may be of greater importance to the supramolecular chemist.
The term calixarene was given to this class o f compound by Gutsche in 1978,^"  ^this term was 
extended to include calixresorcarenes,^^ which due to their vast and separate applications 
have simply been denoted as resorcarenes.
1.11 (B.C.D) Resorcarenes
Resorcarenes were initially synthesised by von Baeyer in 1872 by the condensation o f 
resorcinol and benzaldehyde,^^ however the cyclic nature o f resorcarene was not identified 
until 1940 when Niederl and Vogel proposed the now established cyclic tetrameric 
structure.^^ Primary functionalisation of resorcarenes can be made during the initial synthesis, 
further functionalisation can later be introduced at the wide rim hydroxyl groups, in a similar 
way to that which is common at the lower rim o f calixarenes, via nucleophilic substitution. 
Outlined in Scheme 3 is the general procedure for the synthesis o f resorcarene.
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HO. OH H+
80 °C
Resorcinol
H2O
EtOH
Aldehyde
Resorc[4]arene
Scheme 3 Synthesis of resorc[4]arene
Further functionalisation o f resorcarene can then be made through the ‘pendant group’, 
denoted ‘R ’ in Scheme 3, if an appropriate moiety has been introduced during initial 
synthesis. Also the aromatic hydrogen positioned between the hydroxyls may be 
functionalised, often initially with bromine (discussed within) or by a Mannich-type 
reaction.^^ The latter was then exploited by Danil de Namor et al. for the production o f an 
ethylthiomethylated resorcarene for the formation of complexes with mercury(II), with a 
partially substituted resorcarene eventually being found to be advantageous for 
application. Resorcarene has begun to find application in the development o f new devices 
and molecular sensors, the hydroxyl groups along the wide rim are able to form self- 
assembles on the surface of gold, distributing and binding across the presented surface.^^ The 
applications o f these have yet to reach near to the full capabilities but the future for selective 
sensors and nano instruments waits only for the commitment of funding.
Resorcarene is the precursor to a latter distinct group of macrocycles, the cavitands, in which 
adjacent hydroxyls (being attached to neighbouring aromatic groups) are joined together by 
‘spanning’ groups. For these various groups have been introduced, continued below in 1.13.
1.12 (D.E) Pyrogallolarenes
Pyrogallolarenes were formally considered a subsection of resorcarenes and are often referred 
to in the literature as hydroxyresorcarenes. However as their employment became more 
widespread and their abilities found to be different to resorcarenes they have emerged in their 
own right and deserve to be considered separately and operate under their own name. The 
general procedure for the synthesis o f pyrogallol[4]arene is outlined in Scheme 4.
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OH
HO
Pyrogallol
OH O
Aldehyde
OH
H+
80 °C
HO
EtOH
Pyrogallol[4]arene
Scheme 4 Synthesis o f pyrogallol[4]arene
The possibility for further functionalisation of pyrogallol is made possible through the 
‘pendant group’ if  necessary moieties are introduced at first inception or through the twelve 
hydroxyl groups. The most interesting findings outlined in the literature to date have been the 
fascinating ability to form homo-interactions with additional pyrogallol[4]arenes in solution, 
these are outlined below (1.16).
1.13 (B.C) Cavitands
Cavitands are synthesised from resorcarenes by the introduction of a ‘second bridge’ at the 
wide rim which creates a reinforced cavity large enough to complex with ions or organic 
compounds.^^ Methylene bridges can be introduced using bromochloromethane (Scheme 5) 
whereas the introduction of longer bridges often requires the use o f a ditosylate (2.4.5).
HO, OH
R
Resorcarene
+  4 Br"
DMSO, 80 °C
CS2CO3
Bromochloromethane R
Cavitand
Scheme 5 Synthesis of cavitands
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The first cavitand was synthesised from resorcarene in 1982 by Moran et a l, with reference 
to Scheme 5, the cavitand produced had a methine R g r o u p O u t l i n e d  in Scheme 5 is the 
synthesis o f the simplest cavitand, although many other bridging groups, known as ‘spanners’ 
have been discussed in the literature. Some spanner groups have led to the production of 
cavitands able to form coordination cages, the introduction o f the necessary groups to do 
so has also been produced through the functionalisation o f the vacant upper rim aromatic 
p o s i t i o n . T h e s e  cavitands have either been produced for molecular sensing^^"  ^ or as 
precursors to carceplexes and hemicarceplexes.^^’^ ^^  Cavitands have also been reported as 
able to form uni-molecular host molecules able to complex guests into their vacant inner area 
or ‘pocket’, these complexes are referred to as caviplexes.^®^ But perhaps the most interesting 
functionalisation was the addition of short oligomers to the cavitand, the structural rigidity of 
which provides inflexible spacings between the protein chains, holding them in position and 
providing stability. With these introductions the possibilities increase in terms o f 
biomimicry and on towards additional sophistication and pharmaceutical possibilities for the 
implementation and the study o f supramolecular chemistry.
1.14 (B.C.D.E) Self-assembly and templation
Self-assembly has been defined by Lehn as ‘the evolution towards spacial confinement 
through spontaneous connection o f few/many components, resulting in the formation of 
discrete/extended entities at either the molecular, covalent or molecular level’. B u t  Gibb and 
Gibb provide the most refined definition ‘self-assembly is the spontaneous assembly o f sets 
o f comparatively simple subunits (molecular or otherwise) into a highly complex 
supramolecular structure’. S e l f - a s s e m b l y  therefore requires a level o f complementarity 
between host(s) and guest(s), similar in some respects to solubility. Chapman and Sherman 
derived a selectivity sequence for guests in the system o f carceplex guest 1 (Fig. 7), 
employed here.^°^
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. Guest
Figure 7 The carceplex guest system 1 by Chapman et al. 109,110
From this sequence they were able to derive the template ratio, the different abilities o f guests 
to act as templates for the formation of the host around them. The guest in these chemical 
reactions acts as a scaffold for the supermolecule to form around and in the process entraps 
itself within. The likelihood of the formation o f a carceplex around a guest is consequently 
more probable if the guest being encapsulated is complementary in size to the proposed host- 
cavity. Symmetrical molecules are more easily encapsulated into the host-guest system 1, 
because the presented cavity is also symmetrical. Also for the greatest complementarity the 
ideal guest should be able to form supramolecular bonds with the host, in this way it is able to 
actively participate in its encapsulation and act as a scaffold for the host system to form 
around, producing the highest yields.^ The findings of the study by Chapman and Sherman 
was that in this system the guest of highest complementarity was pyrazine, the properties of 
which that make it such are: symmetry ( 2  axes), formation o f ti-tl bonds with host (as found 
in the crystal structure) and having less than 7 non-hydrogen atoms (experimentally 
determined host prerequisi te) .^Guests which were not readily encapsulated were also 
identified^ and were subsequently employed as solvent for encapsulation reactions. This 
was crucial as it facilitates a situation in which desired guests may be encapsulated even if  the 
guest is not suitable as a solvent. The unsuitable guest may therefore act only as a medium for 
the reaction to take place in, rather than as a competitor. In their study NMP {N- 
methylpyrrolidinone) was identified as such a species and has been subsequently employed as 
a solvent for the formation of (hemi)carcerands and (hemi)carceplexes.
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Rebek’s consummate ‘sports balls’ publication provided early insights into the possibilities 
for self-assembly and molecular encapsula t ion.^Out l ined within were numerous 
supermolecules which presented complementary seams along which supramolecular (usually 
hydrogen) bonds formed.”  ^ In the presence of suitable guests these bonds formed the 
superstructure around guests resulting in encapsulation. Previous work was performed on the 
encapsulation o f cationic species, o f aryl- and alkyl-ammonium into hosts derived from 
resorcarene and calixarene. Here however the focus is on only the encapsulation o f specific 
neutral guests.
1.15 (B.C) H em icarcerands, hemicarceplexes, carcerands and carceplexes
The first synthesis of a carcerand was reported by Cram in 1983 which was a spherical 
molecule which possessed a central cavity that could be occupied by a guest. However it 
wasn’t until 1988 that Cram et al. managed to synthesise the first true carceplex with a guest 
permanently imprisoned within the cavity, joining apposing hemispheres functionalised with 
chlorine and sulphur r e s p e c t i v e l y P o o r  solubility o f this carceplex however did not 
allow for full characterisation, this was due to the methyl functionalisation o f the pendant 
‘arm’ o f the resorcarene from which the hemispheres were constructed. Subsequently in 1989 
the synthesis was further refined by Cram et al.}^^ to the formation o f carceplexes from 
identical cavitand (‘tetrol’ molecules with four hydroxyl groups) with extended pendant arms 
and methylenedioxy spanning and bridging groups, as outline in Scheme This
pioneering work by Cram et 20,29,114,115,117,1 is basis for what is attempted here.
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Scheme 6 Carceplex synthesis from identical tetrol hemispheres bridged by four 
methylenedioxy groups^^’^ ^^
A carceplex is a molecular structure which contains within it an imprisoned guest molecule, 
which may only be liberated by the destruction of the host. A carcerand is a molecule which 
possesses an empty void or ‘pocket’ at its centre. It is an empty carceplex with a ‘pocket’ 
which cannot be filled (due to its inaccessibility). A hemicarcerand is a molecular container 
which possess a ‘pocket’ and portals within its structure which allow for the encapsulation 
and diffusion of guests. By excitation of the molecule by the application of heat, it is possible 
to excite the host (hemicarcerand) in the presence of a desired guest (as solvent, or in a 
suitable solvent). Once reclaimed, the new superstructure complex: hemicarceplex guest is 
produced, only if the portals allow for entry of the guest and the occupation of the guest 
inside the ‘pocket’ of the host is favourable. The advantages of 
hemicarcerands/hemicarceplexes over carceplexes for the encapsulation of species is that 
they do not require the presence of the desired guest during their construction. Subsequently 
the most suitable template molecule may be employed to produce the highest yield possible 
for the hemicarcerand, if the template remains present within, it may be either liberated in 
diphenyl ether (very poor guest) as solvent with heating or applied directly."^ This may most 
advantageously be performed if the desired guest is also a suitable solvent, as the template 
guest may be liberated and replaced by the desired guest. The concentration gradient against
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re-occupation would subsequently allow for the isolation of the desired product. The 
drawbacks of the presence of portals in the design of the hemicarcerand are that once a 
species has been encapsulated into the hemicarceplex it is able to passively diffuse out 
through the portals and may even be replaced.^^’^ ®^'^ ^^  The hemicarcerand: hemicarceplex 
sequence may be interpreted as:
Hemicarcerand + guest (encapsulation) hemicarceplex 
Hemicarceplex -  guest (liberation) -> hemicarcerand
1.16 (D.E) Resorcarene and pyrogallolarene capsules
The first dimer of resorcarene was detailed by Rose et a l with the two resorcarene hydroxyl 
seams held together by hydrogen bonds with propan-2-ol and with a cavity volume o f 230 
(2.3 xlO'^^ cm^).^^  ^ Later work showed that the dimer could also be formed, with the ability 
to encapsulate cationic species with water aiding in the hemisphere j o i n i ng . Sh i va n y u k  and 
Rebek then reported that the formation o f dimeric capsules was possible with pyrogallolarene 
in wet acetonitrile.^^^
The original publication reporting the formation o f hexameric capsules was published in 
Nature by MacGillivray and Atwood in 1997.^^^ A resorcarene hexameric capsule held 
together at the aromatic, hydroxyl seam by intermolecular hydrogen bonds had been created, 
with water aiding the formation o f the hexamer (Fig. 8 ).^^  ^ The conformation o f this was 
likened to that of one o f the 13 Archimedean solids, the snub cube (Fig. 9), with the 6  square 
faces representing the resorcarene, the 8  dark triangles (Fig. 9) representing the water 
molecules.
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Figure 8  A close-up view o f the hydrogen bonds which compose the seam at the ‘edges’ of 
(a) the resorc[4]arene hexamer, where water is also required and (b) pyrogallol[4]arene 
hexamer^ ^^
The level of self-assembly displayed by this supermolecule is remarkable and is able to self- 
assemble around numerous guests with its formation, requiring the establishment o f 60 
hydrogen b o n d s T h i s  is made possible by the homo-complementarity o f the molecule and 
the advantageous water molecules, forming resorc[4]arene6 8 H2 O. X-ray crystallography of 
the hexameric capsules confirmed that the size o f the cavity within is < 1400 (1.4 x 10^^
Shivanyuk and Rebek Jr. continued the research and detailed their findings with 
numerous guests and pendant groups, their paper included their NMR findings and the 
employment o f ROESY (^H NMR 2D correlation spectroscopy) to establish the 
stoichiometry o f the host guest supermolecules produced.
In 1999 Gerkensmeier et al. introduced the pyrogallol[4]arene hexameric capsule, this system 
did not require water to be present to fill in the gaps (as in the above) as the seams were 
entirely complementary and crystals of the hexameric structure were obtained from 
acetonitrile.^^^ The interior space o f the capsule was measured in the solid state to be 1500 
(1.5 X 10’^  ^ cm^), larger than was reported for the resorcarene based h e x a m e r . A t w o o d  
et al were able to characterise the hexamer encapsulating methanol in chloroform-di by 
NMR.*^° A downfield shift for the encapsulated methanol was r e p o r t e d . T h e i r  modelling 
showed agreement with Gerkensmeier for the volume of the hexamer.
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Figure 9 The snub cube on display at The Science Museum, London. The red faces are 
representative o f the pyrogallolarene or resorcarene, the black and blue represent the 
intermolecular seams, in the case o f resorcarene hexamers the black areas are occupied by 
water
A comparison of pyrogallolarene and resorcarene to form hexameric capsules was performed 
with neutral tertiary alkyl amines and charged quaternary alkylamoniums. Resorcarene was 
found to be able to form the hexamer around both species whereas pyrogallolarene was only 
able to form the hexamer around the neutral guests.*^' Later work showed that protonation of 
the guest inside the pyrogallolarene hexamer forced ejection o f the guest from the 
supermolecule.’ Further studies also showed that the pyrogallolarene hexamer possessed 
greater stability in polar solvents than the resorcarene hexamer.’^^ ’’^^  Cave et al. studied the 
effects o f altering the lengths of the alkane chains o f the R group, from C5H 11 to 
Their findings showed that the median length CgHig produced hexameric capsules with a  
smaller internal volume o f ~ 1 2 0 0  ( 1 . 2  x 1 0 '*^  mm^) with the pyrogallolarenes o f longer
and shorter chain length possessing internal volumes o f ~ 1300 A^ (1.3 x lO ’  ^ mm^).’ '^’ The 
reason for the smaller volume was attributed to interactions between neighbouring capsules, 
whereby distortion and twisting of the pyrogallolarenes occur to accommodate the inter-
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capsular hydrogen bonding. Hydrogen bonding inside the hexameric pyrogallolarene capsule 
was studied by Palmer and Rebek, they found that it was possible to encapsulate 
hydrocarbons of increasing length (w-pentane to «-dodecane) within the s y s t e m . T h e  
conclusions drawn were that these molecules could be encapsulated into a pyrogallolarene 
hexamer, however they were not encapsulated in the presence o f preferential guests such as 
c h l o r o f o r m . T h e  authors recognised the importance of the packing coefficient (PC),’^^  
molecules had been found previously to occupy up to 55 % of the available volume (0.55 
PC),’^^  with «-octane reaching the greatest PC of 0.54.’^^
Further information regarding the hexameric capsules can be found in the bibliography (2).
1.17 Research objectives
Presented here is the first (to the authors knowledge) to date wholly guest centric approach to 
encapsulation, especially where the approach has been more than purely academic and the 
guests have been selected for their properties as fuel additives, rather than their molecular 
properties such as size, hydrophobicity or symmetry.
The initial objective of the work was to perform studies related to the cetane improvers (Cl),
here it was rationalised lay the greatest benefits from the production o f the molecular
protection system being developed. As stated the mode of action of the cetane improvers
when combusted as part o f a diesel fuel in a compression-ignition engine, release oxygen
radicals, which assist in propagation of combustion. It was believed that the greatest advances
could be produced from the protection o f the cetane improvers within a host Cl complex.
DTBP and 2-EHN are believed to be the most effective current cetane improvers employed
by the fuel industry. Low doses of them are introduced into almost all diesel fuel blends
because of their efficacy and relative low cost at £ 83.1 Op /I for DTBP and £ 71.80p /I for 2-
EHN.’^^  At a dosage of 0.5 % (v/v) 1 litre of a Cl can treat 2000 litres of diesel. Subsequently
the approximate cost per dose o f both is £ 0.04p /I o f fuel treated. This calculation does not
take into account the likely discounts afforded by the petro-chemical Goliaths, as such these
costs are probably over-estimates by a factor o f ten. Initial experiments were focused on the
introduction of hydrogen bonds between the Cl and ligands. The primary amine ‘N H ’ donor
group was selected for the introduction of complexation through these bonds. Sulphurous
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thiol groups could offer similar complexation abilities however there has been a recent drive 
to reduce sulphur in diesel fuels due to its role in the production of exhaust soot. Also amines 
were selected due to the possible subsequent advantages o f complexes containing nitrogen 
and oxygen when deployed together in fuels.^^
The advantages o f the anti-knock (AK) additives were through their stability as opposed to 
reactivity, affording improved compression characteristics when introduced to a petrol fuel. 
These advantages were also advantageous from the research perspective, as exploited here. 
The AK additives afforded stability when heated which opened up further possibilities for the 
formation of capsules and complexes. Subsequently, increased temperatures could safely be 
applied to these molecules, allowing for the safe implementation of all o f the mentioned 
methods for encapsulation and complexation. This allowed for full laboratory manipulation in 
order to facilitate the formation of an advanced fuel additive, in which complexation affords 
protection when exposed to combustion conditions.
The numerous methods outlined in the pursuit of such molecular entities are detailed in the 
following chapter.
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2.1.1 List of abbreviations
2-EHN 2-Ethylhexyl nitrate
AK Anti-knock
BCD p-Cyclodextrin
BriCHzCl Bromochloromethane
CA Calix[4]arene
CaHz Calcium hydride
CaCb Calcium chloride
CD Cyclodextrin
CDCls Chloroform-d
(CD3)2 C0 Acetone-dô
CD3 OD Methanol-d4
CO Carbon monoxide
COSY correlation SpectroscopY
CP Calix[4]pyrrole
CP(IV) wc50-Tetramethyl-tetra[iV-(2-phenoxyethyl)-A/^’-phenylurea]calix[4]pyrrole
CPK Cory-Pauling-Koltun
CS2 CO3 Caesium carbonate
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c v Cavitand
A8 Change in chemical shift (ppm)
8 Chemical shift (ppm)
D2 O Deuterium oxide, heavy water
DCM Dichloromethane
DEPT Distortionless Enhancement by Polarisation Transfer
DMF A,A-Dimethylformamide
DMSO Dimethyl sulfoxide
DTBP T>i-tert-\mty\ peroxide
EtOAc Ethyl acetate
FAMEs Fatty Acid Methyl Esters
HC Hydrocarbon
H2 O2 Hydrogen peroxide
HCl Hydrochloric acid
HC Hydrocarbon
HD Hemicarcerand
Hex «-hexane
HMBC Heteronuclear Multiple Bond Correlation
HPLC High Performance Liquid Chromatography
HSQC Heteronuclear Single Quantum Correlation
Hz Hertz
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ID Identification
J Coupling constant
L1AIH4 Lithium aluminium hydride
MALDI MS Matrix Assisted Laser Desorption Ionisation ]\
MeCN Acetonitrile
MeOH Methanol
MgS0 4 Magnesium sulphate
m/z Mass to charge ratio
NaOH Sodium hydroxide
Na2 S0 4 Sodium sulphate
Na2S20s Sodium metabisulphite
NNDMA A^A-dimethylaniline
NMA A-Methylaniline
NMR Nuclear Magnetic Resonance
NMP A-methyl-2 -pyrrolidone
NOESY Nuclear Overhauser Effect SpectroscopY
NOx Nitric oxide (NO) and nitrogen dioxide (NO2 )
PA Pyrogallol[4]arene
PM Particulate matter
P4 O 10 Phosphorous pentoxide
ppm Parts per million
Experimental
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Pyrogallol 1,2,3-Trihydroxybenzene
RA Resorc[4]arene
Resorcinol 1,3-Benzenediol
ROESY Rotating frame Overhauser Effect SpectroscopY
Soi. Solvent
TEA Triethylamine
TEL Tetraethyl lead
THAM T ris(hydroxymethyl)aminomethane
THF T etrahydrofuran
TLC Thin Layer Chromatography
TMS T etramethylsilane
UV-VIS Ultraviolet-visible
Number
2.1.2 Nomenclature of macrocycles
It has become convention to refer to calix[4]arene 25, 26, 27, 28 tetrol (Fig. lO.a) as 
calix[4]arene, which is incorrect. This has occurred because o f the distinction that has been 
made from the notable derivatives, calix[4]arene 4, 6 , 10, 12, 16, 18, 22, 24 octol 
(resorc[4]arene) (Fig lO.b) and calix[4]arene 4, 5, 6 , 10, 12, 13, 16, 17, 18, 22, 23, 24 dodecol 
(pyrogallol[4]arene) (Fig. lO.c). All of the structures are derived physically (if not 
synthetically) from calix[4]arene (Fig lO.d) and as such the proper nomenclature refers to this 
foundation.
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(d)OH
HO. .OH
OH
Calix[4]arene 25,26,27,28 tetrol Resorc[4]arene Pyrogallol[4]arene Calix[4]arene
Figure 10 The chemical structures of: (a) calix[4]arcnc 25, 26, 27, 28 tetrol, (b) 
resorc[4]arene, (c) pyrogallol[4]arene and (d) calix[4]arene
Within the work the terms resorcarene and resorc[4]arene are preferred to the alternative 
resorcinarene, resorcin[4] arene and calix[4]resorcinarene for convenience. Also 
pyrogallolarene and pyrogallol[4]arene are preferred over all o f the hydroxy- variants o f the 
above, pyrogarene and pyrog[4]arene are noted here as (possibly) superior alternatives to 
convention, which will be adhered to. All o f the calix variants described within this thesis 
refer to the n = 4 variant, some early work involving: calix[6 ]pyrrole and calix[6 ]arene was 
attempted but was abandoned due to the complexity o f the synthesis of calix[6 ]pyrrole which 
failed to yield the target compound and the overly-flexible nature o f the 
calix[6 ]arene.^^^’^ ^^ ’^ '^  ^This is the only mention within where [n] equals anything other than 4, 
experimentally.
2.1.3 Nomenclature of hemicarcerands, hemicarceplexes, carcerands and 
carceplexes
The nomenclature outlined by Cram et is employed throughout. Here the terms spanner 
and spanning group are used to define the intrahemispheric group introduced to facilitate a 
eavitand molecule and increase its structural rigidity. The terms bridger and bridging group 
are used to define the groups introduced to facilitate the production of a hemicarcerand or 
carceplex. This nomenclature is detailed in Figure 11 and follows the reasoning that groups 
'span' between hydroxyls of the same molecule and 'bridge' between hydroxyls o f different 
molecules (hemispheres).
34
2. Experimental
*1) Bridging group, 
Interhemispheric
*2) Spanning group 
Intrahemispheric
*3) Encapsulated species
R) pendant arm group
R
Figure 11 The general structure and nomenclature for a (hemi)carcerand/(hemi)carceplex
2.1.4 NMR
For reporting NMR data the following abbreviations are used: ‘s’ denotes a singlet, ‘d ’ 
denotes a doublet, ‘t ’ denotes a triplet, ‘q’ denotes a quartet and ‘m ’ denotes a multiplet (of 
multiplicity greater than 4). The prefix ‘b,’ is used to signify that the signal peak is broad. 
The sum of the peaks for doublets and quartets are divided by the number o f peaks to define 
the centre point for the reported 8  (ppm) value, the central peak o f triplets is chosen.
In the case of cavitands, the O-CH2 -O spanning groups produce two doublet signals when 
analysed by NMR. This is because the two hydrogens attached to this carbon sit either 
inside or outside of the bowl of the cavitand. Consequently the two hydrogens are in two 
different environments, causing them to split each other in terms of NMR. This can be 
visualised in Figure 12. The outer proton is always found downfield of the inner proton when 
analysed by NMR. There is a similar case in calixarene chemistry, where the protons 
attached to the bridging groups o f the calixarene structure appear in either the axial or 
equatorial position. This can be visualised in Figure 13. In this case it is possible to determine 
the conformation o f the calixarene by assessing the difference between the chemical shifts of 
the axial and equatorial protons, Aôax-eq? as the axial proton (higher ppm) always appears 
downfield o f the equatorial proton (lower ppm) when analysed by NMR.^"^  ^ The figures 
can vary between solvent but for a perfect ‘cone’ conformation a Aôax-eq of 0.90 ppm is 
e x p e c te d .I t  is possible to confirm that this is the case (that the two protons are attached to
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the same carbon atom) by performing HSQC DEPT NMR, where the two signals show 
correlation with the same carbon atom.
Inner
Outer
Figure 12 Energy minimised molecular model o f the structure o f a cavitand
I
Equatorial
Axial
Figure 13 Energy minimised molecular model o f /?-/er/-butyl-calix[4]arene, rendered in ball- 
stick
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The numbering as detailed in the figures within for NMR purposes are simplified so as to 
describe Va or of the molecule being analysed, the repeating units in the cyclic system 
producing equal and cumulative signals. As such the numbering is inconsistent with the 
molecules in their entirety and is a simplified representation consistent with the signals 
produced of equal halves or quarters o f the macrocycles described.
2.2 List of reagents
2-Butanol, Fisher Scientific, 99+ % (GLC), 10438400.
2-Ethoxyethanol, Sigma-Aldrich, 99 %, 128082.
2-Ethylhexyl nitrate, Sigma-Aldrich, 97 %, 293784.
4 ’-Hydroxyacetophenone, Fluka, purum >98.0 % (HPLC), 54180.
18-Crown-6, Sigma-Aldrich, 99 %, 18665-1.
-Dichloro-w-xylene, Sigma-Aldrich, >98 % (GC), 36580.
Acetic acid, Fisher Scientific, glacial analytical reagent grade 99.7+ %, A/0400/PB17. 
Acetone, Sigma-Aldrich, >99 % (GC), 24201.
Acetone-dô, Fluka, puris D, >99.5 %, 52380.
Acetonitrile, Fisher Scientific, 99.6+ % (HPLC), A/0626/17.
Acetonitrile-ds, Cambridge Isotope Laboratories, D 99.8 % + 0.05 % TMS, DLM-21TB-10. 
Aniline, Sigma-Aldrich, 99 %, 139234.
P-Cyclodextrin, Sigma-Aldrich, >97 %, C4767.
Bromine, Sigma-Aldrich, 99+ %, 20788-8.
Bromoacetonitrile, Sigma-Aldrich, 97 %, 242489.
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Bromochloromethane, Sigma-Aldrich, 99 %, 13526-7.
Caesium carbonate, Sigma-Aldrich, 99 %, 44190-2.
Calcium chloride, Fisher Scientific, anyhydrous, C/1400/62.
Chloroform, Fisher Scientific, 99+ %, C/4920/17.
Chloroform-d, Cambridge Isotope Laboratories, D 99.8 %, TMS +0.05, DLM-7TB-10. 
Deuterium oxide, Cambridge Isotope Laboratories, D 99 %, DLM-4-99-10.
Dibromomethane, Sigma-Aldrich, 99 %, D41686.
Dichloromethane, Sigma-Aldrich, >99 % (GC), 24233.
Diethyl ether, Fisher Scientific, 99+ % (GC) D/2400/17.
Dimethyl sulfoxide, Fisher Scientific, 99+ % (GC), D/4120/PB08.
Dimethyl sulfoxide, Sigma-Aldrich, ACS reagent, >99.9 %, 472301.
Dimethyl sulfoxide-dô, Cambridge Isotope Laboratories, D 99.9 %, +1 % TMS, DLM-10-10. 
Ethanol, Fisher Scientific, 95 %, 10040602.
Ethanol, Fisher Scientific, 99.8+ % (GLC), 10000652.
Ethyl acetate, Fisher Scientific, 99+ %, E/0850/17.
Ethylene glycol, 99+ %, Acros Organics, 146750010.
Guanidine hydrochloride, Acros Organics, 98 %, 120230250.
Hexacyclen, Sigma-Aldrich, purum >97 %, 52045.
Hexanal, Sigma-Aldrich, 98 %, 11560-6.
Hexane, Fisher Scientific, fraction from petroleum, H/0350/17.
Hexane, Fisher Scientific, 95 % (HPLC), H/0406/17.
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Hydrochloric acid, Fisher Scientific, 35-38 %, H/1150/PB17.
Hydrogen peroxide, Fisher Scientific, >30 % w/v, H/1750/15.
Iodine, Sigma-Aldrich, ACS reagent >99.8 %, 207772.
Kryptofix 22, Sigma-Aldrich, >96 %, 29580-9.
Kryptofix 222, Acros Organics, 98 %, 291950010.
Lithium aluminium hydride, Sigma-Aldrich, 95 %, 19987-7.
Magnesium sulphate, Fisher Scientific, 99+ %, 10264630 
Methanesulfonic acid, Sigma-Aldrich, >99.5 %, 471356.
Methanol, Fisher Scientific, analytical reagent grade 99.9+ %, M/4000/PC17.
Methanol-d4 , Cambridge Isotope Laboratories, D 99.8 %, +0.05 % TMS, DLM-24TB-10. 
A^-Bromosuccinimide, Sigma-Aldrich, 99 %, B81255. 
w-Butyllithium 2.5 M in hexane, Sigma-Aldrich, 230707.
#-Methylaniline, Fluka, >98 % (GC), 65760.
27-Methyl-2-pyrrolidinone, Acros Organics, 99 %, 10773891.
A^A-Dimethylaniline, Sigma-Aldrich, 99 %, 515124.
A/A-Dimethylformamide, Sigma-Aldrich, anhydrous 99.8 %, 22705-6. 
A(A/^ ’-Dimethylethylenediamine, Sigma-Aldrich, >98 %, 39030.
/ 7-^erAButylcalix[4 ]arene, Sigma-Aldrich, >97 % (HPLC), 19721.
/ 7-Toluenesulfonyl chloride, Sigma-Aldrich, >98 %, >98 %, T3595-5.
Phenol, Sigma-Aldrich, >99 %, 328111.
Phenyl isocyanate, Sigma-Aldrich, >98 %, 18535-3.
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A^-Phenylurea, Sigma-Aldrich, 97 %, 64-10-8.
Phosphorus pentoxide, Sigma-Aldrich, 79610.
Potassium carbonate, Fisher Scientific, 99+ %, P/4080/53.
Potassium hydroxide, Fisher Scientific, 8 6 + %, P/5640/53.
Pyrazine, Acros Organics, 99+ %, 10735621.
Pyrogallol, Sigma-Aldrich, >99 %, 16040.
Pyrrole, Sigma-Aldrich, reagent grade 98 %, 13170.
Resorcinol, Sigma-Aldrich, 99 %, 30752-1.
Silica 60 A, Fisher Scientific, 40-63 pm, S/0698/53.
Sodium bisulfite, Sigma-Aldrich, 99 %, S-9000.
Sodium chloride, Fisher Scientific, 99.5+ %, S/3120/65.
Sodium hydride, Sigma-Aldrich, 95 %, 223441.
Sodium hydroxide, Fisher Scientific, analytical reagent grade 98+ %, S/4920/53.
Sodium sulphate, Fisher Scientific, 99+ % (anhydrous), S/6600/53. 
rerAButyllithium 1.7M in pentane, Sigma-Aldrich, 186198. 
tert-Quiy\ peroxide, Sigma-Aldrich, 98 %, 168521.
Tetrahydrofuran, Fisher Scientific, 99.8+ % (HPLC), T/0706/PB17.
Triethylamine, Sigma-Aldrich, >99.5 %, 471283.
Triethylamine hydrochloride, Sigma-Aldrich, 98 %, T7276-1.
Trimethylborate, Acros Organics, 99 %, 140121000.
Tris(hydroxymethyl)aminomethane, Sigma-Aldrich, >99.8 %, 252859.
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Urea, Sigma-Aldrich, 98+ %, U5378.
2.3 Purification of reagents
2.3.1 Acetonitrile
Acetonitrile^"^ (MeCN), HPLC grade was placed over calcium hydride (CaH]) in a single­
necked round-bottomed flask, fitted with a reflux condenser, collecting bulb and Drechsel top 
attached to a dry N 2  line. The suspension was refluxed for 1 hour before collecting and stored 
over molecular sieve.
2.3.2 Tetrahydrofuran
Tetrahydrofuran^"^^ (THF) was pre-stored in a Winchester bottle containing sodium wire 
before being transferred to a single-necked round-bottom flask equipped with a reflux 
condenser, collecting bulb and Drechsel top, connected to a dry N 2 line. To the THF was then 
added freshly prepared sodium wire and benzophenone, the suspension was refluxed for 1 
hour or more until the colour of the solution had become a deep purple. The solvent was then 
collected, stored over molecular sieve and sealed until use.
2.3.3 Dimethylsulfoxide
Dimethylsulfoxide^^ (DMSO) was dried overnight in the presence of magnesium sulphate 
(MgSÜ4) then filtered gravitationally and stored over activated 4 Â molecular sieve.
2.3.4 iV,A-dimethylformamide
A(A-dimethylfbrmamide^^ (DMF), HPLC grade was dried over activated 4 Â molecular sieve 
for a period o f 24 hours or more prior to use.
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2.4 Synthesis of macrocycles
2.4.1 (A) Synthesis of 5, 11, 17, 23-tetra-/grt-butyl, 25, 27- 
bis(oxyethylphenylurea), 26, 28-dihydroxycalix[4]arene, CA(III)
A three step procedure for the synthesis o f 5, 11, 17, 23-tetra-tert-buty\, 25, 27 
bis(oxyethylphenylurea), 26, 28-dihydroxycalix[4]arene (CA(III)) was devised, based on 
previous beginning with the synthesis of the initial intermediate 5, 11, 17, 23-
tetra-/er/-butyl, 25, 27-bis(oxyethylnitrile), 26, 28-dihydroxycalix[4]arene CA(I), described 
below.
2.4.1.1 (A) Synthesis of intermediate 5, 11, 17, 23-tetra-tgrt-bntyl, 25, 27 
bis(oxyethylnitrile), 2 6 ,28-dihydroxycalix[4]arene, CA(I)
The initial step in the procedure required for the functionalisation of the parent p-tert- 
butylcalix[4]arene was the production o f intermediate CA(I), as shown in Scheme 7.
O
j9 -/err-butylcalix[4 ]arene
CHsCN
18-crown-6
O O
Scheme 7 Synthetic procedure for the preparation of CA(I) from j9 -^er/-butylcalix[4 ]arene
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To a flame dried three-necked round bottom flask (500 ml), equipped with a thermometer, 
reflux condenser, Drechsel bottle head, magnetic stirrer and dropping funnel in an inert N 2 
environment was placed /?-^er^butylcalix[4]arene (5.03 g, 7.8 mmol), 18-crown-6 (0.53 g, 2.0 
mmol), K2 CO3 (9.04 g, 65 mmol), dissolved in freshly distilled acetonitrile (200 ml) and the 
mixture was stirred at ambient temperature for 1 hour. Then bromoacetonitrile (4.1 ml, 59 
mmol) (extreme irritant: gloves necessary) was dissolved in dry acetonitrile ( 2 0  ml) and 
added drop-wise to the stirring solution. The dropping funnel \yas flushed with additional dry 
acetonitrile (10 ml) and replaced with a stopper. Vigorous stirring was applied and the 
temperature was raised to 75 °C with a silicon oil bath and refluxed. The reaction was 
monitored by TLC, with a «-hexane : EtOAc, 4:1, v/v mixture as the mobile phase and 
developed under iodine. After 24 hours no further evolution was apparent in the TLC plates 
and so the reaction was allowed to cool to room temperature whilst stirring. The contents of 
the vessel were then transferred to a single-neck round-bottom flask and the solvent was 
removed in vacuo to reveal a dark brown viscous oil. Addition of methanol (5 ml, 0 °C) and 
treatment by sonication in ice-water was required to break the oil; a yellow-brown solid 
precipitated which was retrieved by sintered funnel filtration under vacuum. The solid was 
twice washed with further methanol (0 °C, 5 ml), then dried in a vacuum oven at 90 °C.
Yield: 3.82 g, 6 8  %, 5.25 mmol.
NMR (300 MHz, in CDCI3); 5 (ppm); 7.119 (s, phenoxyacetonitrile Ar-H, 4H), 6.725 (s, 
phenol Ar-H, 4H), 5.560 (s, OH, 2H), 4.809 (s, O-CH2 -C, 4H), 4.224 (d, CH 2_ax, 4H), 3.448 
(d, CH 2 -eq, 4H), 1.325 (s, phenoxyacetonitrile CH 3 , 18H), 0.878 (s, phenol CH 3 , 18H).
Aôax-eq: 0.776 ppm, distorted cone conformation.
2.4.1.2 (A) Synthesis of intermediate 5, 11, 17, 23-tetra-tert-butyl, 25, 27- 
bis(oxyethylamine), 2 6 ,28-dihydroxycalix[4]arene, CA(H)
Step 2 in the production of CA(III) required the reduction of the nitrile group to a primary 
amine, to form intermediate 5, 11, 17, 23-tetra-ter^-butyl, 25, 27-bis(oxyethylamine), 26, 28- 
dihydroxycalix[4]arene CA(II) (Scheme 8 ), using a modification to the known 
procedure.
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THF
2
OH O OH O
CA(I) CA(II)
NH
Scheme 8  Synthetic procedure for the production of CA(II) from CA(I)
A three-necked round-bottom flask (500 ml) was flamed dried and equipped with a 
thermometer, magnetic stirrer, reflux condenser and Drechsel bottle head with dry N 2 , freshly 
distilled THF (50 ml) at 0 °C was introduced and the vessel was surrounded by an ice jacket. 
The temperature (0 °C) was ensured and LiAlH4  (1.2 g, 32 mmol) was added and dissolved 
by stirring, CA(I) (3.82 g, 5.25 mmol) was then introduced portion-wise and the temperature 
maintained. The reaction was monitored by TLC with a «-hexane : EtOAc, 4:1, v/v mixture 
as the mobile phase and the plates were developed under iodine. After 4 hours o f continuous 
stirring at 0 °C the reaction was halted with the addition of aqueous NaOH (10 ml, 20 % 
w/v), followed by distilled water (10 ml), forming a white precipitate. The solution was 
filtered gravitationally, then MgS0 4  was added to the filtrate and the suspension was filtered 
gravitationally, the solvent was then removed under reduced pressure to reveal a milky 
yellow solid. The solid was extracted with methanol at 0 °C, reclaimed by sintered funnel 
filtration under vacuum and dried in a vacuum oven at 90 °C.
Yield: 1.65 g, 41 %, 2.245 mmol.
^H NMR: (300 MHz, in CDCI3); 5 (ppm); 6.842 (s, phenoxyethanamine Ar-H, 4H), 6.717 (s, 
phenol Ar-H, 4H), 4.122 (d, CHz ax, 4H), 3.878 (t, O-CH2-CH2, 4H), 3.176 (d, CH2-eq, 4H), 
3.122 (t, CH2-CH2-NH2, 4H), 1.051 (s, phenoxyethanamine CH3, 18H), 0.910 (s, phenol 
CH3, 18H).
Aôaq-eq: 0.946 ppm near-perfect cone conformation.
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2.4.1.3 (A) Synthesis of CA(III) from interm ediate CA(II)
The final product CA(III) (5, 11, 17, 23-tetra-fer^butyl, 25, 27-bis(oxyethylphenylurea), 26,
28-dihydroxycalix[4]arene) was then produced from intermediate CA(II) with the addition of 
phenyl isocyanate.
OH O
DMF
1
Phenyl isocyanate
OH O
Scheme 9 Synthetic procedure for the production of CA(III) from intermediate CA(II)
A flame dried three-necked round-bottom flask (250 ml) was equipped with a magnetic 
stirrer, reflux condenser, dropping funnel and Drechsel bottle top fitted to a dry N 2  line and 
bubbler. CA(III) 1.65 g (2.15 mmol) dissolved in dry DMF (100 ml) was added to the flask 
and stirring was applied. Phenyl isocyanate (0.93 ml, 8.56 mmol) was dissolved in 25 ml o f 
additional dry DMF and added dropwise to the solution over a period o f an hour and half. 
The dropping funnel was flushed with dry DMF (5 ml) and replaced with a stopper. The 
reaction was allowed to stir at ambient temperature and monitored by TLC with a mixture of 
DCM : methanol (99:1, v/v) as the mobile phase and developed under iodine. The reaction 
was allowed to run under these conditions for eight days (192 hours), after which time the 
solvent was removed in vacuo and the resulting oil was broken with methanol chilled to 0 °C, 
in an ice-water ultrasonic bath. The fine white precipitate was obtained by sintered funnel 
filtration with careful progressive application of vacuum as required. Recrystallisation o f the 
precipitate by slow evaporation was required to yield the pure product from a DCM :
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methanol mixture (5:2, v/v), the product was then collected by sintered funnel filtration and 
dried under vacuum at 90 °C.
Yield: 0.871 g (0.895 mmol, 42 %)
'H  NMR: (500 MHz, in CDCI3); 6  (ppm); 8.755 (b,s, Ar-NH, 2H), 7.245 (s, Ar-H, 4H), 7.198 
(t, Ar-H, 4H), 7.128 (t, Ar-H, 4H), 7.071 (s, Ar-H, 4H), 7.013 (s, Ar-H, 4H) 6.977 (t, Ar-H, 
2H), 6.776 (b,s, NH, 2H), 4.240 (d, CRax, 4H), 4.112 (t, O-CH2 , 4H), 3.858 (t, N-CH 2 , 4H), 
3.426 (d, CReq, 4H), 1.257 (s, CH 3 ,18H), 1.120 (s, CH 3 , 18H).
Aôax-eq: 0.814 ppm, near-perfect cone conformation.
Mass spectrometry: Calculated mol. weight: 973.31
TOP ES+ MW: 995.58 (as sodium adduct) corrected mass: 973.60.
2.4.2 (B.C.D) Resorcarene synthesis
Resorcarene was the initial macrocycle, from which the resulting container molecules were 
p rep a red .^ T h e  resorcarene synthesis was performed with a number o f aldehydes each of 
which contained a pendant arm group (0=C-R), R which varied but was a hydrocarbon in all 
instances. Alterations to these R groups have been shown to effect solubility. Three 
compounds in all were used in this work to functionalise the initial resorcarene (and impart 
any additional properties onto the latter products), these were; hexanal (vide infra), undecanal 
and hydrocinnamaldehyde.
2.4.2.1 (B.C.D) M icrowave assisted resorcarene synthesis of 2, 8 , 14, 20- 
tetra-pentyl-resorc[4]arene, RA(I)
‘Green’ techniques must always be employed where available due to their numerous 
ad v an tag es ,a ttem p ts  at employing hydrocinnamaldehyde as the aldehyde in this way were 
unsuccessful, undecanal was not attempted (see results and discussion). Outlined in Scheme 
10 is the synthetic procedure employed to yield 2, 8 , 14, 20-tetra-pentyl-resorc[4]arene (4, 6 ,
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10, 12, 16, 18, 22-octahydroxyl, 2, 8 , 14, 20-tetrapentylcalix[4]arene), RA(I) with
modifications to that devised by Hedidi et al. 152
H O . OH
Resorcinol
Hexanal
2-etho}Q^ethanol
OHHO.
RA(I)
Scheme 10 Microwave assisted resorcarene synthesis for the production o f RA(I)
The microwave ‘CEM: Mars Xpress Xtraction’ was employed for the synthesis, which was 
performed in duplicate microwavable tubes of restrictive volume ( 1 0 0  ml), forcing 
duplication for suitable mass yield. Into each tube was placed resorcinol (5 g, 45 mmol) and 
hexanal 5.5 ml (4.53 g, 45 mmol). To each tube was then added a solution o f hydrochloric 
acid 9.1 ml (12M) and 2-ethoxyethanol (9.1 ml). A reaction occurred immediately in the 
vessels, producing a thick yellow foam. The tubes were sealed and placed inside the 
microwave, pre-programmed to the desired temperature (80 °C), with a 3 minute ramp time, 
followed by a 3 minute run at 100 Watts, then cooled for 5 minutes followed by further time 
after ejection in an ice-water bath before the lids were removed. The contents were filtered by 
sintered vacuum filtration and washed with ice-cold distilled water to yield an orange 
precipitate, which was dried in vacuo at 80 °C.
Yield: 16.55 g (95.64 %, 21.52 mmol)
'H  NMR; (500 MHz, in (CD3)2CO); 5 (ppm); 7.539 (s. Ar-H, 4H), 6.238 (s, Ar-H, 4H), 4.294 
(t, CH, 4H), 2.397 (m, CHj, 8 H), 1.337 (m, CHz, 24H), 0.890 (m, CH 3 , 12H).
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2A.2.2 (B.C.D) Reflux method for resorcarene synthesis: RA(I)
H O . OH
Resorcinol
YhOEtOU
Hexanal
HO, OH
RA(I)
Scheme 11 Acid catalysed resorcarene (RA(I)) synthesis in water/ethanol under reflux
Resorcinol, 6 6 g (599 mmol) was placed into a flame dried 1 litre, three-necked round-bottom 
flask, equipped with a magnetic stirrer, thermometer and dropping funnel and placed in an 
ice-water bath. A solution of distilled water and ethanol (124 ml, 1:1, v/v), was added to the 
flask, stirring was applied and the temperature was monitored. An additional solution of 
distilled water, ethanol and hydrochloric acid (12 M), (1:1:1, v/v, 186 ml) was prepared and 
placed to cool in an ice-water bath. Once the reaction vessel had reached 0 °C the H2 O : 
EtOH : HCl solution was inserted into the dropping funnel and added drop-wise to the 
stirring solution, with the flow monitored and adjusted to keep the reaction vessel 
temperature at 0 °C. Once the contents of the dropping funnel were exhausted it was then re­
charged with hexanal (72.73 ml, 60.0 g, 599 mmol), which was added drop-wise to the 
reaction vessel with the temperature maintained at 0 °C. Following the complete hexanal 
addition the vessel was removed from the ice bath, which was replaced with a silicon oil bath 
and allowed to warm gently to ambient temperature, whilst stirring without the application of 
heat for 1 hour. The temperature was then increased and the reaction set to reflux at 80 °C for 
16 hours. The heat was then removed from the reaction, which was then allowed to cool 
gradually to ambient temperature, followed by submersion o f the vessel into an ice-water 
bath. The product was filtered directly from the reaction vessel by sintered funnel vacuum 
filtration and washed with ice-cold distilled water and ethanol 1 : 1  (v/v) to yield a yellow- 
orange precipitate, which was dried in vacuo at 80 °C.
Yield: 106.4 g (92.39 %, 138.36 mmol)
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^HNMR: (500 MHz, in (CD3)2 CO); Ô (ppm); 7.539 (s, Ar-H, 4H), 6.238 (s, Ar-H, 4H), 4.294 
(t, CH, 4H), 2.397 (m, CHz, 8 H), 1.337 (m, CH], 24H), 0.890 (m, CH 3 , 12H).
2.4.2.S (B.C) Brom ination of resorcarene (RA(I)) with brom ine in acetic 
acid to yield RA(H)
The procedure for the addition o f bromine to RA(I) was based on the bromination of phenol 
as described by Fumiss et al. The procedure was modified to yield 2, 8 , 14, 20-tetra-pentyl, 
5, 11, 17, 23-tetrabromoresorc[4]arene (4, 6 , 10, 12, 16,18, 22, 24-octahydroxyl, 5, 11, 15, 
23-tetrabromo, 2, 8 , 14, 20-tetrapentylcalix[4]arene), RA(II) is outlined in Scheme 12.
Br
HO. OH
+  2 BP2
Acetic acid
OHHO,
Scheme 12 Bromination of resorcarene to RA(II) with bromine in acetic acid
RA(I), (16.55 g, 21.52 mmol) was placed in a 1 litre round-bottom flask equipped with a 
magnetic stirrer and reflux condenser fitted with a CaCl] tube and dissolved in 700 ml of 
acetic acid. Following heating with stirring to reflux for 20 minutes, the heat was removed 
and the solution allowed to cool to ambient temperature. The reflux condenser was removed 
and bromine ( 6  ml, 96 mmol) dissolved in 15 ml additional acetic acid was added slowly to 
the reaction vessel. The solution was then allowed to stir for 2 hours at ambient temperature. 
The reaction was stopped by slowly pouring the contents o f the reaction vessel into two 800 
ml beakers (equipped with large magnetic stirrers) containing -350 ml distilled water under 
stirring. The contents of the beakers were then filtered by sintered funnel vacuum filtration
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and multiple washings with distilled water to remove the acid and were performed until the 
filtrate became clear. The brown product was then extracted and dried in vacuo at 90 °C.
Yield: 5.94 g (5.48 mmol, 25.8 %)
‘H NMR: (500 MHz, in (CD3)2CO); 8  (ppm); 7.620 (s. Ar-H, 4H), 4.437 (t, CH, 4M), 2.300 
(m, CHz, 8 H), 1.309 (m, CH;, 24H), 0.850 (m, CH3, 12H).
2.4.2.4 (B.C) Brom ination of resorcarene (RA(I)) w ith N-
bromosuccinimide in 2-butanol to yield RA(II)
The procedure for the bromination of resorcarene was based on that outlined by Kass et 
and is displayed in Scheme 13.
HO. OH
+ 4 o
2-butanone
25 °C
Y-bromosuccinamide
HO. OH
Scheme 13 Bromination of resorcarene to RA(II) with iV-bromosuccinimide in 2-butanone
RA(I), (104.64 g, 136.07 mmol) was dissolved in 2-butanone (650 ml) in a 1 litre single-neck 
round-bottom flask equipped with a magnetic stirrer. RA(I) was allowed to stir until 
dissolved, then Y-bromosuccinimide (145.23 g, 815.99 mmol) was added slowly and portion 
wise to the solution. The solution was allowed to stir for 4 hours, then cooled to 0 °C in an 
ice-water bath along with a vessel of further 2-butanone for washing. The product was then 
collected by sintered funnel filtration under vacuum in the fume hood and washed with the
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minimum quantity of ice-cold 2 -butanone possible to yield a white solid, which was dried in 
vacuo at 80 °C.
Yield: 109.66 g (101.11 mmol, 74 %)
'H  NMR: (500 MHz, in (CD3)2CO); 8  (ppm); 7.620 (s, Ar-H, 4H), 4.437 (t, CH, 4H), 2.300 
(m, CH2 , 8 H), 1.309 (m, CH2 , 24H), 0.850 (m, CH 3 ,12H).
2.4.3 (B.C) Cavitand synthesis: 4, 24- 6, 10- 12, 16- 18, 22- 
tetramethylenedioxy, 5, 11, 17, 23-tetrabromo, 2, 8, 14, 20-
tetrapentylcalix[4]arene, CV(I)
Multiple techniques for the synthesis o f cavitands were required due to progressive safety 
considerations. These forced a halt to the use o f pressure tubes and also the withdrawal from 
sale of bromochloromethane due to its ozone depleting properties. The employed syntheses 
are detailed below.
2.4.3.1 (B.C) Pressure tube cavitaud synthesis: CV(I)
The 4, 24- 6 , 10- 12,16- 18,22-tetramethylenedioxy, 5, 11, 17, 23-tetrabromo, 2, 8 , 14, 20- 
tetrapentylcalix[4]arene, CV(I) was synthesised from RA(II) using the procedure outlined by 
Roman et where the induction of pressure by sealing the reaction vessel tubes increases 
the boiling point of the reactants and subsequently increases yield. The synthetic procedure 
inside the pressure tubes is outlined in Scheme 14. Pressure tube cavitand syntheses were 
always performed in duplicate, in order to maximise the throughput and equipment available.
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HO, OH
RA(II)
+ 4Br' DMSO, 80 °C
CS2CO3
-* 4 Bromochloromethane
CV(I)
Scheme 14 Synthetic procedure for the production o f CV(I) utilising pressure tubes
Into a pair o f Ace pressure tubes (back seal bushing type, 100 ml) each equipped with a 
magnetic stirrer was placed RA(II) (4 g, 3.69 mmol), CS2CO3 (4 g, 12.28 mmol), 
bromochloromethane ( 8  ml, 15.93 g, 123.13 mmol) and DMSO (80 ml). The vessels were 
sealed, shaken, vortex mixed and sonicated, the resulting pressure from which was then 
released. The vessels were then re-sealed and placed into separate silicon oil baths at 80-90 
°C and heated with stirring applied for 5 hours. Following this period the vessels were 
removed from the oil and placed into a beaker under running cold water for 30 minutes, the 
vessels were opened carefully in the fume hood and the contents poured into ice-cold water 
(400 ml), the product precipitated and was collected by sintered funnel filtration under 
vacuum and washed with further ice-cold water then dried in vacuo at 80 °C.
Yield: 3.98 g (3.51 mmol, 95 %)
‘H NMR: (500 MHz, in (CD3)2CO); 5 (ppm); 7.642 (s, Ar-H, 4H), 6.000 (s, 0-C H , 4H),
4.840 (t, CH, 4H), 2.397 (m, CHz, 8 H), 1.377 (m, CH 2 , 24H), 0.972 (m, CH 3 , 12H).
2.4.3.2 (B.C) Bromochloromethane, reflux cavitand synthesis: CV(I)
Following issues regarding the safety of the pressure vessels it was necessary to employ an 
alternative method for the production o f CV(I), the required reagents were identical to those 
described above but the synthesis was performed under reflux instead of in pressure vessels.
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As a consequence the expected yields were far lower and additional steps for purification 
were required, subsequently the method was built upon the work of various groups to 
produce the most efficient synthesis. As such the method described below and outlined in 
Scheme 15 was based upon the work o f Roman et al}^^ (pressure tube synthesis), Cram et 
al}^'^ (original cavitand synthesis) and employed the Soxhlet extraction technique of Kass et
+ 4 Br ^ci DMSO, 70 « C
CS2CO3
4 Bromochloromethane
CV(I)
Scheme 15 Reflux synthesis of CV(I)
A 1 litre, three-necked round bottom flask, immersed in a silicon oil bath and equipped with a 
thermometer, magnetic stirrer, reflux condenser and attached to a dry N 2  line was assembled. 
The system was flushed with nitrogen and to the flask was added RA(II) (56.4 g, 52.00 
mmol), DMSO (800 ml), CS2 CO3 (40 g, 122.77 mmol) and bromochloromethane (28 ml, 
55.75 g, 430.89 mmol), stirring was induced and heating was applied and the reaction was 
allowed to reflux at 70 °C. The progress of the reaction was monitored by TLC in a 4:1 DCM 
: «-hexane mixture. After 72 hours no further changes were identified by TLC, subsequently 
the vessel was removed from the oil and allowed to cool. The contents of the reaction vessel 
were poured portion-wise into a 1 litre beaker half-filled with distilled water, the precipitate 
was collected by sintered funnel vacuum filtration and dried under vacuum at 80 °C. The 
brown solid was then loaded into an extraction thimble and subjected to Soxhlet extraction in 
a 9:1 «-hexane : EtOAc mixture for 10 hours. Rotary evaporation of the solvent yielded a 
white crystalline solid.
Yield: 27.13 g (23.95 mmol, 46.06%)
53
2.______________________________________________________   Expérimental
‘h  NMR: (500 MHz, in (CD3)2CO); 8  (ppm); 7.642 (s, Ar-H, 4H), 6.000 (s, 0-C H , 4M),
4.840 (t, CH, 4M), 2.397 (m, CHz, 8 H), 1.377 (m, CHz, 24H), 0.972 (m, CH;, 12H).
2.4.3.3 (B.C) D ibrom om ethane, reflux cavitand synthesis: CV(I)
The removal from market o f bromochloromethane {vide supra)^^^ required a new method of 
synthesis of CV(I) to be devised. For containers with longer bridging structures ditosylates 
are regularly used/^^'^^^ which cannot be used to yield CV(I) due to the unavailability o f the 
required ditosylate and the difficulties in its production, as the required diol (methylene 
glycol) is unavailable also.
Br
HO, OH
RA(I)
4
4 Dibromomethane
DMSO, 100 °C
CaiCO]
CV(I)
Scheme 16 Synthesis o f CV(I) under reflux with dibromomethane
To a 1 litre, three-necked round-bottom flask, equipped with a thermometer, magnetic stirrer, 
reflux condenser, connected to a dry nitrogen feed was added RA(I) (64.76 g, 59.71 mmol), 
CS2 CO3 (45 g, 138.11 mmol), dibromomethane (33.52 ml, 83.03 g, 478 mmol) and DMSO 
(800 ml). Stirring was induced and heating applied until reflux was achieved at 100 °C, the 
reaction was monitored by TLC using a mixture o f DCM : «-hexane (4:1, v/v). After 72 hours 
no further changes were apparent by TLC and the reaction was removed from heat, allowed 
to cool and poured portion-wise into a beaker containing distilled water. The brown 
precipitate was collected by sintered funnel vacuum filtration and dried in vacuo at 80 °C. 
The brown solid was then loaded into an extraction thimble and extracted with 9:1 «-hexane : 
EtOAc for 10 hours, removal of the solvent yielded a white crystalline solid.
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Yield: 36.09 g (31.86 mmol, 53.36 %)
'H  NMR: (500 MHz, in (CDghCO); 5 (ppm); 7.642 (s, Ar-H, 4H), 6.000 (s, 0-C H , 4H),
4.840 (t, CH, 4H), 2.397 (m, CHj, 8 H), 1.377 (m, CHz, 24H), 0.972 (m, CH 3 , 12H).
2.4.4 (B.C) Tetrol synthesis: 4, 24- 6 , 10- 12,16- 1 8 ,22-tetraethylenedioxy, 
5 ,1 1 ,1 7 ,23-tetrahydroxyI, 2, 8 ,1 4 ,20-tetrapentyIcalix[4]arene, CV(II)
The synthesis o f 4, 24- 6 , 10- 12,16- 18, 22-tetraethylenedioxy, 5, 11, 17, 23-tetrahydroxyl, 2, 
8 , 14, 20-tetrapentylcalix[4]arene, CV(II) (tetrol) required a two-step, one-pot synthetic 
procedure from the starting material CV(I). Excessive chromatography was required to 
harvest the pure, fully substituted material from the product, which is a mixture o f partially 
hydroxylated cavitands. Ideally the possibility of using a Soxhlet extraction technique, 
similar to above would have been explored but neither yield nor time made this possible, 
even from the large quantities brought forward from the previous syntheses. The methods 
employed were modified interpretations o f those performed previously
CV(I)
OH
-80 “C 
THF
°C
THF
?ert-butyHithium 
1.7 M inpentane 
Trimethyl borate
aq. sol NaOH 1.5M 
H2O2 15 % (v/v)
Dimethyl borate fimctionalised CV intermediate
Scheme 17 Abridged synthetic procedure for the production of tetrol, CV(II)
To a flame-dried three-neck round-bottom flask (500 ml) equipped with a magnetic stirrer, 
thermometer and a drying tube, was added CV(I) (3.8 g, 3.4 mmol). Then freshly distilled 
THF (450 ml) was introduced, the mixture was allowed to stir until the CV(I) had dissolved. 
The solution was then cooled to -80 °C with dry-ice in methanol. Then ^er^-butyllithium 
(exercise extreme caution: pyrophoric, ignites spontaneously in air) in pentane (27 ml, 1.7 M)
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was added slowly to the reaction vessel which stirred for 10 minutes. Following this 
trimethylborate (9.2 ml, 82.5 mmol) was added under constant stirring and the reaction was 
allowed to warm to ambient temperature and stir for two hours. The solution was then cooled 
again to -80 °C and an aqueous solution o f sodium hydroxide and hydrogen peroxide (78 ml,
1.5 M NaOH, 15 % H2 O2  (v/v)) was added slowly. The reaction vessel was allowed to warm 
to ambient temperature and stir for a further three hours. Then the flask was immersed in an 
ice-bath (to control the exotherm*) and the reaction was halted with the slow, careful, 
portion-wise addition of Na2 S2 0 5  (15.2 g, 79.95 mmol). The suspension was then transferred 
and the solvent removed in vacuo. The pale-yellow product was then dissolved in 
chloroform, silica was added and the solvent was removed by careful rotary evaporation. The 
silica-mounted product was dry loaded onto a pre-packed M-hexane-silica (60 Â) column and 
eluted with a mixture o f 3:1 EtOAc : «-hexane (v/v).
Yield: 0.988 g (1.12 mmol, 29.5 %)
'H  NMR: 500 MHz in (CD3)2 CO; 8  (ppm): 7.710 (s, Ar-O-H, 4H), 6.892 (s, Ar-H, 4H), 
5.682 (d, 0-CH2eq-0, 4H), 4.573 (t, Ar-CH-Ar, 4H), 4.254 (d, O-CHzax-O, 4H), 2.157 (q, 
CH-CH2-CH2 , 8 H), 1.251 (m, CH2 -CH2 -CH2-CH2-CH3 , 16H), 0.772 (t, CH2 -CH 3 ,12H ).
*An important addition to the method due to the violent exothermic character of the reaction 
by the addition o f sodium metabisulfite to the vessel can cause problems, especially when 
manipulating large quantities. Patience and care must be taken with the additions; it is 
advisable to monitor the temperature inside the vessels for the duration of the process.
n.b. Both tert-hvXy\ lithium 1.7 M in pentane and «-butyl lithium 2.5 M in «-hexane were 
used, references for each are to be found and incorporated and this note adjusted, the yields 
were seemingly unaffected by this substitution and products were identical.
2.4.5 (B.C) Synthesis of 2-(p-Tolylsulfonyloxy)ethyI 4-
methylbenzenesulfonate, ED
Multiple ditosylates were produced: namely ethylene ditosylate (ED, 2-(p-
Tolylsulfonyloxy)ethyl 4-methylbenzenesulfonate), propylene ditosylate (2-(p-
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Tolylsulfonyloxy)propyl 4-methylbenzenesulfonate) and butylene ditosylate (2-(p- 
Tolylsulfonyloxy)butyl 4-methylbenzenesulfonate). The procedures employed varied only in 
the diol required as a spacer to lengthen the chain. As such only the first procedure based 
upon the work of Yoshida et al}^^ is defined as it was optimised (especially in terms of 
purification) prior to further application. Subsequently the reaction was repeated and the diol 
replaced accordingly with increasing chain-spacer lengths.
Ettylene glycol
TEA
Trimethylamine • HCl 
MeCN
/i-Tobenesulforyl chtoride
2-(p-tofylsulfoEyb3Q/)etfayl4-melhyIbenzenesiilfcnate
(ED)
Scheme 18 Synthetic procedure for the production of ED
To a flame-dried single-neck round-bottom flask (250 ml) equipped with a magnetic stirrer 
and capped with a CaCh drying tube, was placed j9 -toluenesulfonyl chloride (28.6 g 150 
mmol) which dissolved with stirring in freshly distilled MeCN (100 ml). A solution of 
ethylene glycol (2.78 ml, 50 mmol, 3.09 g), triethylamine (20.94 ml, 150 mmol, 15.20 g) and 
trimethylamine hydrochloride (0.95 g, 10 mmol) was prepared in MeCN (50 ml). The 
solution was then and added to the stirring reaction vessel, which was then capped with the 
drying tube and allowed to stir for an hour and half. Then AA^’-dimethylethylenediamine 
(7.94 ml, 74 mmol, 6.50 g) was introduced and the solution stirred for a further 10 minutes, 
distilled water (40 ml) was then added and the contents were transferred to a separating 
funnel. EtOAc (250 ml) was then added and the aqueous phase was extracted. The organic 
phase was retained and washed twice with 250 ml o f distilled water, followed by two 
washings with 250 ml of brine. The organic phase was dried with MgSÜ4  and filtered
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gravitationally, the solvent was removed in vacuo and the yellow solid was transferred to a 1 
litre single-neck round bottom flask. Then distilled water (800 ml) was added and a reflux 
condenser attached and the flask was brought to boil on a heating mantle and allowed to 
reflux gently for 5 minutes, the flask was allowed to cool then treated with sonication in an 
ultrasonic bath for ten minutes. Following this the heat was reapplied to reflux for a further 
five minutes, then allowed to cool to near ambient temperature and filtered gravitationally. 
The resulting off-white precipitate was allowed to air dry, harvested and dried in a vacuum 
oven at 95 °C.
Yield: 16.37 g (44 mmol, 8 8  %).
‘H NMR: (300 MHz, in CDCI3); Ô (ppm); 7.737 (d, Ar-H, 4H), 7.341 (d, Ar-H, 4H), 4.186 (s, 
CH 2 ,4H), 2.459 (s, CH3 , 6 H).
2.4.6 (C) Hemicarcerand synthesis: 4, 24- 6, 10- 12, 16- 18, 22- 4% 24’- 6’, 
10’- 12’, 16’- 18’, 22’-octamethyIenedioxy, 5, 5’- 11, 11’- 17, 17’- 23, 23’-tetra- 
we/fl-dimethoxybenzene, 2, 8, 14, 20, 2’, 8’, 14’, 20’-octapentyl-bis-calix[4]arene, 
HD
Synthesis of a hemicarcerand allows for the introduction o f the guest following assembly of 
the host. Hemicarcerand, 4, 24- 6 , 10- 12, 16- 18, 22- 4 ’, 24’- 6 ’, 10’- 12’, 16’- 18’, 22’- 
octamethylenedioxy, 5, 5’-1 1 , 11’-1 7 , 17’- 23, 23’-tetra-me^a-dimethoxybenzene, 2, 8 , 14, 
20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis-calix[4]arene (HD) was synthesised, with portals present in 
order to allow the introduction of the guest of choice into the vacant capsule post-synthesis. 
As such the hemicarcerand produced by Helgeson et al. was produced from tetrol and a ,a ’- 
dichloro-«2e^«-xylene, the procedure for which is outlined in Scheme 19 and detailed below.
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NMP
CS2CO3
HD
Scheme 19 Abridged synthetic procedure for the production of hemicarcerand, HD
A flame-dried 1 litre three-neck round-bottom flask was prepared with a reflux condenser, 
magnetic stirrer and Drechsel top connected to a dry nitrogen supply to which was added: 
CV(II) (0.38 g, 0.43 mmol), « ,« ’-dichloro-weto-xylene (0.38 g, 2.17 mmol) and CS2 CO3 
(3.04 g, 9.33 mmol). Stirring was induced and the temperature was set at 25 °C for 6 6  hours. 
Then an additional portion of «,«'-dichloro-weto-xylene (0.38 g, 2.17 mmol) was introduced 
and the temperature was raised to 6 6  °C for 48 hours. The reaction was then removed from 
the heat and allowed to cool, the contents were transferred and the solvent removed in vacuo. 
A water-chloroform phase extraction was performed, the organic layer was retained and dried 
with MgS0 4 , silica was added and the solvent was removed carefully in vacuo. The silica- 
mounted mixture was then dry-loaded onto a «-hexane-mounted silica column (60 Â) and
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eluted with 4:1 DCM : «-hexane mixture. The white product was isolated and dried in a 
vacuum oven at 80 °C.
Yield: 0.15 g (0.069 mmol, 36.4 %)
^HNMR 500 MHz in CDCI3 : 8  (ppm): 7.463 (s, ArH, inner ortho, 0 -CH2 -ArH-CH 2 -0 , 4H), 
7.304 (t, ArH, outer meta, 0 -CH2 -ArH-ArH-ArH-CH2 -0 , 4H), 7.204 (d, ArH outer ortho, O- 
CH2 -ArH-ArH-ArH-CH2 -0 , 8 H), 6.826 (s, ArH cavitand, CH-ArH-CH, 4H), 5.459 (d, O- 
CH2eq-0 , 4H), 4.900 (s, 0 -CH2 -Ar-CH2 -0 , 16H), 4.721 (t, Ar-CH-Ar, 4H), 4.187 (d, O-CH2 - 
O, 4H), 2.198 (q, CH-CH2 -CH2 , 8 H), 1.486-1.313 (m, CH2 -CH2 -CH 2 -CH2 -CH3 , 24H), 0.941 
(t, CH2 -CH 3 , 12H).
2.4.7 (B) Carceplex synthesis: 4, 4- 5, 5’- 6,1 0 - 11,11 - 12,16- 17 ,17’- 18, 
22- 23, 23’- 4’, 24’- 6’, 10’- 12’, 16’-1 8 ’, 22’-dodecamethylenedioxy, 2, 8, 14, 20, 
2’, 8’, 14’, 20’-octapentyl-bis-calix[4]arene ‘ aniline, AC
The synthesis of a carceplex requires the desired guest molecule to be present during the 
synthesis of the capsule. As such the guest must also act as a template or scaffold for the 
macromolecule to assemble around. The ideal properties for such a guest, requires a 
symmetrical molecule of appropriate size.^^^’^ ^^
The experiments reported in the following section investigated the possibilities of forcing 
guests into a carceplex and the possible advantages forwarded by the induction o f pressure 
onto the reaction system. Investigations into the relative importance of restricting the 
availability o f the bridging group of the reaction were performed. Reactions were performed 
in parallel with one pressure tube receiving a single addition o f the spanning group and the 
other being cooled half way through the reaction allowing for the introduction o f a second 
portion. Subsequently, the two-step method ultimately received an identical dose o f the 
spanner to that of the single-step method. Additions during a reflux experiment are easily 
performed when the reaction proceeds in a three-necked round-bottom flask, through a side- 
neck. This is not the case when reactions are performed in pressure tubes as the vessel must 
be cooled to allow for reduction in pressure before an addition can be made. By
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implementation o f the methods described allows for the understanding o f the consequences 
(if any) of this.
2.4.7.1 (B) Failed carceplex synthesis: aniline as solvent (TAx)
The initial experiment was performed in aniline, using it as both solvent and guest, as 
previously reported, with alternative s o l v e n t s . T h e s e  were performed following 
unsuccessful attempts to encapsulate aniline using the system outlined in Schemes 20 & 21, 
implementing the reflux method of Chapman et a l
2
cv(n)
+  4 B r  ^C!
Bromochloromethane
Aniline X
TA
Scheme 20 Abridged procedure for attempted carceplex synthesis with aniline guest (AC)
To two 100 ml Ace pressure tubes (back-seal, bushing type), each equipped with a magnetic
stirrer was placed aniline (80 ml), CS2 CO3 (2 g, 6.14 mmol) and CV(II) (0.06 g, 0.068 mmol)
respectively. To both tubes bromochloromethane was introduced: tube 1 (0.017 ml, 0.035 g,
0.27 mmol) and tube 2 (0.009 ml, 0.018 g, 0.14 mmol). Both were sealed and immersed in oil
baths to the solvent line, stirring was induced and the reaction proceeded at 90 °C for 4 hours.
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Tube 2 was then removed from the heat, cooled under constant running water for 10 minutes, 
the lid was opened carefully in the fume hood and further bromochloromethane (0.009 ml) 
was added to the vessel. This was sealed and returned to the oil bath to heat and stir for a 
further 4 hours (tube 1 remained untouched). Then, both tubes were worked-up 
independently, cooling was first completed by placing the tubes in a beaker under constantly 
running cold water for 15 minutes. Then by pouring the contents into beakers half-filled with 
distilled water, a precipitate became apparent, which was collected by sintered funnel 
filtration in vacuo. The products were air dried, then dissolved in chloroform, silica was 
added and the solvent removed in vacuo. The silica-mounted products were then dry loaded 
onto a M-hexane-silica (60 Â) column and eluted with DCM.
No novel product was harvested, only some partially substituted CV(II), mostly starting 
material was recovered with additional mixtures not indicative of either macrocyclic 
compound: starting material or target compound.
2.4.T.2 (B) Carceplex synthesis: NMP as solvent (TAy) to yield 4, 24- 5, 5 ’- 
6 , 10- 11, 11’- 12, 16- 17, 17’- 18, 22- 23, 23’- 4 ’, 24’- 6’, 10’- 12’, 16’- 18’, 22’-
dodecamethylenedioxy, 2, 8, 14, 20, 2 ’, 8’, 14’, 20’-octapenty 1-bis-calix[4]arene ' 
aniline, AC
Following the failure of the above and also the reflux experiments (detailed in chapter 3) also 
the following method was employed to yield the target compound. Here NMP (l-methyl-2- 
pyrrolidinone) was used as the solvent, with a small amount of aniline introduced as the 
species for encapsulation. NMP is a preferred solvent for encapsulation reactions, as previous 
work has shown it to be a poor templating molecule, which is not (readily) encapsulated. 
The synthesis proceeded as above and yielded the target compound 4, 24- 5, 5’- 6 , 10- 11,
11’- 12, 16- 17, 17’- 18, 22- 23, 23’- 4 ’, 24’- 6 ’, 10’- 12’, 16’- 18’, 22’-
dodecamethylenedioxy, 2, 8 , 14, 20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis-calix[4]arene aniline 
(AC).
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Scheme 21 Abridged procedure for the production of the aniline encapsulated carceplex, AC
Two Ace pressure tubes (100 ml, back-seal, bushing type) were prepared containing magnetic 
stirrers, and to each was added: NMP (90 ml), CS2 CO3 (2 g, 6.14 mmol), CV(II) (0.06 g, 
0.068 mmol) and aniline (1 ml, 10.97 mmol, 1.022 g). To both tubes bromochloromethane 
was added: tube 1 (0.017 ml, 0.035 g, 0.27 mmol) and tube 2 (0.009 ml, 0.018 g, 0.14 mmol). 
The tubes were sealed and submerged to the solvent line in silicon oil; heating to 90 °C was 
applied along with vigorous stirring. After 4 hours tube 2 was removed from heat and cooled 
in a beaker under running cold water for 10 minutes. The lid was removed carefully in the 
fume hood and further bromochloromethane (0.009 ml) was added, the tube was re-sealed 
and placed back in the oil bath for a further 4 hours (tube 1 remained untouched). After 4 
hours the two tubes were cooled in a beaker under running cold water for 15 minutes, the lids 
were removed carefully in the ftime hood and the tubes were worked-up separately. Their 
contents were poured into two 400 ml beakers, half-filled with distilled water. The products 
precipitated and were extracted by sintered funnel filtration (in vacuo), the precipitates were 
air dried then dissolved in chloroform, to which silica was added and the solvent was
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removed carefully in vacuo. The silica-mounted products were then dry-loaded onto n- 
hexane-silica columns and eluted with a 4:1 DCM : «-hexane mixture.
Only tube 1 produced a product representative of the target material (AC), tube 2 yielded 
only starting material and mixed side reaction products.
Yield, tube 1 : analytical, approx. 6  mg
NMR in CDCI3 at 500 MHz: 5 (ppm): 7.230 (t, ArH aniline meta (to NH2), 2H), 6.487 (d, 
ArH aniline para, IH), 6.701 (d, ArH aniline ortho, 2H), 6.663 (s, ArH cavitand (moiety), 
8 H), 6.554 (s, O-CH2-O bridging, 8 H), 6.210 (d, 0 -CH2eq- 0  spanning, 8 H), 4.757 (t, CH, 
8 H,), 4.327 (d, 0 -CH2 ax- 0  spanning, 8 H), 2.134 (q, CH-CH2 -CH2 , 16H), 1.463-1.213 (m, 
CH2 -CH2 -CH2-CH3,48H), 0.907 (t, CH3 , 24H).
'^C NMR in CDCI3 at 500 MHz: ô (ppm): 144.370 (C-NH2  aniline, 1C), 143.907 (A rC-0- 
CH2  cavitand, 16C), 140.444 (ArC-O-CHj bridging, 80), 139.806 (ArC-CH, 80), 129.595 
(ArC aniline meta, 2C), 119.263 (ArC aniline para, 1C), 113.588 (ArC aniline ortho, 2C), 
102.546 (O-CH2 -O spanning, 8 C), 91.472 (O-CH2 -O bridging, 4C), 37.071 (CH, 8 C), 32.161 
(CH3 -CH2 -CH2 , 8 C), 30.369 (CH-CH2 -CH2 , 8 C), 27.799 (CH-CH2 -CH2 , 8 C), 22.907 (CH3- 
CH2 , 8 C), 14.313 (CH3 , 8 C).
Mass spectrometry: Calculated mol. weight: 1903.30
TOP ES+ MW: 2078.38 (as TP A adduct) corrected mass: 1990.83.
2.4.8 (D.E) Pyrogallolarene synthesis: 2, 8 , 14, 20-
tetrapentylpyrogallol [4] arene, PA(I)
With the small yields resulting from the multi-step approach, a simpler self-assembly 
approach was begun with the aim o f producing useable quantities of products. As such 
investigations continued with pyrogallol[4]arene to produce the hexamerie capsules.
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2.4.8.1 (D.E) M icrowave assisted pyrogallolarene synthesis, PA(I)
The microwave ‘CEM: Mars Xpress Xtraction’ was employed and the method proceeded as 
described above (2.4.2.1 Microwave assisted resorcarene synthesis RA(I)) with resorcinol 
replaced by equimolar pyrogallol. The full details of the microwave adjusted synthesis of 2, 
8 , 14, 20-tetrapentylpyrogallol[4]arene (4, 5, 6 , 10, 11, 12, 16, 17, 18, 22, 23, 24- 
dodecahydroxyl, 2, 8 , 14, 20-tetrapentylcalix[4]arene), PA(I) is outlined below and in 
Scheme 22.
OH
HO
Pyrogallol
OH
OH
Hexanal
HO, OH
H+, 80 °C
2-ethoxyethanol
PA(I)
Scheme 22 Microwave assisted pyrogallol[4]arene (PA(I)) synthesis
The alterations made were the substitution of pyrogallol (5 g, 39.65 mmol) for resorcinol and 
the quantity o f hexanal (4.8 ml, 39.65 mmol, 3.97 g). The reaction proceeded as described 
and the only variation observed was the pink colour of the material yielded. No further 
refinements were made to the procedure due to the low yield. Subsequently the reflux method 
was preferred due to the increased quantity which could be produced.
Yield 8.02 (89.4 %, 0.96 mmol)
H NMR (500 MHz, in CDCI3): ô (ppm): 8.772 (s, Ar-OH meta, 4H), 7.499 (s, Ar-OH para, 
4H), 6.877 (s, Ar-OH meta\ 4H), 6.835 (s, Ar-H, 4M), 4.370 (t, CH, 4H), 2.280-2.183 (m, 
CH-CH2-CH2, 8 H), 1.67-1.324 (m, CH2-CH2-CH2-CH2-CH3, 24H), 0.795 (t, CH3, 1 2 H).
13C NMR (500 MHz, in CDCI3): 8  (ppm) 138.442 (ArC-OH meta, 4C), 137.363 (ArC-OH 
meta\ 40), 131.388 (ArC-OH para, AC), 125.432 (ArC ortho, 4C), 124.105 (ArC ortho\
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4C), 113.763 (ArC, 4C), 34.168 (CH, 4C), 33.142 (CH-CH2 -CH2 , 4C), 32.145 (CH-CH2 - 
CH2 ,4C ), 27.988 (CH2 -CH2 -CH3 , 4C), 22.688 (CH2 -CH 2 -CH3 , 4C), 14.153 (CH3 , 4C).
2.4.S.2 (D.E) Reflux method for pyrogallolarene synthesis, PA(I)
The reflux method for pyrogallolarene synthesis is similar to that for the production of 
resorcarene, the method employed was based upon that of Gerkensmeier et scaled up 
successfully and is given in Scheme 23.
OH
HO
Pyrogallol
OH
OH H+
80 °C
EtOH
Hexanal
HO. OH
PA(I)
Scheme 23 Reflux synthesis of pyrogallol[4]arene, PA(I)
Pyrogallol (39.189g, 311 mmol) was placed into a flame-dried 1 litre, three-necked round- 
bottom flask, equipped with a magnetic stirrer, thermometer and dropping funnel and placed 
in an ice-water bath. Ethanol (200 ml) was added and the solution was stirred, when 0 °C had 
been achieved a solution of ethanol (100 ml) and hydrochloric acid (12 M, 60 ml) was 
prepared and added dropwise to the stirring solution with the temperature maintained at 0 °C. 
Once the contents of the dropping funnel were exhausted it was then re-charged with hexanal 
(48 ml, 311 mmol, 39.66 g) in ethanol (50 ml), which was added dropwise to the reaction 
vessel with the flow adjusted to maintain the temperature at 0 °C. Following the complete 
hexanal addition the vessel was removed from the ice bath which was replaced with a silicon 
oil bath and heat was applied. The reaction was set to reflux at 80 °C for 16 hours, following 
this period the heat was removed from the reaction and allowed to cool gradually to ambient 
temperature. The vessel was then submerged into an ice-water bath and the purple product
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was then filtered directly from the reaction vessel by sintered funnel vacuum filtration. Then 
washed with ice-cold ethanol, to yield a purple precipitate which was then dried in vacuo at 
80 °C.
Yield 74.3 g (94.23 %, 89.19 mmol)
NMR (500 MHz, in CDCI3): ô (ppm): 8.772 (s, Ar-OH meta, 4H), 7.499 (s, Ar-OH para, 
4H), 6.877 (s, Ar-OH meta\ 4H), 6.835 (s, Ar-H, 4H), 4.370 (t, CH, 4H), 2.280-2.183 (m, 
CH-CH2 -CH2 , 8 H), 1.67-1.324 (m, CH2 -CH 2 -CH2 -CH 2 -CH3 , 24H), 0.795 (t, CH 3 , 1 2 H).
NMR (500 MHz, in CDCI3): 5 (ppm) 138.442 (ArC-OH meta, 4C), 137.363 (ArC-OH 
meta\ 4C), 131.388 (ArC-OH para, 4C), 125.432 (ArC ortho, 4C), 124.105 (ArC ortho\ 
4C), 113.763 (ArC, 4C), 34.168 (CH, 4C), 33.142 (CH-CH2 -CH2 , 4C), 32.145 (CH-CH2 - 
CH2 , 4C), 27.988 (CH2 -CH2 -CH3 , 4C), 2 2 . 6 8 8  (CH2 -CH2 -CH3 , 4C), 14.153 (CH3 , 4C).
2.4.9 (E) Pyrogallolarene based capsule synthesis of 4, 24- 5, 4’- 6 , 5’- 10, 
11’- 12, 16- 17, 16’- 18, 17’- 22, 23’- 23, 24’- 6 ’, 10’- 18’, 22’- 
dodecamethylenedioxy, 2, 8 , 14, 20, 2’, 8 ’, 14’, 20’-octapenty 1-bis-calix[4]arene, 
PP
With the small yields achieved from applications o f the known methods for capsule synthesis 
an alternative and ‘short-cut’ method was devised using the previously synthesised 
pyrogallol[4]arene with the simplest available spanning and bridging group: 
bromochloromethane. Early attempts to encapsulate aniline and its derivatives with this 
technique failed to yield a product indicative o f a capsule, returning partially fimctionalised 
and raw materials. Subsequently the approach was applied to the ‘ideal’ guest, pyrazine 
within the system and the product was expected to be identical to 2.4.7 but with pyrazine 
instead of aniline as the guest; this was not the case.^®  ^ The synthetic procedure for the 
joining ofPA (I) to 4, 24- 5, 4 ’- 6 , 5’- 10, 11’- 12, 16- 17, 16’- 18, 17’- 22, 23’- 23, 24’- 6 ’, 
10’- 18’, 22’-dodecamethylenedioxy, 2, 8 , 14, 20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis- 
calix[4]arene (PP) is detailed below and outlined in short in Scheme 24.
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HO. OH NMP
Pyrazine
CS2CO 3
Bromochloromethane
PP
Scheme 24 Abridged synthesis of the pyrogallol [4] arene based capsule, PP
Pyrazine (10 g) was placed into a flame dried 2 litre two-necked round-bottom flask, 
equipped with a magnetic stirrer, reflux condenser, stopper and Drechsel top connected to a 
dry N2  line and placed into a silicon oil bath. NMP (1500 ml) was added, along with CS2 CO3 
(33.18 g, 240 mmol) and PA(I) (2 g, 2.40 mmol). Bromochloromethane (1.24 ml, 19.1 mmol, 
2.47 g) was added and the reaction was allowed to stir for 24 hours at 25 °C. Following this 
period the temperature was increased to 65 °C and the reaction stirred for 24 hours, then 
additional bromochloromethane (1.24 ml) was added and the reaction stirred for 24 hours. 
This was followed by the final additional of bromochloromethane (1.24 ml) and the reaction 
was allowed to proceed for a further 72 hours at 65 °C. The reaction was then cooled to 
ambient temperature and transferred portion-wise to a smaller single-necked round-bottom 
flask and the solvent was removed in vacuo. The remaining contents were then dissolved in 
chloroform ( 2 0 0  ml) and partitioned twice with water ( 2 0 0  ml) and twice with brine ( 2 0 0  ml). 
MgS0 4  was added to the organic phase and the suspension was filtered gravitationally. To 
the chloroform solution was then added ~2 g of silica and the solvent was removed by rotary
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evaporation and the silica-mounted product was dry-loaded onto a «-hexane-silica (60 Â) 
column and eluted with DCM.
Yield: Analytical, approx. 8  mg
A break in symmetry led to two sets o f peaks for the hexyl chain pendant arms of the 
pyrogallol[4]arene moiety, each set integrated to the same number o f protons, two sets of 
peaks were also identified for the spanning O-CH2 -O groups, the extra sets were denoted as 
prime (’), in-line with convention.
NMR 500 MHz in CDCI3 : 5 (ppm): 6.851 (s, ArH, 8 H), 5.906 (s, O-CH2 -O spanning, 
8 H), 5.867 (d, 0 -CH2 eq- 0  cavitand, 4H), 5.825 (s, 0 -CH2 ’ - 0  spanning, 8 H), 4.674 (t, CH, 
4H), 4.583 (d, 0 -CH2ax- 0  cavitand, 4H), 4.210 (t, CH’, 4H), 2.234 (q, CH-CH2 -CH2 , 8 H), 
1.990 (q, CH’-CH2 ’-CH2 ’, 8 H), 1.498-1.326 (m, CH3 -CH2 -CH2 -CH2 -CH2 , 24H), 1.292- 
1.171 (m, CH3 ’-CH2 ’-CH2 ’-CH2 ’-CH2 ’, 24H), 0.948 (t, CH3 , 12H), 0.861 (t, CH3 ’, 12H).
^^ C NMR 500 MHz in CDCI3: 5 (ppm): 144.508 (ArC-0CH2 ortho spanning, 8 C) 138.384 
(ArC-CH, 8 C) 138.187 (ArC’-CH, 8 C), 136.069 (ArC-0CH2 para spanning, 8 C), 122.597 
(ArC-0CH2 cavitand, 8 C), 114.494 (ArCH, 8 C), 101.5445 (O-CH2-O spanning, 8 C), 
100.369 (O-CH2-O cavitand, 4C), 36.168 (CH, 4C), 35.215 (CH-CH2-CH2, 4C), 34.474 
(CH’, 4C), 32.003 (CH-CH2-CH2, 4C), 31.941 (C W -C W -C W ,  4C), 31.577 (CH’-CH2’- 
CH2’, 4C), 27.566 (CH3’-CH2’-CH2’, 4C), 27.285, (CH3-CH2-CH2, 4C), 22.732 (CH3’-CH2’- 
CH2’, 4C), 22.518, (CH3-CH2-CH2, 4C), 14.130 (CH3’, 4C), 14.065 (CH3, 4C).
Mass spectrometry: Calculated mol. weight: 1810.17
TOP ES+ MW: 1891.73 (as TFA adduct) corrected mass: 1809.98.
2.5 (C.D.F) Encapsulation methods
2.5.1 (C.D) Hemicarcerand (HD) encapsulation experiments
Due to the explosive, flame propagative nature o f the cetane improvers (especially DTBP,
‘H242’),^^’^  ^ heating could not be applied safely; as such only the anilines were selected for
hemicarcerand encapsulation experiments. The application of heating was the only way o f
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forcing the portals of the hemicarcerand to open and allow for the required guest molecules to 
fill the void/^^
2.5.1.1 (C.D) M ethod A: Reflux hem icarcerand (HD) experiments
Hemicarcerand (HD) (0.1 g) was placed into three 100 ml single-necked round bottom flasks 
equipped with a magnetic stirrer, to which the required guest: aniline, A-methylaniline 
(NMA) and A,A-dimethylaniline (NNDMA) (20 ml, respectively) were added. The flasks 
were then placed into a silicon oil bath, a reflux condenser fitted with a Drechsel top
connected to a dry N 2 line were connected and heating to 120 °C and reflux temperature
(184-194 °C) respectively, along with stirring were applied for 72 hours.
After cooling, the following work up procedures were then explored:
i) Precipitation into ice-cold methanol
The solutions were poured into 100 ml beakers, each containing ice-cold methanol (25 ml), 
the dark precipitates were then extracted by careful sintered funnel filtration in vacuo.
ii) Rotary evaporation
The solvent was removed from the samples by rotary evaporation, harsh conditions o f 98 °C 
and 10 mBar were required to remove the solvent. The samples were then extracted from the 
flasks with CDCI3 for analysis.
iii) Solid phase extraction
The samples were passed through SPE columns, following the specified necessary pre­
treatment steps and extracted. The solutions were then allowed to evaporate slowly in the 
fume cupboard prior to analysis.
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2.5.1.2 (C) Method B: Microwave hemicarcerand (HD) encapsulation 
experiments
Into each microwaveable vessel was placed: aniline, NMA and NNDMA (23 ml, 
respectively). The tubes were sealed and placed into the microwave at
a) 100 W, set for 1 minute ramp time followed by 4 minutes run at 60 °C
b) 1600 W, set for 10 minute ramp time followed by 10 minutes run at 150 °C 
Following cooling work up procedures (i), (ii) and (iii) p70, were applied.
2.5.2 (F) p-cyclodextrin encapsulation experiments
Two P-cyclodextrins (BCDs) were employed for the formation o f an inclusion complex with 
aniline, previously r e p o r t e d . T o  a set o f three, 100 ml conical flasks equipped with 
magnetic stirrers was placed BCD (0.17 g) followed by distilled water (10 ml) and aniline, 
NMA or NNDMA (5 ml) respectively. The flasks were then covered and allowed to stir for 
72 hrs. The experiment was repeated with an equimolar, ratio of BCD to Aniline, NMA and 
NNDMA respectively. After each period a precipitate was apparent which was claimed by 
sintered funnel filtration with the application o f delicate vacuum where appropriate. Samples 
were then dried by vacuum desiccation over P4 O 10 (phosphorous pentoxide).
2.5.3 (D) Pyrogallolarene (PA(I)) and resorc[4]arene (RA(I))
encapsulation experiments
2.5.3.1 (D) Method A
Into a 100 ml single-necked round-bottom flask equipped with a reflux condenser was placed 
PA(I) (5 g), the flask was held with a retention clamp and to it the required guest: aniline, 
NMA or NNDMA (50 ml) respectively, was added. The flask was then heated to reflux 
temperature (184-194 °C) in a heating mantle and agitation was induced with the swirling o f 
the flask. The contents were allowed to reflux gently for 5 minutes then the precipitate was
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achieved by pouring the contents of the flask whilst hot through a sintered funnel under zero- 
mild vacuum. Work-up procedures (i) and (iii) p70, were also employed.
2.5.3.2 (D) Method B
The general procedure for attempted capsule formation employing ‘method B ’ involved 
dissolving the ligand directly into the guest as solvent. A small quantity o f solvent (~10 ml) 
was added to a test tube to which the host was added until saturation was reached, the test 
tube was then sealed with a stopper and secured with Parafilm® then vortex mixed for 2 
minutes, sonicated for 30 minutes and vortex mixed for a further 2 minutes. Full dissolution 
was visually checked and samples were filtered gravitationally into the crucibles in the fume 
cupboard and left for the slow evaporation of the solvent. Once dry, the resulting materials 
were analysed by NMR and compared to control (PA(I)). Further studies investigated the 
solubility of the ligand in suitable standard laboratory solvents and their combination with the 
host insoluble guest solvents (1:1, v/v) combined with the host, as above. The resulting solids 
were then analysed by NMR.
2.6 (D) Stability of supramolecular capsules
Before being able to investigate the thermal stability o f the capsules it was necessary to seal 
the samples into NMR tubes so as to avoid evaporation and maintain constant uniform 
conditions throughout the duration of the experiment.
2.6.1 (D) Producing sealed NMR tubes
A methane-oxygen torch was required along with suitable NMR tubes able to be subjected 
safely to the incubation temperatures which will later be applied. The final technique required 
a small flame with mix of methane and oxygen to produce a blue flame with a white centre. 
The sarnple pre-fllled tube was then inserted into the flame at the open ended tip (cap 
removed) ~2 mm and constant rotation applied. The tip was allowed to melt, glow and seal.
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A  bulb formed and expanded rapidly, at this point the sealed tube was removed from the 
flame, placed in an oven at 100 °C for 1 minute and allowed to cool to room temperature.
2.6.2 (D) Thermal stability of supramolecular capsules in solution
To investigate the thermal stability of the supramolecular capsules, each complex (5 mg) was 
inserted into a set of NMR tubes and the deuterated solvent (500 pi) was added (in the case of 
mixtures the ratio was 1:1, v/v, 250 pi : 250pl, least polar first) over the complexes which 
dissolved readily. The NMR tubes were then flame-sealed and analysed by NMR at 298 
K. Incubation was then applied at this temperature, equilibrium was achieved (24 hr 
incubation periods or greater) and analysis performed, followed by increases in incubation 
temperature and analysis by NMR at the incubation temperature.
2.6.3 (D) Breaking the supramolecular capsules
To gain further information about the complexes formed it was necessary to investigate if 
they could be broken and then analyse the products. The method employed required a 
mixture of deuterated solvents: CDCI3 and CD3OD (250 pi o f each, least polar first), added 
into the NMR tube after the complex. The complex was subjected to sonication in an 
ultrasonic bath for 2 minutes and analysed. The differences in the spectra produced confirmed 
the breaking o f the complex.
Following this the stability of the complexes in CDCI3 , CD3OD and CDCI3 : CD3OD were 
performed, which are detailed below.
Additionally, following dissolution of the complexes in CDCI3 (500 pi, less polar) and 
analysis by NMR, to the samples was then added CD3OD (500 pi) and the sample was 
sonicated for 2 hours in an ultrasonic bath. The samples were then re-analysed by NMR.
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2.7 NMR studies
Proton NMR is an incredibly versatile technique, additional to being crucial in modem 
organic chemistry for characterisation. In the instance o f analysing host guest interactions it is 
possible to mix the guest in excess with the host in deuterated solvent, analyse and compare 
to controls of the host and guest respectively in the same solvent. Overlaying the spectra 
allowed for the identification o f interactions. Analysis of peak shifting incidences and 
changes in proton integrations allowed for the identification of the sites o f interaction.
2.7.1 NMR characterisation
Characterisation was performed in suitable deuterated solvents (often CDCI3), the solubility 
of the compound or complex in the solvent was o f key concern, followed by the overlap of 
residual peaks. Solvents were assessed based upon these principles to produce the clearest 
spectra.
NMR experiments were performed using a Bruker DRX-500 pulse Fourier Transform NMR 
Spectrometer with TopSpin software on a Windows 7 computer.
For NMR the operating conditions employed a pulse or flip angle of 30 °, spectra width 
(SW) o f 20.66 ppm, spectral frequency (SF) of 500.15 MHz, spectral reference frequency 
(SRF) of 15.57 Hz, delay time of 0.5 s, acquisition time (AQ) o f 3.99 s, and line broadening 
of 0.3 Hz. Solutions of the samples of interest (9 xlO'"  ^-  6  xlO'^ mol. dm'^) were prepared in 
the appropriate deuterated solvent. These were placed in 5 mm NMR tubes with TMS 
(tetramethylsilane) as the internal reference.
The operating conditions for NMR involved pulse or flip angle o f 63 °, spectra width 
(SW) of 248.47 ppm, spectral frequency (SF) of 125.7 MHz, delay time o f 2.0 s, acquisition 
time (AQ) of 1.04 s, and line broadening of 1.0 Hz. For DEPT NMR experiments 
employed a pulse of flip angle of 135 °, SW of 216.06 ppm, SF of 125.76 MHz, delay time of 
2.0 s, AQ of 1.21 s, and line broadening of 1.0 Hz.
2D NMR proton-proton correlations experiments were performed with the following 
parameters. ^H-^H NOESY experiments employed a pulse or flip angle o f 90 °, SW of 6.89
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ppm, SF of 500.13 MHz, delay time of 1.86s, AQ of 0.3 s and line broadening of 1 Hz. ^H-^H 
COSY experiments employed a pulse/flip angle of 90 °, SW of 8.00 ppm, SF of 500.13 MHz, 
delay time of 1.90 s, AQ of 0.26 s, and line broadening of 1.0 Hz.^H-^H ROESY 
(CAMELSPESl) experiments involved pulse/flip angle o f 90 °, SW of 10.2 ppm, SF o f 500.13 
MHz, delay time o f 1.98 s, AQ of 0.20 s and line broadening o f 0.30 Hz. ^H-^H TOCSY 
experiments involved pulse/flip angle of 90 °, SW of 8.62 ppm, SF of 500.13 MHz, delay 
time of 1.77 s, AQ of 0.24 s and line broadening o f 1.0 Hz.
Proton-carbon-13 correlation experiments were performed with the following parameters. ^H- 
HSQC DEPT employed a pulse/flip angle of 90 °, SW of 8.62 ppm, SF of 500.13 MHz, 
delay time o f 1.77 s, AQ of 0.24 s and line broadening of 1.0 Hz. ^H-^^C HMBC employed a 
pulse/flip angle of 90 °, SW of 8.62 ppm, SF of 500.13 MHz, delay time of 1.77 s, AQ of 
0.24 s and line broadening o f 1.0 Hz.
2.7.2 H NMR complexation studies
Complexation studies were performed by addition o f a ten times excess of guest compounds 
into an NMR tube containing the ligand dissolved in CDCI3 (1 mg/ml) and TMS was used as 
an internal standard for axis calibration along with the solvent residual peak(s). The resulting 
chemical shift differences (A5) along the x  axis were then calculated from the equation:
A 8  — 8c — 8p
Equation 1
6 c is the chemical shift in ppm of the complex between ligand and guest and 6 p is the 
chemical shift in ppm of the pure ligand.
As the molecules o f interest in this study are organic, chemical shifts were also investigated 
in the signals representative of the guest molecule. A significant interaction is deemed as an 
interaction with a A6  value greater than 0.1 ppm in either direction. This indicates the
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likelihood of the presence o f an interaction which is o f sufficient intensity to warrant further 
investigation.
2.7.3 H NMR titrations
Using the principles outlined above NMR titrations were performed in which a reference 
sample was produced at a concentration o f 1 g/1 of the host in 0.5 ml o f deuterated solvent, an 
additional solution of the guest is then produced at 2 g/1 in 2 ml of the same solvent. The 
reference sample was analysed by NMR spectroscopy, then the guest sample was added 
portionwise to the reference at regular intervals with NMR spectroscopy performed 
following each addition. As organic compounds were being titrated which produce signals 
when analysed by NMR an additional reference sample is produced at 1 g/1 in deuterated 
solvent and analysed. Comparisons were then made between the control samples and the 
experimental with alterations tracked primarily in terms o f their A5 values. Occasionally it is 
possible to track changes in terms of integration, this is necessary for proton transfer 
reactions and redox reactions.
NMR titrations may also be performed with the addition of an alternate solvent to the one in 
which a complex is present in order to introduce a change in polarity o f the solvent system 
which may destabilise the complex and eventually break it into its constituent parts.
2.8 (A) Conductance measurements
2.8.1 (A) Conductometric titration
Conductometric studies were employed in order to determine the conductance o f ionic 
compounds in solution at very low concentration by measuring the resistance in solution. The 
compound of interest in dry acetonitrile at 298 K was titrated at a constant volume and at 
regular intervals. The reciprocal of resistance ( k)  was then calculated from the equation:
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1
Equation 2
R is the notation employed to indicate resistance (D).
2.8.2 (A) Determination of the cell constant
The cell constant was determined by titrating at regular intervals aqueous potassium chloride 
(0.1 M) into de-ionised water (25 ml) at 298 K whilst stirring. Ten additions o f potassium 
hydroxide solution (150 pi, 0.15 ml) every three minutes were made and conductivity 
readings were taken prior to the next addition. The molar conductance Am could then be 
calculated from equation 3:^^^
Am =  149.93 -  96.45Vc +  58 .74clogc +  198.4c
Equation 3
Am and c are the notations used to indicate molar conductance and molar concentration 
respectively.
The cell constant (0) could then be derived from the equation:
0 = Kiooo
Equation 4
2.9 (A) Calibration of the Tronac 450 calorimeter
The Tronac 450 calorimeter calibration was performed by titrating an aqueous solution of 
THAM (Tris(hydroxymethyl)aminomethane) (0.4 M) from the burette into a solution o f HCl 
(0.1 M, 50 ml) in the reaction vessel.^^^
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2.9.1 (A) Determination of the burette delivery rate
The burette was filled with de-ionised water of known density and titrations were made into a 
pre-weighed vessel. The mass of the water was recorded along with the time duration of 
addition, which was increased with each titration and a graph was plotted o f time (s) verses 
volume (ml), the gradient o f the line (z) was then determined.
2.9.2 (A) Electrical calibration
The THAM solution in the burette was titrated into the reaction vessel containing aqueous 
HCl the measurements for Vi and V2  were taken along with the time duration of delivery. The 
calibration constant (s) can subsequently be derived from the equation:
ViV2t
^ ~ R d
Equation 5
R and s are the notations used to represent calorimetric internal resistance (100.02 H) and the 
heat capacity o f the calorimeter (J K'^), Vi and Y 2 are standard resistance (Q) and heater 
resistance (H) respectively. Also d is the corrected temperature change (mm, chart unit) and t 
is the delivery time (s).
2.9.3 (A) Chemical calibration
The THAM solution in the burette was titrated into the reaction vessel containing aqueous 
HCl, measurements for t and d were taken which could then be used to calculate ApH.
The heat of protonation (qp) can be calculated from the observed total heat o f each addition 
(qt) corrected for the hydrolysis o f THAM in water (qn):
Equation 6
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The observed total heat o f addition can be rationalised by:
Qt =
The hydrolysis of THAM can be represented by:
THAM + H2 O ^  HTHAM-^ + OH'
The hydrolysis constant Kh is then given by:
[HTHAM+]. [0H~]
[THAM]
The concentration of OH’ was calculated from:
The heat associated with the hydrolysis of THAM can be computed from:
Equation 7
Equation 8
Equation 9
Equation 10
Equation 11
Eq. 8  may then be employed in the calculation o f the enthalpy o f protonation (Eq. 12):
Equation 12
Where n indicates the number of moles of THAM.
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2.10 (A) Calorim etric analysis; Tronac 450 calorim eter
Calorimetric titrations were performed following the technique developed by Christensen et 
al  Volumes of the titrant (guest dissolved in dry acetonitrile) were titrated from the burette 
into the reaction vessel (containing the ligand dissolved in dry acetonitrile). The resulting, 
temperature change was detected, converted into an electronic current by a Wheatstone 
bridge, amplified and recorded on a chart recorder and the duration of the addition was noted.
2.11 (A) Solvation experiments
In to a set of four pre-weighed porcelain crucibles, a known quantity of the organic 
compound of interest (~2 g) was placed, with another crucible left empty for reference. The 
crucibles were then placed into a desiccator, part filled below the gauze with the solvent of 
interest and sealed, creating a solvent saturated environment. The crucibles were then 
weighed periodically to check for solvent uptake.^^’^ ^^
2.12 (A) Partition studies
When a substance is mixed between two immiscible solvents it is distributed between them in 
a manner which depends on its solubility in the two solvents individually and also on whether 
or not it possesses the same molecular weight in each.^^^ If an analyte has the same molecular 
weight in two immiscible solvents it will be distributed between the solvents in a manner 
which is dependent on temperature but independent of concentration, which is true only in 
the case o f very dilute solutions. These statements form the basis o f partition studies.
2.12.1 (A) UV-VIS analysis
The UV-VIS spectrophotometry analysed partition studies were carried out by first setting up
a mutually saturated solvent system of «-hexane and methanol. A concentration gradient o f
the analyte in each solvent was then established. Aliquots of the analyte at known
concentrations along this gradient dissolved in methanol were then added to a set o f tubes, to
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which an equal volume o f «-hexane was added. A reference tube was also prepared 
containing the saturated solvents in the absence o f the analyte. The tubes were sealed, vortex 
mixed and allowed to equilibrate at 298 K for 24 hours. A calibration curve was established 
in each of «-hexane and methanol by UV-VIS spectrophotometry, following which the 
respective fractions from the partition tubes were analysed and the concentration o f the 
analyte in each of the solvents was established with reference to the calibration curve. It was 
then possible to determine the partition constant Kp from the equation:^^
" ■
Equation 13
In Eq. 13 [A] and s are the notations used for analyte concentration and solvent respectively, 
with numbers employed to differentiate between solvents.
2.12.2 (A) NMR analysis
The NMR analysed partition studies were carried out by first setting up a mutually 
saturated solvent system o f «-hexane and methanol-d4 . A concentration gradient o f the 
analyte in methanol-d4  was then established. Aliquots o f the analyte at known concentrations 
along this gradient in methanol-d4 were added to a set of tubes, to which an equal volume o f 
«-hexane was added. The tubes were sealed, vortex mixed and allowed to equilibrate for 24 
hours at 298 K. A calibration curve in methanol-d4  was established by NMR analysis 
using the «-hexane residual peak as an internal standard for concentration. Afterwards the 
methanol-d4  solution from the tubes was extracted and analysed by NMR and the 
concentration of the analyte was established. The concentration present in the «-hexane 
fraction could then be determined from Eq. 11 :
=  \A \to t — McDoOD
Subsequently it was then possible to establish Kp from Equation 13.
Equation 14
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2.13 Molecular modelling
An appraisal o f the software options available was initially performed, comparing the models 
produced to published crystal structures. The two short-listed software packages were 
‘Spartan Student’ and ‘ArgusLab’, the initial modelling experiments were performed and 
compared the orientations of the moieties present in the molecules and crucially the 
orientation of the pyrazine when modelled inside the carceplex, the crystal structure o f which 
was presented by Chapman et al}^^ this model is shown in Figure 13. ArgusLab was found 
to produce the model closest to real-world results and so was employed for all modelling 
experiments. ArgusLab version 4.0.1 Operating system: Windows 7 (64 bit).
Figure 14 Molecular model produced using ArgusLab of the reported carceplex*^®
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3. Results and Discussion
3.1 (A) Cetane improver complexation study
Before beginning the functionalisation of calixarene (2.4.1) it was necessary to test the 
theories outlined by Hay et a l from their theoretical study o f interactions with nitrates and 
a m i n e s . T h i s  was manifested in a number of small molecule interaction studies, detailed 
below.
3.1.1 (A) Investigations into the nature of the guests in solution
3.1.1.1 (A) Cetane improver conductometric titrations
Following the calibration of the equipment and the establishment of the cell constant (0 =
1.08 cm'^), the conductance o f 2-ethylhexylnitrate (2-EHN) and di-^er^-butylperoxide 
(DTBP) was established in dry acetonitrile (MeCN). Figures 15 and 16 display the 
conductometric titration plots of the molar conductance (Am) against increasing analyte 
concentration for 2-EHN and DTBP respectively. In both cases a change in conductance was 
observed before reaching plateaux, these levels however were far below the level expected 
for ionic species in solution.
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I  0.4
0.001 0.002 0.003
^[2-EHN]
0.004 0.005
Figure 15 Molar conductance of 2-EHN in MeCN at 298 K
0.001 0.002 0.003
V[DTBP]
0.004 0.005
Figure 16 Molar conductance of DTBP in MeCN at 298 K
These results confirmed that both of the cetane improvers were present in solution as neutral 
species. Consequently, supramolecular interactions through ionic bonds could not be formed 
nor would further study of these compounds by conductance measurements in solution be 
viable. The obvious short-coming o f this work was the solvent employed as it was not
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representative of the solvent o f end use. However, MeCN is a dipolar aprotic solvent, far 
more polar than any other model solvent system (e.g. toluene) or the solvent of final 
application (diesel). As such if the analytes do not display ionic spéciation in a dipolar aprotic 
solvent, then they will also not display ionic spéciation in a non-polar solvent. The design of 
the ligand was greater informed as a consequence and possible functionalisations were ruled 
out.
3.1.1.2 (A) Cetane improver partition studies
3.1.1.2.1 (A) Partition of 2-EHN, «-hexane : methanol
The partition data for 2-EHN between «-hexane and methanol, as measured by UV-VIS 
spectrophotometry at 206.5 nm is displayed in Figure 17.
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Figure 17 Plot of the partition constant of 2-EHN in methanol ; «-hexane at 298 K
From the plot it can be realised that the partition constant Kp is practically unchanged along 
the concentration gradient. As such it was possible to conclude from the experiments that the 
analyte in the prescribed solvent system was predominantly present as a monomeric species. 
Consequently the polar head (NO3) moiety remained available for complexation in solution
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and was not involved in homo-interactions. This information was crucial as with this additive 
the only region available for significant supramolecular complexation is the NO 3 group as the 
extreme neutrality o f the branched hydrocarbon chain offers little scope for detecting 
complexation with the receptor.
3.1.1.2.2 (A) Partition of DTBP, «-hexane : m ethanol-d4
Through repeated attempts and the production o f multiple calibration plots there was not a 
link between concentration and absorbance when measured by UV-VIS spectrophotometry 
for the analysis of DTBP when partitioned between «-hexane and methanol. A new method 
for analysing the concentration of this analyte in solution became a necessity. The devised 
method using NMR was employed to evaluate the concentration o f DTBP when 
partitioned between «-hexane and methanol-d4  (CD3 OD), the results of which are displayed 
in Figure 18.
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Figure 18 Plot of the partition constant of DTBP in CD3 OD : «-hexane at 298 K
Although the method for determining concentration is different the results led to the 
conclusion that DTBP is present in the given solvent system predominantly as a monomer. 
The same conclusion as above could be drawn and hosts and small molecules could begin to
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be investigated for their ability to form complexes with the oxygens present in the structures 
o f the two cetane improvers.
3.1.1.3 (A) Solvation experiments
2-EHN was analysed for solvate formation with «-hexane and methanol, solvate formation 
was apparent and thus it was not possible to determine the solubility of 2-EHN in either of 
these solvents.
3.1.2 (A) NM R complexation analysis w ith lib rary  compounds
Three known and commercially available ligands were selected for initial complexation 
analysis with the cetane improvers, these were hexacyclen (1,4,7,10,13,16- 
hexaazacyclooctadecane), kryptofix 22 (1,4,10,13-tetraoxa-7,16-diazacyclooctadecane) and 
kryptofix 222 (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) (Fig. 19).
Hexacyclen
4
KiyptoGx 22
3
Kryptofix 222
Figure 19 The chemical structures of the library compounds: hexacyclen, kryptofix 22 and 
kryptofix 222 studied for interaction with the cetane improvers, numbered for ^H NMR 
purposes
Hexacyclen was selected as a compound of interest as it contained a ring o f secondary amines 
bridged between each pair by ethylene groups. As such it appeared an ideal candidate, 
thought likely to interact with the two guest c o m p o u n d s . T h e  results shown in Table 1
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displayed a lack o f interaction with hexacyclen as no significant interactions were observed. 
It is possible that the reason for this is that steric factors do not allow for the two molecules to 
come together in close enough contact, blocking any possible interaction.
Table 1 NMR complexation study of hexacyclen with 2-EHN and DTBP in CDCI3 at 298 
K
Proton #
Hexacyclen
(ppm)
Hexacyclen 
+ 2-EHN 
(ppm)
AS
(ppm)
Hexacyclen 
+ DTBP 
(ppm)
AS
(ppm)
1 1.679 1.619 -0.060 1.658 -0 . 0 2 1
2 2.740 2.740 0 . 0 0 0 2.746 0.006
Sol. 7.263 7.260 -0.003 7.262 -0 . 0 0 1
The interaction was studied between kryptofix 22 and the two guests, the results of which are 
given in Table 2. A significant interaction was identified between kryptofix 22 and DTBP, 
with an up-field shift, representative o f a proton shielding event. However the peak 
presenting the shift was in a region usually representative of trace water in CDCI3 so the 
sample was doped with H2 O and the analysis was repeated.
Table 2 ^H NMR complexation study of kryptofix 22 with 2-EHN and DTBP in CDCI3 at 
298 K
Proton #
Kryptofix 22 
(ppm)
Kryptofix 22 
+ 2-EHN 
(ppm)
AS
(ppm)
Kryptofix 
22 + DTBP 
(ppm)
AS
(ppm)
1 2 . 0 2 2 2.028 0.006 1.837 -0.185
2 2.796 2.796 0 . 0 0 0 2.796 0 . 0 0 0
3 3.598 3.598 0 . 0 0 0 3.598 0 . 0 0 0
4 3.617 3.616 -0 . 0 0 1 3.617 0 . 0 0 0
Sol. 7.265 7.265 0 . 0 0 0 7.263 -0 . 0 0 2
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Following doping an additional peak was identified at 4.808 ppm, the conclusion was drawn 
that the interacting proton could not be water. The peak was noticed to sharpen significantly 
and shift towards the opposite side, to a position downfield of where it was observed in the 
pure sample to 2.189 ppm, AS 0.167 ppm representing a significant downfield shift and a 
proton deshielding event. Subsequently some interaction with water was implied which lead 
to an alteration in the interaction with DTBP. It was decided that further study by calorimetric 
means was required, performed under anhydrous conditions, see section 3.1.8.
Subsequent to the displayed interaction between DTBP and kryptofix 22 it was deemed 
prevalent to analyse the sister compound kryptofix 2 2 2  with the two guests, the data from 
which are displayed in Table 3. Some interaction between kryptofix 222 and 2-EHN was 
observed from a proton identified as the protonation of the nitrogen. As with kryptofix 22 the 
analysis was repeated with the addition o f water, in this case the peak again strengthened but 
the interaction instead shifted further away from that recorded in the control sample from 
1.762 to 2.149 ppm (Aô 0.387 ppm).^^^’*^  ^It was determined that the addition o f water allows 
for the interaction to take place. The study was consequently ceased because the presence of 
water in fuel is highly undesirable.
Table 3 ^H NMR complexation study of kryptofix 222 with 2-EHN and DTBP in CDCI3 at 
298 K
Proton #
Kryptofix 222 
(ppm)
Kryptofix 222 
+ 2-EHN 
(ppm)
A8
(ppm)
Kryptofix 222 
+ DTBP 
(ppm)
AÔ
(ppm)
4 1.762 1.991 0.229 - -
1 2.646 2.646 0 . 0 0 0 2.648 0 . 0 0 2
2 3.595 3.594 -0 . 0 0 1 3.594 -0 . 0 0 1
3 3.688 3.687 -0 . 0 0 1 3.686 -0 . 0 0 2
Sol. 7.264 7.269 0.005 7.267 0.003
- indicates that no signal was identified
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3.1.3 (A) Calix[4] pyrrole and the cetane improvers
Calix[4]pyrrole has a great advantage over other ligands, in that it is easily synthesised from 
standard laboratory reagents. As it possessed the identified, desired hydrogen bond donating 
secondary amine group, it was synthesised following the established procedure^^"^ and 
analysed for complexation with the cetane improvers (Cl). The resulting calix[4]pyrrole 
structure is displayed in Figure 20.
Figure 20 The chemical structure of calix[4]pyrrole
Table 4 ^HNMR complexation study of calix[4]pyrrole with 2-EHN and DTBP in CDCI3 at 
298 K
Proton #
Calix[4]pyrrole
(ppm)
Calix[4]pyrrole 
+ 2-EHN (ppm)
AS
(ppm)
Calix[4]pyrrole 
+ DTBP (ppm)
AS
(ppm)
3 1.505 - - - -
2 5.892 5.845 -0.047 5.833 -0.059
2 5.901 5.854 -0.047 5.842 -0.059
1 7.005 7.046 0.041 6.961 -0.044
Sol. 7.26 7.26 0 7.26 0
- denotes that the peak was not identified, due to overlap from the guest spectra, proton 2  was 
present as a doublet, both peaks are included due to the simplicity of the molecule
No significant interaction was observed between calix[4]pyrrole and either o f the guests as 
shown in Table 4. It is likely that the reason that the two do not interact is caused by steric 
hindrance. The lower rim of calix[4]pyrrole is narrow and may be inaccessible to the oxygens 
of the CIs, consequently blocking hydrogen bond formation. There is evidence o f a slight
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interaction with the CIs as such it may be possible to form a complex with a larger 
calixpyrrole. The synthesis of this was unsuccessful following a direct approach and was 
subsequently abandoned but could be returned to following the established calixfuran 
approach/
3.1.4 (A) Small molecule complexation analysis
Numerous small molecules containing secondary amines and amides (NH) groups identified 
as functional groups suitable for complexation with oxygen lone pairs of DTBP and 2-EHN 
through hydrogen bonding were selected for analysis to investigate their suitability for 
introduction into the structure of a calixarene. The small molecules selected were urea, N- 
phenylurea, phenyl isocyanate, guanidine HCl. (Fig. 21). From this group only the 
combination of A-phenylurea with DTBP displayed (suitable) significant interactions, as 
shown in Table 5.
Urea
^NH-
A-Phenylurea
NH
HCl
Phenyl isocyanate Guanidine hydrochloride
Figure 21 The chemical structures of urea, A-phenylurea, phenyl isocyanate and guanidine 
HCl
Analysis o f the data indicated an interaction between the proton of the secondary amide of N- 
phenylurea and DTBP in chloroform-di, as displayed in Table 5, represented by a downfield 
shift from a proton deshielding event. A-Phenylurea alone could not introduce the protection 
of the cetane improvers required simply because o f its small size; incorporation o f the moiety 
by the functionalisation of a larger host molecule was the intended progression from these
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experiments, 2.4.1. The group which was used to introduce the final functionality (phenyl 
isocyanate) was also studied and along with the other molecules displayed in Figure 21 
showed no interaction when studied by the same method.
Table 5 Interaction of A-phenylurea with 2-EHN and DTBP by ^H NMR in CDCI3 at 298 K
Proton #
A-Phenylurea
(ppm)
A-Phenylurea + 
2-EHN (ppm) AÔ (ppm)
A-Phenylurea + 
DTBP (ppm) AÔ (ppm)
1 4.635 4.620 -0.015 4.731 0.096
2 6.391 6.411 0 . 0 2 0 6.665 0.274
5 7.124 - - 7.084 -0.040
5 7.147 7.140 -0.007 7.098 -0.049
5 7.170 - - 7.112 -0.058
Sol. 7.261 7.262 0 . 0 0 1 7.262 0 . 0 0 1
4 7.288 7.320 0.032 7.293 0.005
4 7.313 - - 7.325 0 . 0 1 2
3 7.329 7.344 0.015 7.340 0 . 0 1 1
3 7.351 7.350 -0 . 0 0 1 7.356 0.005
- denotes overlaps in the spectra, unable to identify the position of the peak, the variations in 
this remaining in the same region, consequently not o f significant intensity to be o f interest.
3.1.5 (A) /we5£?-TetramethyI-tetra[A-(2-plienoxyethyI)-A^’-phenyIurea]
calix[4]pyrrole, CP(IV) with the cetane improvers
An initial study was performed with a calix[4]pyrrole derivative outlined by Danil de Namor 
and Shehab denoted by the authors as CP(IV), Figure 22.^^^ This ligand was expected to be 
able to interact with the cetane improvers through the presented secondary amines and 
amides as hydrogen bond donors. However, ^H NMR studies performed in CDCI3 showed no 
evidence of significant interaction. The synthesis was consequently modified for application 
with the ?er^-butylcalix[4]arene, it is not clear why this ligand failed to interact with the 
selected guests although it may have been due to the innate flexibility o f the ligand or homo­
interactions (Fig. 23). A low intensity interaction was identified with DTBP, however as the
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induced A5 shift was less than 0.1 ppm no further investigation was performed with the 
ligand.
12 11 
Me5o-Tetramethyl-tetra[iV'-(2-phenoxyetliyl)-iV-plienylurea]calix[4]pyrrole
Figure 22 The structure of the modified calix[4]pyrrole, we50-tetramethyl-tetra[A-(2- 
phenoxyethyl)-A'-phenylurea] calix [4]pyrrole, CP(IV)^^
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Table 6  NMR complexation study of CP(IV) with 2-EHN and DTBP in CDCI3 at 298 K
Proton #
CP(IV)
(ppm)
CP(IV) + 2-EHN 
(ppm)
A8
(ppm)
CP(IV) + DTBP 
(ppm)
A8
(ppm)
3 1.581 1.578 -0.003 1.599 0.018
6 1.865 1.867 0 . 0 0 2 1.864 -0 . 0 0 1
1 2.534 2.543 0.009 2.544 0 . 0 1 0
' 7 3.824 3.826 0 . 0 0 2 3.820 -0.004
2 4.689 4.696 0.007 4.688 -0 . 0 0 1
4,5 6.067 6.067 0 . 0 0 0 6.067 0 . 0 0 0
1 0 6.761 6.766 0.005 6.757 -0.004
8 6.829 6.847 0.018 6.925 0.096
Sol. 7.258 7.266 0.008 7.260 0 . 0 0 2
9 7.346 7.351 0.005 7.373 0.027
1 1 , 1 2 8.989 8.987 -0 . 0 0 2 8.996 0.007
The strongest observed interaction was in a shift from the peak o f pure CP(IV) at 6.829 ppm 
in combination with DTBP as presented in Table 6 . It is likely that the reason that no 
significant interaction was observed was due to steric hindrance as the functional group had 
displayed interaction previously (JV-phenylurea, Table 5). As an interaction of low intensity 
has been observed the same functional group would be introduced into calix[4]arene. 
Calix[4]arene was selected as it allowed for adaptation of the synthetic procedure to yield a 
novel ligand which contained functional groups which have indicated desired complexation.
The urea moiety has been shown to form self-assemblies, as exploited by Rebek for the 
formation of calix[4]arene dimers.^^ It may be possible that CP(IV) forms a self-assembly at 
the lower-rim along the urea groups, potentially blocking or weakening interactions with 
external receptors, as shown in Figure 23.
94
3. Results & Discussion
Figure 23 Representations of CP(IV): (a) a sketch with the possible seam formation through 
hydrogen bonds denoted by dotted lines and (b) energy minimised, ball-stick molecular
model.
The complexation previously investigated with this ligand was the result o f ion-dipole 
complexation,”  ^ the strength o f which would overcome and interrupt the hydrogen-bonding
of the self-assembly, if present.
3.1.6 (A) Interactions between 5, I I ,  17, 23-tetra-/er/-butyI, 25, 27- 
bis(oxyethylamine), 26, 28-dihydroxycalix[4]arene, CA(II) and the cetane 
improvers
The three-step synthetic procedure for the synthesis of 5, 11, 17, 23-tetra-^er/-butyl, 25, 27- 
bis(oxyethylamine), 26, 28-dihydroxycalix[4]arene, CA(II) produced a ligand which 
displayed a primary amine, as such the ligand was analysed for the presence of interaction 
with the cetane improvers. Table 7 displays the results o f the complexation study. The
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characterisation o f CA(II) confirmed that the structure achieved was as displayed in Figure 
24.
OH
NH.^
10
Figure 24 Representations of CA(II): (a) energy minimised molecular model (ball-stick) and 
(b) chemical structure with proton numbers for NMR purposes
No interactions were identified as shown in Table 7. The primary amine present on the 
pendant arm o f the calixarene is a basic functional group and was unable to perform the 
required hydrogen bond donation. It is a proton acceptor, which would be able to lend itself 
to other interactions but is not able to form complexes with the guests in question.
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Table 7 Results of the NMR complexation experiments between CA(II) with DTBP and 
2-EHN in C D C l3at298K
Proton #
CA(II)
(ppm)
CA(II) +2-EHN 
(ppm)
A6
(ppm)
CA(II) + DTBP 
(ppm)
A6
(ppm)
1 1.096 1.096 0 . 0 0 0 1.096 0 . 0 0 0
2 1.247 - - 1.248 0 . 0 0 1
8 3.306 3.306 0 . 0 0 0 3.305 -0 . 0 0 1
5 3.343 3.344 0 . 0 0 1 3.344 0 . 0 0 1
5 3.386 3.387 0 . 0 0 1 3.387 0 . 0 0 1
9 4.070 4.071 0 . 0 0 1 4.071 0 . 0 0 1
6 4.311 4.311 0 . 0 0 0 4.300 -0 . 0 1 1
6 4.355 4.351 -0.004 4.360 0.005
3 6.968 6.969 0 . 0 0 1 6.968 0 . 0 0 0
4 7.053 7.036 -0.017 7.036 -0.017
Sol. 7.259 7.259 0 . 0 0 0 7.259 0 . 0 0 0
1 0 8.357 8.366 0.009 8.356 -0 . 0 0 1
- denotes an overlap in spectra, prohibiting proton identification
The hydroxyl group, proton 7 was not identified in any of the spectra; it is possible that this is 
due to an interaction between the amine group and the hydroxyl or a proton transfer reaction 
with the solvent.
3.1.7 (A) Interactions between (5, 11, 17, 23-tetra-/er/-butyl, 25, 27- 
bis(oxyethylphenylurea), 26, 28-dihydroxycalix[4]arene, CA(III) and the cetane 
improvers
Following the synthesis 5, 11, 17, 23-tetra-^err-butyl, 25, 27-bis(oxyethylphenylurea), 26, 28- 
dihydroxycalix[4]arene, CA(III), the structure was confirmed to be as displayed in Figure 25. 
Studies were then performed to assess the interactions in solution with the cetane improvers. 
The first analytic method employed was NMR. Table 8  shows the results of the NMR 
complexation study performed in chloroform-di at 298 K.
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Figure 25 Representations o f CA(III): (a) energy minimised molecular model (ball-stick) and 
(b) chemical structure with proton numbers labelled for NMR purposes
The results of the interaction study showed that the ligand performed as expected and was 
able to interact with the guests via the secondary amide groups present. The interactions were 
however different between the two guests analysed, this was also to be expected due to the 
differences in the structures of the molecules and the moieties presented within for the ligand 
to interact with. In the case o f the 2 -EHN interaction with CA(III), only one active site can be 
determined which is o f the NH group identified to be nearer to the main cyclic structure of 
the ligand. Whereas in the case o f the interaction with DTBP interactions are occurring at 
both the secondary amide and amine sites on the ligand. The interactions are also 
significantly different, with the NH adjacent to the lower aromatic moiety displaying a 
significant downfield shift, with an upfield shift noticed for the other NH group present. The 
results suggest that the interaction with DTBP is stronger than with 2-EHN, thus the ligand 
probably exhibits selectivity for DTBP over 2-EHN.
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Table 8  H NMR complexation study of CA(III) with 2-EHN and DTBP in CDCI3 at 298 K
Proton #
CA(III)
(ppm)
CA(III) + 2- 
EHN (ppm)
AS (ppm)
CA(III) + 
DTBP (ppm)
AS (ppm)
1 1.119 - - - -
2 1.258 - - - -
5 3.413 3.410 -0.003 3.400 -0.013
5 3.439 3.437 -0 . 0 0 2 3.426 -0.013
9 3.848 3.855 -0.007 3.856 -0.008
8 4.112 4.120 0.008 4.114 0 . 0 0 2
6 4.226 4.252 0.026 4.247 0 . 0 2 1
6 4.253 4.278 0.025 4.273 0 . 0 2 0
7 5.261 5.260 -0 . 0 0 1 5.260 -0 . 0 0 1
1 1 6.776 6.877 0.101 6.927 0.151
12,13 6.977 6.952 -0.025 6.956 -0 . 0 2 1
3 7.013 7.016 0.003 - -
4 7.071 7.084 0.013 - -
14 7.128 7.179 0.051 7.179 0.051
Sol. 7.258 7.263 0.005 7.256 -0 . 0 0 2
1 0 8.755 8 . 6 6 8 -0.087 8.560 -0.195
- indicates an overlap in spectra prohibiting identification
When the results are compared for those achieved for complexation of the CIs with CP(IV) 
the conclusion may be implied that the partial functionalisation of calix[4]arene with 
bromoacetonitrile (2.4.1.1) became advantageous. This was due to the steric factors, the 
partial functionality was carried through to the final product CA(III). The differences in the 
structures of calix[4]arene and CP(I) lead to these variations, which are displayed in Figure 
26. Subsequently the calixarene was functionalised with only two urea containing pendant 
arms which would be unable to complex strongly with each other. This may be the cause of 
the variation in interaction between the two ligands with the CIs.
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Figure 26 Energy minimised CPK molecular models of (a) CP(I) and (b) CA(II)
3.1.8 (A) Calorimetric analysis
The ligands presenting significant interaction with the targets {vide supra) were analysed by 
calorimetry, none of the analyses produced any heat of reaction. This may have been due to 
the switch in solvents between the two experiments from chloroform-d to acetonitrile, the 
necessity of which was required due to the incompatibility of the calorimeter for use with 
chloroform. Any heats associated with the interaction were below the sensitivity of the 
instrument. The necessitated change in solvent does not allow for a conclusion on the 
thermodynamics on the interaction, however the deduction was made that the interaction was 
not o f sufficient strength for final application.
3.2 (F) Cyclodextrin experiments
The formation of an inclusion complex with ^-cyclodextrin (BCD) was attempted, however 
BCD shows incredibly poor solubility in methanol and water, as analysed by NMR in 
methanol-d4  and heavy water, D2 O. This made it incredibly difficult to study the effects as 
the results were at such low intensities in the NMR spectra that it was impossible to have 
confidence in the data produced. The carbon spectra only showed TMS and solvent signals
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(see appendix). The other solvent option for study was DMSO-dô; however Danil de Namor 
et al. studied p-cyclodextrin extensively and found it to be more soluble in water than in any 
other s o l v e n t . T h e  other factor was that even if an inclusion complex could be formed with 
aniline or its derivatives the structure of the cyclodextrin would still require modification in 
two ways:
i) To alter the outer structure so as to make it soluble in non-polar solvents and 
solvent systems
ii) To cap BCD inclusion complex at both ends
It would be necessary to cap the inclusion complex because in an aqueous solvent system the 
inclusion complex is held together by the guests incompatibility with the solvent. In a non­
polar solvent system the guest would be able to easily diffuse out. Ultimately the combination 
o f these factors led to the abandonment of the project in this direction.
3.3 (B.C.D) Capsule synthetic precursors
3.3.1 (B.C.D) Resorcarene, RA(I) (2, 8 ,14 , 20-tetra-pentyl-resorc[4]arene, 
o r 4, 6 , 10, 12, 16, 18, 22, 24-octahydroxyl, 2, 8 , 14, 20-tetrapentyIcaIix[4]arene) 
synthesis
There was little further progress or scientific input to be made regarding the synthesis of 
resorcarene, the process has been well defined and optimised. The products were analysed 
and found to be identical. Subsequently for the purposes o f this work the reflux method o f 
synthesis was found to be superior, as for the research chemist often it is contact time rather 
than reaction time which is key. Here this was the case, although the microwave offers 
advantages, in terms of percentage yield and reaction time it was found to be impractical to 
produce the bulk quantity required with the equipment available. The microwave used for 
synthesis was designed for extraction and consequently the vessels available were present in 
significant quantity and volume (>100 ml). However it was necessary to produce multiple 
tubes, which proved costly in terms of time. The reflux method is sufficiently simple and 
easily scalable and limited only by the size of the vessel available, as such for the large bulk 
quantities required in order to compensate for the down-stream yield-loss the reflux method
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was deemed superior. This was because the process takes 24 hours, requires common 
laboratory solvents and can be conveniently scaled up. Also the percentage yield difference 
between the techniques was found in practice to be reasonably negligible 95.6 % for the 
microwave synthesis compared to 93.39 % for the reflux synthesis with the greatest 
difference being in mass yield, each microwave tube yielded 8.3 g compared to 106.4 g for 
the reflux synthesis.
3.3.2 (B.C) Bromination of resorcarene, RA(II) (2, 8 ,14 , 20-tetrapentyl, 5, 
11, 17, 23-tetrabromo-resorc[4]arene, or 4, 6, 10,12, 16,18, 22, 24-oxtahydroxyl, 
5 ,1 1 ,1 7 ,23-tetrabromo 2, 8 ,1 4 ,20-tetrapentyIcaIix[4]arene)
Two significantly different techniques were applied in this work for the bromination of 
resorcarene, the first was based on the bromination of phenol as outlined by Vogel,^^^ the 
other from the bromination o f resorcarene. As above the products produced were identical,
however the yields and work-up varied greatly. Firstly in the case o f the bromination in acetic 
acid (2.4.2.3), it is an incredibly lengthy procedure to wash the product and remove all o f the 
acetic acid. Failure to do so leads to a charred product when vacuum dried at above ambient 
temperature and the vaporisation of the latent acetic acid. Also attempts to neutralise the acid 
with aqueous sodium bicarbonate also led to the destruction o f the product. It is difficult to 
achieve via this method the white precipitate (yielded in 2-butanone, 2.4.2.4), also the yield 
produced was much lower. This is caused in the most part by the solubility o f resorcarene in 
acetic acid, the solubility is poor, sonication, heating and vigorous stirring were all applied 
along with filtration prior to addition of the bromine. None of these were able to compensate 
for the reduced solubility, the best results were produced from the employment o f dilute 
concentrations of resorcarene in acetic acid. However, once the method outlined in 2.4.2.4 
was employed 2.4.2.3 was not returned to. The major advantage is derived from the vastly 
superior solubility o f resorcarene in 2-butanol. The subsequent addition reaction is then able 
to proceed smoothly, with vastly superior yield. The most difficult part of the reaction was 
the work-up. As the precipitate is washed with 2-butanone, due to its high solubility in the 
solvent with each wash a quantity o f the product is lost. However, cooling the 2-butanone 
beforehand reduces the solubility of the resorcarene and aids in the selective removal o f the
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residual iV-bromosuccinimide and succinimide. The correct application however renders a 
white precipitous product, near free from impurities.
Characterisation of the product was relatively simple, following the NMR of the previous 
product and viewing the elimination o f the peak for the proton in-between the two hydroxyl 
groups confirmed the presence o f a billy substituted ‘bromo-resorcarene’, RA(Il) (Fig. 27).
H numbered in 
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numbered in
red
OH
l l
Figure 27 Structure of RA(II) labelled for NMR purposes
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Water
Figure 28 ’H NMR spectrum of RA(II) in acetone-de at 298 K
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The NMR spectrum o f RA(II) in acetone-dg, Figure 28 showed the absence o f the peak 
representative o f the aromatic proton between the hydroxyls at 6.238 ppm. This indicated the 
successful substitution o f the hydrogen at positions 5, 11, 17 and 23 for bromine. These data 
was tabulated and are presented in Table 9.
Table 9 NMR data for RA(II) in (CD3)2 CO at 298 K
Proton # Multiplicity
5 value 
(ppm)
1 t 0.871
2, 3 ,4 m 1.231-1.381
5 q 2.307
6 t 4.442
7 s 7.631
8 s 8.347
Table 10 NMR data for RA(II) in (CD3)2 CO at 298 K
Carbon # A value (ppm)
1 14.414
2 23.437
4 28.536
5 32.616
3 34.452
6 36.491
1 100.901
8 124.498
9 126.119
1 0 149.730
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Table 11 H NMR COSY correlations for RA(II) in CDCI3 at 298 K
Proton # Proton #
1 2,3,4 5 6 7 8 water
1 X
2,3,4 X X
5 X X X
6 X X
7 X X
8 X
water X
The carbon-13 data were in-line with expeeted as shown in Table 10, the absence o f 
additional peaks was confirmation of a pure product. The NMR COSY data displays the 
proton correlations, employed to ensure the eonformation of RA(II) was as expected. The 
correlations outlined in Table 11 are in agreement with the structure and were viewed to 
occur only where expected. The experimental data achieved confirmed the presence and 
isolation of RA(II), with validation of the bromine substitution at positions 5, 11, 17 and 23 
identified from the deletion of the indicative proton at 6.24 ppm. The subsequent structure o f 
RA(II) is depicted below in Figure 29.
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Figure 29 Energy minimised molecular model of RA(II), rendered in ball-stick
3.3.3 (B.C) Cavitand formation, CV(I) (4, 24- 6, 10- 12, 16- 18, 22- 
tetramethylenedioxy, 5, 11, 17, 23-tetrabromo, 2, 8, 14, 20-
tetrapentylcalix[4]arene)
Each of the three methods o f cavitand synthesis produced the identical, required product 
(after purification), however it was external and internal forces which required the method of 
synthesis for cavitand production to vary throughout the course of the work. The method 
outlined in 2 .4 .3 .1 , pressure tube synthesis was superior in terms of yield and product purity. 
The pressure in the system raises the boiling point of bromochloromethane, allowing it to 
remain in solution and overcome the reaction energy which inhibits full substitution. 
Consequently the percentage yield was superior along with the purity as the method pushes 
the products to be predominantly fully substituted; this is as yet not the case for any reported 
reflux synthesis. With the pressure tube method it is possible to yield a product of 
approximately 95 % purity suitable for the next step o f the synthesis from recrystallisation of 
the crude material in DCM : MeOH. However for either reflux synthesis this was not the 
case, fortunately the Soxhlet extraction method for purification devised by Kass et al. 
proved an elegant purification method. Employment of this yielded a pure cavitand product
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from a complex mixture o f cavitands, partially substituted cavitand-resorcarenes and 
resorcarene. The alternative method employed was column chromatography through a n- 
hexane-packed silica column (60 Â) eluted with DCM : «-hexane (4:1, v/v). In this solvent 
system it was possible to visualise the product and partially substituted intermediates as four 
spots on the TLC with the cavitand having the longest retention factor. Subsequently 
purification was effective and allows for isolation o f the partially substituted intermediates. 
The technique remains a useful one but is outdone in terms of efficiency by the Soxhlet 
method for specific isolation of the fully substituted cavitands.
However with the safety risks arising from the use o f pressure systems and the removal from 
market of bromochloromethane it was necessary to devise method 2.4.3.3. Dibromomethane 
and the vastly more expensive bromoiodomethane offer the only alternatives to 
bromochloromethane for introducing spanning groups o f the length employed here. As such, 
method 2.4.3.3 offers a way in which the production o f these types of cavitands can continue 
without the requirement for the ozone depleter bromochloromethane and without the expense 
of bromoiodomethane. The only reason for the technique not to be optimised with pressure 
vessels (as the boiling point is still relatively low, 96-98 °C) are the hazards involved in 
employing pressure systems. For a researcher to do so, plenty of head-space is recommended 
in the vessel to allow for the evolution of gas (CO2) from the reaction and the introduction of 
a stringent safety regime, ideally including a pressure release valve in the pressure tubes or 
the use of a modified autoclave.
Analysis of the product was performed by NMR, the numbering of the constituent protons 
and carbons is displayed in Figure 30.
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Figure 30 Structure of CV(I) with protons and carbons numbered for NMR purposes
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Figure 31 'H  NMR spectrum of CV(1) in CDCI3 at 298 K
The important observations to be made in the 'H  spectrum (Fig. 31) is the absence o f a peak 
representative o f a hydroxyl group, in the given solvent (chloroform-d,) however proton 
transfer can occur so this cannot be trusted. The peaks of greatest interest are the doublets at 
4.392 and 5.956 with a AS value o f 1.564 ppm. These are the peaks indicative o f the inner
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and outer protons of the cavitand. The data were subsequently tabulated and are shown in 
Table 12.
Table 12 ‘H NMR data for CV(I) in CDCI3 at 298 K
Proton # Multiplicity
5 value 
(ppm)
1 t 0.915
2, 3 ,4 m 1.258-1.430
5 q 2.198
8* d 4.392
6 t 4.852
d 5.956
7 s 7.034
* 8  & 9 are two protons attached to the same carbon but in different environments, as such 
they split each other and give two different doublet signals. 8  signifies the inner proton, 9 
signifies the outer proton.
A AÔ value o f 1.564 ppm was obtained for the cavitand, however unlike in the case of the 
axial and equatorial protons o f calix[4]arene a study seems not to have been performed to 
link these values to conformation. However the value can be used to track any induced 
conformational changes from later manipulation.
The carbon-13 NMR peaks are presented in Table 13, HSQC correlations identified carbon 8  
at 98.487 ppm as the newly introduced spanning carbon, indicative of the cavitand.
Table 14 displays the carbon-hydrogen correlations as investigated by HSQC DEPT NMR, 
the significant observation from these data are the correlation o f protons 8  and 9  with carbon 
8 . This confirmation along with the discrete ^H signals which exhibit n+1 splitting o f each 
other are indicative of the spanners o f the cavitand. This pattern occurs due to the distinct 
inner and outer environments which the protons occupy. The results were found to be in 
agreement with the structure for CV(I) as displayed in Figure 32.
109
5. Results & Discussion
Table 13 "C  NMR data for CV(I) in CDCI3 at 298 K
Carbon # A value (ppm)
i 14.065
2 22.655
4 27.429
5 29.837
3 31.876
6 37.694
8 98.487
7 113.527
9 119.052
1 0 139.306
1 1 152.07
Table 14 HSQC DEPT correlations for CV(I) in CDCI3 at 298 K
Carbon # Proton #
1 2,3,4 5 8 6 9 7
i X
2 X
4 X
5 X
3 X
6 X
8 X X
7 X
9
1 0
1 1
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Figure 32 Energy minimised molecular model of CV(1), rendered in ball-stick
3.3.4 (B.C) Tetrol synthesis, CV(II) (4, 24- 6, 10- 12, 16- 18, 22- 
tetraethylenedioxy, 5, 11, 17, 23-tetrahydroxyl, 2, 8, 14, 20-
tetrapentylcalix[4] arene)
The intermediate is commonly referred to in the literature as tetrol due, to the four hydroxyl 
groups sitting atop the cavitand, regardless of the length or nature of the pendant arm or 
spanning group, CV(II). Issues in the synthesis were derived from the length and linearity of 
the preceding reactions, yield loss and most crucially o f all purity. The substitution of  
bromine for hydroxyls is not favourable towards full substitution. This leads to difficulties in 
purification as tetrol gives a short retention factor by TLC in EtOAc : «-hexane (3:1, v/v) 
with the impurities visible as 3 additional spots with longer retention factors. As such, a long 
column was required, along with a substantial quantity of solvent eluted over an extended 
period of time to initially elute the partially substituted precursors from tetrol, CV(II). 
Complications also arose with mixtures of triol (partially substituted CV(ll), with three 
hydroxyl groups) and tetrol in the same fractions at significant quantities. These fractions
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were separated from the tetrol fractions and recrystallised from DCM : MeOH, with slow 
evaporation over time to yield CV(II), reclaimed by sintered funnel filtration. It is likely that 
a suitable solvent system could be developed for Soxhlet extraction o f tetrol from the product 
o f this reaction. This would save both time and solvent and would subsequently be more cost 
efficient and ‘greener’. Soxhlet extraction has proved a remarkably efficient method for the 
isolation o f CV(I) from mixtures, 2.4.3. However the challenge would be somewhat greater, 
due to the differences between CV(I) and CV(II) and their respective precursors. The product 
of the CV(I) synthesis is non-polar whereas the partially substituted cavi-resorcarenes present 
significant polarity in the vacant hydroxyl positions. In the ease of CV(II) the precursors may 
vary in a single hydroxyl position, separation from those which may be achieved but the 
isolation of tetrol from triol would likely prove a more challenging and delicate task. 
Subsequently an attempt at finding a suitable solvent system was not made but would prove 
useful, especially for scaling.
It was essential for the latter encapsulation experiments that the tetrol sample introduced was 
of the highest possible purity, as the presence of a hydrogen or indeed bromine at the required 
hydroxyl substituted position would introduce into any subsequent capsule structure a portal 
(or additional portal), not included in the design. Indeed these structures have been studied by 
Sherman and Cram et likely due in part to the significant harvest of partially
substituted triol from the tertrol synthetic procedure.
The structure o f CV(ll) is presented in Figure 33 with numbering for NMR purposes only, 
consistent with Tables 15-17.
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Figure 33 Tetrol (CV(II)) structure, numbered for NMR purposes
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Figure 34 NMR spectrum of tetrol (CV(II)) in CDCI3 at 298 K
The important signal o f interest in the NMR spectrum of CV(II) (Fig. 34) is the 
appearance o f the new peak 5.343 indicative of the hydroxylation of CV(I) at positions 5, 11, 
17 and 23 of the cavitand to yield the crucial tetrol molecule. These data were tabulated and
are presented in Table 15.
In both sets of NMR data THF was identified as an impurity (Tables 15 and 16), it would 
seem that an affinity is present between CV(II) and THF as purification was extensive and 
the samples were treated with many other solvents during the extensive work-up procedure 
following extraction from the THF containing reaction vessel. Samples were dried under 
vacuum at 80 °C in an attempt to eliminate the THF before further use. A change in the 
chemical shift for the spanning protons from 1.564 o f CV(I) to 1.525 (Aô 0.039 ppm) o f 
CV(II) was identified, this is consistent with the conformational change as induced by the 
substitution. The change in chemical shift was as a consequence o f a proton shift o f the inner 
proton (8 ), from 4.392 downfield to 4.433 (AÔ 0.041 ppm), with the outer proton (9) 
practically unchanged, 5.956 to 5.958 (AÔ -0.002 ppm).
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Table 15 NMR data for tetrol (CV(II)) in CDCI3 at 298 K
Proton # Multiplicity Ô value (ppm)
1 t 0.915
2, 3 ,4 m 1.324-1.438
5 q 2.171
8 d 4.433
6 t 4.694
1 0 s 5.343
9 d 5.958
7 s 6.636
Table 16 ‘^ C NMR data for tetrol (CV(II)) in CDCI3 at 298 K
Carbon # A value (ppm) DEPT
i 14.106 +ve
2 22.696 -ve
4 27.513 -ve
5 29.560 -ve
3 32.011 -ve
6 36.844 +ve
8 99.787 -ve
7 110.156 +ve
1 0 138.553 -
9 140.784 -
1 1 141.954 +ve
THF as impurity at 25.62 & 67.99 ppm C, 1.85 & 3.75 ppm H, brought through with the 
product from the synthetic procedure. -  denotes no signal due to quaternary carbon
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Table 17 HSQC DEPT correlations for tetrol (CV(Il)) in CDCI3 at 298 K
Carbon # Proton #
1 2,3,4 5 8 6 1 0 9 7
i X
2 X
4 X
5 X
3 X
6 X
8 X X
7 X
1 0
9
1 1
Figure 35 Energy minimised molecular model CV(ll), Tetrol rendered in ball-stick
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Table 17 details the HSQC DEPT correlations as achieved by NMR, proton 10 was
shown not to correlate with a carbon signal as it is indicative of the four hydroxyl groups of 
CV(II) at positions 5, 11, 15 and 23. As such the results confirmed that the structure of 
CV(II), as displayed in Figure 35.
3.3.5 (B.C) P recursor interaction studies
Each o f the precursors outlined in 3.3 were studied in solution (CDCI3) by ^H NMR with the 
guest compounds to see if any significant interactions were able to take place between the 
intermediates synthesised and the guests o f interest. None of the combinations of host and 
guests produced chemical shifts indicative o f an interaction and so no further investigations 
were performed. However other applications may be found for these intermediates for 
complexation, for instance with ionie speeies.
3.4 (B.C) Failed syntheses
Both of the experiments carried out for the encapsulation o f aniline from the joining of two 
tetrol (CV(II)) hemispheres with bromochloromethane were carried out in aniline and NMP 
respectively as solvent. The reactions were sealed up versions o f the reported 2.4.7.1 & 2 
performed under reflux. The reflux synthesis offers the advantage over pressure tubes, in that 
reactants may be added during the course o f the reaction without affecting the reaction 
conditions. In this way it was possible to begin the reaetions at 25 °C with 1/3 of the total 
bromochloromethane required and proceeded with stirring for 24 hours, followed by a 
temperature increase to reflux for 24 hours. This was then followed by the second 1/3 o f total 
bromochloromethane and 24 hours at reflux temperature. The final addition was then 
introduced and then a further 48 hours of reflux. Rotary evaporation o f the solvent was 
followed by extraction with chloroform and column chromatography. The major drawback of 
the reactions is the incompatibility o f both solvents with TLC, eonsequently it was not 
possible to follow the progress of the reaction. Neither reaction proceeded to the desired 
product. Following the success of the reaction outlined in 2.4.7.2 further reflux reactions 
were completed in a sealed N 2  environment, where the top of the reflux condenser was
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capped with a rubber septum, to which a balloon filled with nitrogen was attached. This 
modification to the synthesis also failed to yield the desired product.
Although it was possible to produce the bridging molecule ED subsequent syntheses which 
included it as a reagent to introduce the bridge between two tetrol hemispheres were 
unsuecessful, these were attempted under reflux as described above. Full details o f the 
syntheses are not included as full conformation that the carceplex was not yielded was not 
achieved. Research was not pursued further with ethylene ditosylate as the bridging 
eompound but it seems possible that encapsulation o f the anilines could be achieved and ED 
also employed for the introduction o f the spanning groups to produce wider cavitands. The 
yields from these syntheses were lower than those achieved by implementation o f pressure 
tubes and bromochloromethane (2.4.3.1). However since bromochloromethane is no longer 
available the introduction of methylenedioxy may only be performed by method 2.4.3 3 the 
alternative with ED may become favourable for cavitand synthesis and carceplex formation, 
Sehemes in appendix. Application o f Soxhlet extraction purification as described (2.4.3.1) 
may yield a pure material for both eavitand and carceplex, investigations should be 
performed and slight adjustments to the solvent systems may be necessary.
3.5 (C) H em icarcerand, HD (4, 24- 6 , 10- 12, 16- 18, 22- 4’, 24’- 6 ’, 10’- 12’, 16’- 
18’, 22’-octamethylenedioxy, 5, 5’- 11, 11’- 17, 17’- 23, 23’-tetra-w ^/a-
dimethoxybenzene, 2, 8 , 14, 20, 2 ’, 8 ’, 14’ 20’-octapentyl-bis-calix[4]arene) 
encapsulation study
No encapsulation was achieved with the hemiearcerand, although multiple techniques and 
conditions were applied to the host-guest system in attempts to introduce the desired guests 
into the void of the hemicarcerand through the portals. Multiple work-up procedures were 
then applied to rule out possible reasons for guest liberation from the host. The results 
confirmed that it was not possible to introduce the desired guests into the host system. The 
reasoning for this was that the guests were likely too large to pass through the excited portals 
of the host and consequently were unable to oceupy the void. For encapsulation to be 
aehieved in this way the work would require the synthesis of a host which possesses further 
extended and more flexible spanning sections which would allow access for the guest
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molecules to enter the host system. This was shown to be the case by Robbins et al. who 
were able to encapsulate aniline with the ligand displayed in Figure 36, however the 
outcomes of their study showed that aniline could only be held in this system for a maximum 
of 5 days and as such was not suitable for the purposes defined. Their work did however 
influence some o f the other research worked around these molecules with the attempts to 
produce carceplexes and hemicarceplexes with the extended alkane chains and ditosylates 
they employed to make this host.
Figure 36 The hemicarcerand synthesised by Robbins et al. 
aniline
141 whieh was able to encapsulate
The conditions employed by Robbins et al. to achieve encapsulation with this host were 
stated as 145 °C, times of several days are quoted along with a work-up procedure involving 
precipitation with m e th a n o l . T h e s e  techniques were employed here with HD, to no avail. It 
is unfortunate that this is the case as a comparison o f the two would have been most 
interesting. As such an attempt to form a complex of greater longevity, with different, less 
flexible spanning sections in order to facilitate this led to no complex formation with a host 
unable to accommodate the desired guests. Figure 37 depicts the structure of HD numbered 
for NMR purposes, the following Tables describe the NMR data achieved on this molecule.
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Figure 37 Chemical structure of the hemicarcerand HD numbered for NMR purposes 
Table 18 'H  NMR data for hemicarcerand (HD) in CDCI3 at 298 K
Proton # Multiplicity
Ô value 
(ppm)
1 t 0.941
2, 3 ,4 m 1.326-1.491
5 q 2.197
8 d 4.187
6 t 4.722
1 0 s 4.900
9 d 5.459
7 s 6.826
1 2 d 7.204
13 t 7.308
1 1 s 7.463
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Figure 38 *H NMR spectrum for hemicarcerand (HD) in CDCI3 at 298 K, with zoomed inset
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Table 19 NMR data for hemicarcerand (HD) in CDCI3 at 298 K
Carbon # A value (ppm) DEPT
i 14.152 +ve
2 22.729 -ve
4 27.727 -ve
5 30.000 -ve
3 32.173 -ve
6 37.063 +ve
1 2 75.456 -ve
8 99.613 -ve
7 114.106 +ve
16 125.414 +ve
14 126.479 +ve
15 127.883 +ve
13 138.615 -
i i 138.945 -
9 144.711 -
iO 148.029 +ve
-  denotes no signal due to quaternary carbon
121
Results & Discussion
Table 20 H NMR hemicarcerand (HD) COSY correlations in CDCI3 at 298 K
Proton # Proton #
1 2,3,4 5 8 6 1 0 9 7 1 2 13 1 1
1 X
2,3,4 X X X
5 X X
8 X
6 X
1 0 X X
9 X
7
1 2 X X X
13 X
1 1 X X
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Table 21 Hemicarcerand (HD) HSQC DEPT correlations in CDCI3 at 298 K
Carbon # Proton #
1 2,3,4 5 8 6 1 0 9 7 1 2 13 1 1
i X X
2 X
4 X
5 X
3 X
6 X
1 2 X
8 X X
7 X
16 X
14 X
15 X
13
i i
9
1 0
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Table 22 Hemicarcerand (HD) HMBC correlations in CDCI3 at 298 K
Carbon # Proton #
1 2,3,4 5 8 6 1 0 9 7 1 2 13 1 1
i X
2 X
4 X X
5 X
3 X X
6 X
1 2 X X
8
7 X
16 X X
14 X X
15
13 X X X
i i X X X X X
1 0 X X
9 X X X X
The sample was not identified in the pure state, impurities were identified as silicon grease: 
'H, S, 0.070, " c  1.022 and ‘Grease’ 'H, M, 0.86 & S, 1.255, "C , 29.752 in-line with the 
findings of Gottlieb et al. and as such are not given in Table 18 which quantitatively details 
the proton speetrum. These impurities arise from vaeuum lubricants applied to the glassware 
and are near-impossible to remove. The chemical shift between the two protons was 
calculated for the spanning groups as Aô = 1.272 ppm showing varianee with both CV(I) and 
CV(II). Upfield shifts were identified for both the inner and outer proton of the cavitand 
spanning group in the formation o f the hemicareerand, with the shift greatest in the outer 
proton.
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HSQC DEPT correlations (Table 21) assisted in the full elucidation of the peaks in the proton 
(Fig. 38 and Table 18) and carbon (Table 19) spectra. The ’^ C DEPT experiment was in 
agreement with the nature o f the protons attached to the carbons (Table 19). These along with 
the COSY characterisation (Table 20) and HMBC correlations (Table 22) were in-line with 
predicted for HD.
Figure 39 Energy minimised molecular models representative of hemicareerand HD 
displayed with (a) CPK and (b) ball-stick rendering, orientated to display the portals for 
guests to enter and exit
The combination of the NMR data, along with a multitude of MALDI TOP MS analyses 
displayed in Table 23 (calculated moleeular weight o f HD = 2170.66) proved negative for 
encapsulation confirmed the structure of the hemiearceplex to be as shown in Figure 39.
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Table 23 MALDI TOP data for hemicarcerand (HD) and attempted aniline, NMA and 
NNDMA complexes produced from reflux and microwave heated experiments
Sample
Mass o f highest 
intensity
nd
Mass o f 2 highest 
intensity
Hemicarcerand 2279.169 2500.895
Hemicarcerand • aniline 2278.680 2499.368
Hemicarcerand • NMA 2279.526 2547.088
Hemicarcerand • NNDMA 2278.609 2546.345
Hemicarcerand • NNDMA 2278.583 2499.053
Hemicarcerand • aniline 
(microwave) 2278.166 2497.192
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Table 24 NMR data for hemicarcerand (HD) with desired guests: aniline, NMA and 
NNDMA precipitated from methanol in CDCI3 at 298 K
Proton ID Control
HD + 
aniline
A6
(ppm)
HD + 
NMA
AÔ (ppm)
HD + 
NNDMA
A6
(ppm)
IM S 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0
Silicon
grease
0.070 0.069 0 . 0 0 1 0.070 0 . 0 0 0 0.070 0 . 0 0 0
1 0.941 0.408 0.533 0.941 0 . 0 0 0 0.941 0 . 0 0 0
Grease 1.255 1.255 0 . 0 0 0 0.126 1.129 1.255 0 . 0 0 0
2,3,4 1.357 1.357 0 . 0 0 0 1.357 -0 . 0 0 1 1.343 0.014
2,3,4 1.454 1.454 0 . 0 0 0 1.454 0 . 0 0 0 1.454 0 . 0 0 0
H2 O 1.527 1.540 -0.013 1.545 -0.018 1.540 -0.013
5 2.197 2.197 0 . 0 0 0 2203 -0.006 2.197 0 . 0 0 0
8 4.186 4.186 0 . 0 0 0 4.187 -0 . 0 0 1 4.188 -0 . 0 0 2
6 4.721 4.721 0 . 0 0 0 4.721 0 . 0 0 1 4.722 -0 . 0 0 1
1 0 4.901 4.901 0 . 0 0 0 4.901 0 . 0 0 0 4.900 0 . 0 0 0
9 5.458 5.458 -0 . 0 0 1 5.459 -0 . 0 0 2 5.460 -0 . 0 0 2
7 &826 6^26 0 . 0 0 1 6.825 0 . 0 0 1 &827 0 . 0 0 0
1 2 7.202 7.205 -0.003 7.206 -0.004 7.218 -0.016
Chloroform 7255 7.260 -0.005 7.261 -0.006 7.250 0.004
13 7.303 7.305 -0 . 0 0 2 7.305 -0 . 0 0 2 7203 0 . 0 0 0
1 1 7.467 7.465 0 . 0 0 1 7.462 0.005 7.463 0.003
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Table 25 NMR data for hemicarcerand (HD) with desired guests: aniline, NMA and 
NNDMA employing SPE work-up in CDCI3 at 298 K
Proton ID Control H D +A
A8
(ppm)
HD+NM A
A8
(ppm)
HD+
NNDMA
A8
(ppm)
IM S 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0
Silicon
grease
0.070 0.070 0 . 0 0 0 0.070 0 . 0 0 0 0.071 -0 . 0 0 1
1 0.941 0.941 0 . 0 0 0 0.941 0 . 0 0 0 0.941 0 . 0 0 0
Grease 1.255 1.254 0 . 0 0 0 1.254 0 . 0 0 1 1.254 0 . 0 0 0
2,3,4 1.357 1.333 0.023 1.342 0.014 1.342 0.015
2,3,4 1.454 1.487 -0.032 1.486 -0.032 1.487 -0.032
H2 O 1.527 1.546 -0.019 1.552 -0.025 1.536 -0.008
5 2.197 2.197 0 . 0 0 0 2.197 0 . 0 0 0 2.198 -0 . 0 0 1
8 4.186 4.184 0 . 0 0 1 4.185 0 . 0 0 1 4.186 0 . 0 0 0
6 4.721 4.721 0 . 0 0 1 4.720 0 . 0 0 1 4.722 -0 . 0 0 1
1 0 4.901 4.901 -0 . 0 0 1 4.901 0 . 0 0 0 4.901 0 . 0 0 0
9 5.458 5.456 0 . 0 0 1 5.457 0 . 0 0 1 5.457 0 . 0 0 0
7 6226 6227 -0 . 0 0 1 6.826 0 . 0 0 0 6228 -0 . 0 0 2
1 2 7.202 7.200 0 . 0 0 2 7.202 0 . 0 0 0 7.189 0.013
Chloroform 7.255 7.258 -0.003 7.259 -0.004 7.247 0.007
13 7.303 7.304 0 . 0 0 0 7.304 -0 . 0 0 1 7.302 0 . 0 0 2
1 1 7.467 7.471 -0.005 7.469 -0 . 0 0 2 7.471 -0.004
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Table 26 Hemicarcerand (HD), aniline microwave (attempted encapsulation) study, results 
achieved by ^H NMR in CDCI3 at 298 K
Proton ID Control (1) HD aniline M/wave AS (ppm)
TMS 0 . 0 0 0 0 . 0 0 0 0 . 0 0 0
Silicon
Grease
0.070 0.070 0 . 0 0 0
1 0.941 0.941 0 . 0 0 0
Grease 1.255 1.254 0 . 0 0 0
2,3,4 1.357 1.343 0.014
2,3,4 1.454 1.454 0 . 0 0 0
H2 O 1.527 1.525 0 . 0 0 2
5 2.197 2.197 0 . 0 0 0
8 4.186 4.188 -0 . 0 0 2
6 4.721 4.722 0 . 0 0 0
1 0 4.901 4.900 0 . 0 0 1
9 5.458 5.461 -0.003
7 6226 6225 0 . 0 0 1
1 2 7.202 7.207 -0.005
Chloroform 7.255 7.257 -0.003
13 7.303 7.305 -0 . 0 0 2
1 1 7.467 7.459 0.007
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Table 27 Hemicarcerand (HD), phenol attempted encapsulation study, results achieved by ^H 
NMR in CDCI3 at 298 K
Proton ID Control HD phenol
TMS 0 . 0 0 0 0 . 0 0 0
Silicon grease 0.070 0.070
Grease 0 . 8 6 6 0 . 8 6 6
1 0.941 0.941
Grease 1.255 1.255
2,3,4 1.357 1.357
2,3,4 1.454 1.454
H 20 1.527 1.527
5 2.197 2.197
8 4.1860 4.186
6 4.722 4.722
1 0 4.901 4.901
9 5.458 5.458
7 6.826 6.826
1 2 7.202 7.202
Chloroform 7.255 7255
13 7.303 7.303
1 1 7.467 7.467
Tables 24-27 compare the ^H NMR spectra of HD with samples of HD which were dissolved 
in the guests (aniline, NMA, NNDMA and phenol) as solvents and reclaimed by the various 
methods detailed. No significant shifts were identified in the spectra, producing clear 
evidence that encapsulation had not been achieved.
The chemical shift for the guest molecules were also measured verses control, free guest in 
identical solvent, no significant variations were identified. According to the literature 
chemical shifts should be identified in all o f the bridging protons, most notably proton 10. No 
significant variations were observed. The effect o f the solvent for precipitation was studied
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and found not to be the cause of the non-encapsulation as seen in the comparison o f Tables 
24 and 25 where the work-up procedure was altered. As such the conclusion was made that 
the hemicarcerand produced was unable to encapsulate the desired guests. Comparison with 
the hemicarcerand displayed in Figure 36 produced by Robbins et al. showed that although 
the length o f the bridging groups for the hemicarcerand HD studied were longer than in 
Figure 36 the flexibility of the bridging group of HD is reduced in comparison. Robbins et 
al. reported that the hemicarcerand was able to rotate through the y axis creating a twist in 
the bridging groups which could close the hemispheres into each other and constricting the 
portals. This twisting is not afforded by the aromatic spanning group in the hemicarcerand 
produced. The subsequent effect of which along with increased steric factors did not allow 
for the desired guests to enter into the hemicarcerand through the presented portals and 
subsequently blocked the formation of a hemicarceplex with the guests studied. The risk had 
to he taken to attempt to form a complex which would not allow for the guest to exit and 
would remain stable and hold the guest within for a prolonged period o f time for the final 
application. In this case it did not work out and it may not be possible to produce a 
hemicarceplex with such properties with the desired guests. The progression for this work 
would be to produce a hemicarceplex from CV(II) with spanning groups introduced with 2- 
(/7-Tolylsulfonyloxy)propyl 4-methylbenzenesulfonate to yield a hemicarceplex with a 
propylenedioxy spanning group. However, the same problems may be encountered due to 
inhibition o f complex formation caused by spanning groups o f insufficient length to afford 
guest entry into the hemicarcerand. It may be that the hemicarceplex described by Robbins et 
al. is the optimum hemicarceplex for aniline and indeed the derivatives, replication o f their 
work for comparison and further attempts at complex formation with NMA and NNDMA 
would he advantageous.
The yields experienced from hemicarcerand synthesis when compared to carceplex synthesis 
with the guests employed, which seemingly possess poor properties for temptation have been 
found to be advantageous. It is unfortunate that no hemicarceplex was achieved in this work 
as the study o f the stability of the guests inside the host and their ability to diffuse out over 
time would have been a fascinating study. However due to these reports and the 
incompatibility o f such occurrences with the end goal attention was drawn elsewhere.
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3.6 (B) Carceplex, AC (4, 24- 5, 5’- 6, 10- 11,11 - 12,16- 17 ,17’- 18, 22- 23, 23’- 
4’, 24 - 6’, 10 - 12’, 16 - 18’, 22’-dodecamethylenedioxy, 2, 8, 14, 20, 2 ’, 8’, 14’, 20’- 
octapentyl-bis-caIix[4]arene ' aniline) encapsulation study
Subsequently focus was reverted to the introduction of the desired guests at the final stage of 
the synthesis, the major drawback being that additional study such as thermodynamics could 
not be performed. To achieve the desired carceplex formation around the aniline guest it was 
necessary to attempt numerous encapsulation experiments based upon the joining of tetrol 
(CV(II)) hemispheres using different bridging groups to encapsulated aniline.
*H numbered in 
blue
numbered in
8,9red
1
14
Figure 40 Structure o f carceplex aniline (AC) with protons and carbons numbered for NMR 
purposes
Figure 40 displays the structure of the carceplex aniline (AC) supermolecule achieved from
the joining o f two tetrol, CV(II) hemispheres with 4 methylenedioxy bridging groups,
achieving the encapsulation o f aniline within, with the protons and carbons labelled for NMR
purposes only. The proton NMR spectrum for the carceplex is given in Figure 41; of
importance are the small but significant peaks in the negative region upfield o f TMS, these
are indicative o f the encapsulated guest showing significant shielding manifestations as
caused by the encapsulation of aniline. The low concentration of the sample and the ratio of
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host peaks : guest peaks o f 8 : 1  means that the peaks representative o f the guest occurred at 
low intensity. The new bridging group joining the hemispheres produced a singlet, with the 
representative peak identified at 6.554 ppm, Table 28. A chemical shift o f AÔ = 1.883 ppm 
was identified for the spanning groups of the opposing hemispheres. Perfect symmetry of the 
molecule was identified with both sets of protons for the two joined hemispheres producing 
identical peaks. Interestingly the protons representative o f the methylenediol spanning group 
produced a singlet signal which indicated that unlike the protons o f the bridging (cavitand) 
methylenedioxys reside in the same environment.
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Figure 41 NMR spectrum of AC in CDCI3 at 298 K
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Table 28 NMR data for AC in CDCI3 at 298 K
Proton # Multiplicity
Ô value 
(ppm)
1 t 0.907
2, 3 ,4 m 1.463-1.213
5 q 2.134
8 d 4.327
6 t 4.757
9 d 6 . 2 1 0
1 0 s 6.554
7 s 6.663
1 2 d 6.701
1 1 d 6.487
13 t 7.230
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Table 29 NMR data for AC in CDCI3 at 298 K
Carbon # 5 value (ppm)
i 14.313
2 22.907
4 27.779
5 30.369
3 32.161
6 37.071
1 2 91.472
1 1 102.546
7 113.304
14 113.588
16 119.263
15 129.595
8 139.806
1 0 140.444
9 143.907
13 144.370
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Table 30 HSQC DEPT NMR correlations for AC in CDCI3 at 298 K
Carbon # Proton #
1 2-4 5 6 7 8 9 1 0 1 1 1 2 13 14
1 X
2 X
3 X
4 X
5 X
6 X
7 X
8
9
1 0
1 1 X X
1 2 X
13
14 - X X
15 X
16 X
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Table 31 HMBC NMR correlations for AC in CDCI3 at 298 K
Carbon # Proton #
1 2,3,4 5 6 7 8 9 1 0 1 1 1 2 13 14
i X
2 X X X
3 X X
4 X X
5 X X
6 X X X
7 X
8 X X X
9 X X X X
1 0 X
Ü
1 2
13 X
14 X
15 X
16 X
The interaction o f proton 13 with carbon 6  can be attributed to an overlap with proton 7, with 
these protons laying in close proximity along the x axis o f the proton spectra a false positive 
correlation was generated.
These results acted as confirmation that the aniline representative peaks were not 
representative of an encapsulated species.
It is apparent that the modification of the reaction to include the employment o f pressure 
tubes, given the correct conditions can overcome the problems encountered with the 
synthesis. This follows the discovery o f Roman et al. in their use o f pressure tubes to 
overcome the low boiling point of bromochloromethane for the formation o f cavitands.^^^
137
Results & Discussion
With the variation in the results between the two methods of addition that it is likely that had 
the second tube, produced from 2  additions of bromochloromethane had been allowed to run 
for an increased duration o f time following the second addition that it would have proceeded 
to completion. The results of the synthesis display that aniline is a poor guest for this system 
but nonetheless with some effort may be introduced into the carceplex with the assistance of 
increased pressure. The increase in pressure critically increases the boiling point of 
bromochloromethane allowing it to remain in the liquid phase at a higher temperature which 
aids in overcoming the activation energy required to complete the reaction. It is unfortunate 
that the analysis of the products from the reaction failed to yield spectra indicative of 
intermediates, which would have given an indication into how the reaction was progressing 
before reaching the final product. It has been reported that the rate limiting step is the 
addition o f the final bromochloromethane bridging group to the partially formed capsule.^
The reasons for aniline being a poor guest in this system are as follows; it is at the limit for 
the capsule in terms of molecular size, containing 7 non-hydrogen atoms, the degree of 
symmetry is only along a single axis. These factors participated in the difficulties in 
introducing it into the carceplex. The way that they were overcome suggests that there may be 
more scope for all reported carceplexes and they may be capable o f encapsulating additional 
guests, especially in the case o f the carceplex reported with the bridging group employed. It 
would be interesting to see whether the introduction o f pressure to the reaction can increase 
the yield of previously reported reactions, to gain a greater understanding of what causes the 
rate limitations. However it is highly unlikely that the adoption of this technique could lead to 
an increased yield in this system for the encapsulation o f pyrazine, due to the considerably 
remarkable yield reported.^ This is because of the way in which pyrazine must participate in 
the reported reaction to produce these yields. This technique instead may offer benefits to 
poorer guests, which due to shape or presence of less than desirable groups, which are unable 
to template and provide the scaffold for the carceplex to form around them, in the way in 
which pyrazine does.
A contrast was present in the effect o f capsule formation on the cavitand protons when 
compared to the hemicarcerand, in the case of AC the outer proton (9) was found to have 
shifted downfield, whereas in HD the shift was upfield, both in comparison to CV(I) and 
CV(II). These shifts lead to the greatest observed A5 value for the cavitand protons o f 1.883
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Figure 42 Molecular modelling energy minimised structure of carceplex aniline, AC: (a) 
CPK host with ball-stock guest and (b) ball-stick host with CPK guest
Ultimately the main drawbacks of this work for employment of the product are the low 
concentrations at which the encapsulation step must be performed under to minimise side 
reactions, such as polymerisation and ultimately the low yields encountered with aniline as 
the guest. Consequently the quantity of AC produced was only analytical, allowing only for 
characterisation and not test implementation. Scaling o f the reaction would be incredibly time 
consuming due to the restrictive volume of the pressure tubes. However if an autoclave could 
be modified for purpose, this could be employed for both the formation o f the cavitand 
intermediate, CV(I) and the final encapsulation step. The difficulties encountered in the 
production of tetrol (CV(II)) could be counteracted with the development o f a suitable 
solvent system for Soxhlet extraction (as mentioned, 2.4.3.3). Although ultimately the
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number of steps required for the production of AC would likely prove prohibitive for 
application, regardless of any improvements which may be inferred into a fuel. Following so 
much effort it seems ridiculous to combust such an elegant supermolecule (Fig. 42).
The 2D NMR data did not extend into the negative region ROSE Y NMR data achieved did 
not include the peaks in the negative ppm region to identify special correlation between the 
host and guest species.
3.7 (E) Pyrogallolarene based carcerand, PP (4,24- 5 ,4 ’- 6, 5’- 10,11 - 12 ,16-17, 
16’- 18 ,17’- 22, 23’- 23, 24’- 6’, 10’- 18’, 22’-dodecamethylenedioxy, 2, 8, 14, 20, 2’, 8’, 
14’, 20’-octapentyl-bis-calix[4]arene) study
The procedures described above for the formation of carceplexes and hemicarceplexes are 
extensive, requiring 5 steps to produce a capsule. Initial attempts were performed to introduce 
aniline into a capsule from pyrogallolarene as is described here which were unsuccessful, as 
such an occurrence had not been reported before fundamental research into the possibility 
was begun which yielded PP, 4-24, 5-4’, 6-5’, 10-11’, 12-16, 17-16’, 18-17’, 22-23’, 23-24’, 
6’-10’, 18’-22’ dodecamethylenedioxy, 2, 8 , 14, 20, 2’, 8 ’, 14’, 20’ octapentyl-bis- 
calix[4]arene.
Outlined below is the extensive NMR characterisation performed on the product of the 
reaction between PA(I) and bromochloromethane in NMP with pyrazine. The expected 
product from a successful reaction was predicted to be as shown in Figure 43.
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Figure 43 The expected product from a successful union of bromochloromethane with PA(I) 
around pyrazine (not yielded)
This structure was reported from the joining o f equal tetrol hemispheres (CV(II)) with 
bromochloromethane employing pyrazine as templation scaffold which became the 
imprisoned guest o f the carceplex. In this structure 8  spanning groups were introduced as 
described in 2.4.3, followed by hydroxylation and then the bridging groups were introduced. 
It was considered that the same reactions may be possible from a single step synthesis from 
pyrogallol[4]arene, PA(I). However the structure achieved (Fig. 44) was quite different from 
expected.
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PP
Figure 44 Chemical structure of PP with protons and carbons labelled for NMR purposes
The initial observation in the ’H NMR spectrum that the molecule produced was not expected 
was the appearance of extra sets of peaks representative of the hexyl chains from the parent 
pyrogallolarene. Additionally the number of protons representative o f the cavitand bridging 
groups (as recorded from integration of the spectrum) were half what would be expected from 
a usual carcerand molecule. These results were subsequently found to be consistent with the 
structure detailed above, with the reduced number of spanning incidences, increased number 
of bridging groups which lead to a break in symmetry along the pendant groups caused by the 
differences in constraints exhibited by the methylenedioxy groups of the aromatics to which 
they are attached. Figure 45 displays the proton NMR spectrum achieved from PP. The break 
in symmetry is patently viewed from the two sets of adjacent groups of peaks, the indicators 
of the presence in an NMR spectrum of all of the pentyl pendant containing macrocycles 
experienced.
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Figure 45 ’H NMR spectrum of PP in CDCI3 at 298 K with inset for protons 15-17
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Table 32 NMR chemical shift values to assigned proton numbers for PP at 298 K
Proton ID 5 (ppm)
TMS 0 . 0 0 0
1 0.861
7 0.948
2-4 & 8-10 1.173-1.498
5 1.989
Acetone 2.170
1 1 2.234
6 4.209
14 4.570
1 2 4.674
DCM 5.285
17 5.857
15 5.874
16 5.905
13 6.850
Chloroform 7.255
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Table 33 "C  NMR data for PP in CDCI3 at 298 K
-  denotes no signa
Carbon ID 6  (ppm) Intensity (abs) DEPT
TMS 0 0 . 1 -
i 14.062 1.9 +ve
7 14.128 1.9 +ve
2 22.515 1 . 8 -ve
8 22.729 1 . 8 -ve
3 27.282 1.3 -ve
9 27.564 1 . 2 -ve
‘Grease’ 29.705 0.4 -
Ü 30.677 0 . 8 -ve
1 0 31.575 1 . 6 -ve
4 32.001 1 . 6 -ve
1 2 34.471 1 . 0 +ve
5 35.212 0.9 -ve
6 36.165 1 . 0 +ve
DCM 53.423 0 . 1 -
Chloroform 76.780 4.3 -
Chloroform 77.0340 4.4 -
Chloroform 77.288 4.2 -
16 100.367 0.7 -ve
18 101.542 1 . 8 -ve
13 114.491 1.7 +ve
14 122.594 1.7 -
17 136.066 1 . 6 -
19 138.184 1.7 +ve
2 0 138.381 1.5 -
15 144.506 1 . 6 +ve
due to quaternary carbon
The verification of DCM was compiled between both proton and carbon NMR to verify that 
it was not the presenee of eneapsulated pyrazine, the presence o f acetone was also detected.
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Table 34 HSQC DEPT correlations for PP in CDCI3 at 298 K
Carbon ID Proton ID
1 7 2 3 4 8 9 10 5 11 6 14 12 DCM 17 15 16 13
1 X
1 X
2 X
8 X
3 X
9 X
11 X
10 X
4 X
12 X
5
6 X
DCM X
16 X X
18 X X
13 X
14
17
19
20
15
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Table 35 HMBC NMR correlations for PP in CDCI3 at 298 K
Carbon ID Proton #
1 7 2 3 4 8 9 1 0 5 1 1 6 14 1 2 17 15 16 13
i X X X
7 X X
2 X X X
8 X X
3 X X X X
9 X X X X
1 1 X X X
1 0 X X X X X
4 X X X X X
1 2 X X
5 X
6 X X
DCM
16
18
13 X X
14 X X X
17 X X X
19 X X X X
2 0 X X X X X
15 X X X X
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Table 36 NMR COSY correlations for PP in CDCI3 at 298 K
Proton # Proton #
1 7 2,3,4 8,9,10 5 1 1 6 14 1 2 17 15 16 13
1 X
7 X
2,3,4 X X
8,9,10 X X
5 X X
1 1 X X
6 X X
14 X
1 2 X X
17 X
15 X
16 X
13 X X
The data confirm the synthesis of PP from PA(I), pyrazine and bromochloromethane (with 
CS2 CO3 as basic catalyst) at low concentration in NMP. To the author’s knowledge this is the 
first report of a careerand from pyrogallolarene and o f PP. It is fascinating how the bonds 
have arranged, the data confirms the presence o f both spanning and bridging methane groups, 
with the splitting pattern of the protons representative o f the spanning, cavitand type groups, 
integrating to half that of the methane bridging groups. A break in symmetry affords two 
separate sets of signals for the pendant pentyl chains, these correlate to the presenee o f the 
spanning group adjacent to the chain or the presence o f an interhemisphere bridging group 
being adjaeent. These may be visualised in Figure 46, b) the upper section pentyl chain lays 
adjacent to the bridging groups and the lower section is adjacent to the spanning group, each 
set of chains, 4 o f each in total in the moleeule.
In terms of the cavitand type protons of PP the inner (14) was identified in a position 
downfield of any reported within and the outer proton (15) was identified upfield o f the
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comparable protons of CV(I) and CV(II). The AS value was calculated as 1.304 ppm, nearest 
to the value encountered for HD (1.272 ppm).
The results show no evidence o f the encapsulation of pyrazine within the carcerand, instead it 
is assumed that pyrazine takes part in the reaction, forming a scaffold for the complex 
arrangement to form around but is then ejected from the structure before the final groups 
close the centre. At present there is no evidence to confirm this, however the reaction could 
be performed again in the absence o f pyrazine to confirm this hypothesis. However it is 
highly likely to be the case, given the desirable properties o f the guest and the reported high 
yields o f the earlier system upon which this was based. Indeed it was expected that if 
successful the structure would be identical. Fascinatingly this was not the case; it is amazing 
to consider the formation o f this molecule and the way in which the bridging and spanning 
groups self-organise to produce the molecule. What is most astounding is that the presented 
synthesis displays the joining together o f 14 molecules: 2 PA(I) and 12 BrCHiCl with the 
formation o f 24 new molecular bonds in a single step!
Figure 46 Molecular modelling energy minimised structure for the PP rendered as (a) a CPK 
model and (b) a ball-stick model
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3.8 (D) Supramolecular capsules study of 2, 8 , 14, 20-
tetrapentyIpyrogalIol[4]arene (PA(I))‘ anilines
The method which led to the complexation o f PA(I) with aniline, NMA and NNDMA 
respectively was produced from the dissolution o f PA(I) into each respective aniline with 
sonication. This was followed by gravitational filtration into crucibles which were allowed to 
evaporate to dryness. Complexation with phenol was not achieved. The pyrogallol[4]arene 
aniline(s) complexes: PA(I) ' aniline, PA(I) NMA and PA(I) NNDMA are now discussed.
3.8.1 (D) NMR complexation analysis
It has been well established that a self-assembled supramolecular system formed from 
resorcarene requires additional molecules to assist in forming the seam holding the 
arrangement in place, the focus o f the work was on the employment of pyrogallolarene for 
the encapsulation o f the desired guests. Although some research was performed with 
resorcarene for this purpose no results indicative of complexation were recorded. The 
structure of PA(I) 2, 8 , 14, 20-tetrapentylpyrogallol[4]arene (2, 8 , 14, 20-
tetrapentylcalix[4]arene 4, 5, 6 , 10, 12, 13, 16, 17, 18, 22, 23, 24 dodecol) is given in Figure 
48 with the structure numbered for NMR purposes. Figure 47 depicts the aniline, phenol and 
the aniline derivatives: A-methylaniline (NMA) and A,A-dimethylaniline (NNDMA) with 
numbering for NMR complexation purposes with PA(I).
numbered in 
blue
i^C numbered in 
red
15 17 14
N H j 14 1 7 '^ N H 14 O H 14
^ 1 3 iiJL nJL s J 314 r 14
- .1 3 14 '-13 14 r
15 15 ^ 1 2 15 15 M 2
16 11 1611 16 11 Mil
Aniline .V-Metliylaniline
(NMA)
.V.A-Dinietln)aniline
nndnIa
Phenol
Figure 47 Chemical structures o f aniline, NMA, NNDMA and phenol labelled for NMR 
purposes with PA(I)
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OH
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H numbered in 
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red
OH
.OHHO,
OHHO
OHHO
OHHO
OHHO'
OH
PA(I)
Figure 48 The chemical structure o f PA(I): (a) structure labelled for NMR purposes, (b) 
complete chemical structure
The presence of these complexes was first discovered by ’H NMR, their appearance was 
quite different from that which had been reported and shows distinct alterations when 
compared with the control samples of the host and guests alone. Figures 49-53.
Lettering is introduced after the proton number to display the multiple environments which 
the protons occupy once complexed with aniline and NMA. Complexation with NNDMA did 
not induce the extra environments.
151
Results & Discussion
PA(I) aniline
2 0 (ppm]46
Figure 49 Three ’H NMR spectra in CDCI3 at 298 K: (a) aniline, green; (b) PA(I), red; (c) 
PA(I) aniline complex, blue
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Table 37 NMR complexation data for PA(I) aniline, in CDCI3 at 298 K, proton numbers 
with significant chemical shifts highlighted in bold
Control
Multiplicity Proton #
Control
(ppm)
P4A A 
(ppm)
P4A ■ aniline 
Multiplicity AÔ (ppm)
t 1 &922 0.923 m 0.001
m 2- 1.325 1.323 m -0.002
m 4 1.435 1.378 m -0.056
q 5 2.217 2.201 q -0.016
t 6a 4.370 4.206 t -0.164
t 6b 4.370 4.271 t -0.099
s 7a &835 6.005 b,s -0.830
s 7b &835 6.066 b,s -0.769
s 7c &835 6.120 b,s -0.715
s 7d &835 6J36 b,s -0.599
s 7e &835 6.431 d -0.404
s 7f &835 6.446 d -0.389
s 8 6.877 - b,s -
s 9 7.461 - b,s -
s 10 8.772 - b,s -
d 13 6.673 6.611 d -0.062
t 11 6.751 6.745 t -0.005
t 12 7.147 6.999 t -0.148
b,s 14 3^23 - b,s -
- indicates that the peak could not be identified
The identity of the peaks was confirmed by HSQC DEPT correlations, hence why it was not 
possible to identify the hydroxyls or the amines for comparison. “Grease" was identified as 
an impurity in the sample at 1.2479 ppm and also underlying at 0.86, correlation was made 
by HSQC DEPT to 29.7 ppm in the spectrum.
Given the data displayed in Table 37 it would appear that the aromatic proton 7 when 
complexed is present in 6 different environments, with the lower bridging proton 6 is present
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in two environments, o f which one (6 b) is predominant over the other. Aniline shows a 
significant chemical shift for proton 12, proton 13 also shows a shift. None o f the hydroxyls 
or amine protons could be confirmed by HSQC DEPT. The lack o f peak shifting for proton 
1 1  may indicate the presence o f a quantity o f ‘free’ aniline in the sample, however this is not 
present when analysed by TGA, Figure 56. What is interesting is that chemical shifts were 
also identified in the carbon spectra. Figure 50 and Table 38.
120 100 BO140 60 40 20 [ppm]
Figure 50 Overlaid NMR spectra produced in CDCI3 at 298 K of: (a) PA(I), blue; (b) 
aniline, red and (c) PA(I) aniline complex, green
54
Results & Discussion
Table 38 NMR complexation data for PA(I) aniline, in CDCI3 at 298 K, with significant 
chemical shifts highlighted in bold
Carbon # Control (ppm) Complex (ppm) AS (ppm)
l a 14.154 14.083 -0.071
lb 14.154 14.131 -0.023
2 a 22.760 22.732 -0.028
2 b 22.760 22.749 -0 . 0 1 1
3a 22.760 27.238 4.477
3b 22.760 27.349 4.589
3c 27.989 27.476 -0.513
3d 27.988 27.630 -0.358
4a 32.146 31.640 -0.507
4b 32.146 31.713 -0.433
4c 32.146 31.877 -0.269
5a 33.143 33.561 0.418
5b 33.143 33j#3 0.750
6 a 34.169 34.216 0.047
A 34.169 34.373 0.204
7a 113.764 114.017 0.254
7b 113.764 114.192 0.428
8 124.106 119.634 -4.472
9a 125.433 119.842 -5.590
9b 125.433 123.645 -1.788
1 0 131.389 148.326 16.936
1 1 137.364 148.570 11.206
1 2 a 138.510 138.902 0.392
1 2 b 138.510 148.748 10.238
13a 146.356 145.827 -0.528
13b 146.356 146.205 -0.151
14 115.070 115.211 0.142
15a 123.258 129.071 5.812
15b 123.258 129.178 5.919
15c 129.258 129.277 0.019
16 118.514 118.675 0.161
- indicates that the peak could not be identified
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Certainty cannot be guaranteed for the identification o f carbons increasing from # 10 because 
significant overlaps appeared when correlations were performed by HMBC and HSQC. 
However what can be concluded is the great effect on the conformation o f PA(I) induced by 
the formation o f the complex.
PA(I) NMA
8 e 4 2 (ppm)
Figure 51 Three H NMR spectra in CDCI3 at 298 K: (a) NMA, green; (b) PA(I), red and (c) 
PA(I) NMA complex, blue
Figure 51 depicts the three spectra relevant to interpret the formation of a complex between 
PA(I) and NMA. Great differences between the complex spectrum (blue) and the controls o f 
PA(1) (red) and NMA (green) were easily identified. The identification o f the complex is 
remarkable, usually complexation may be identified from the transition o f a single proton at a 
discrete position over a distance o f 0.1 ppm. Here multiple sites o f interaction are easily 
identified and tabulated in full in Table 39, with HSQC DEPT correlations employed to aid in 
the identification o f protons in the complex for accurate definition o f transitions (Aô values in 
ppm)
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Table 39 NMR complexation data for PA(I) NMA, in CDCI3 at 298 K, proton numbers 
with significant chemical shifts highlighted in bold
Control
multiplicity
Proton
#
Control 5 
(ppm)
Complex 5 
(ppm)
Complex
multiplicity
AÔ
(ppm)
t 1 0.922 0.908 m -0.014
m 2 1.325 1.362 hump 0.037
m 3 1.365 1.421 hump 0.056
m 4a 1.435 1.443 hump 0.009
m 4b 1.435 2.810 d 1.375
q 5a 2.217 2 J5 6 s 0.539
q 5b 2.217 2.922 t 0.705
q 5c 2.217 3.038 s 0.821
q 5d 2.217 3.142 s 0.925
q 5e 2.217 3.776 s 1.559
t 6 a 4.370 4.273 t -0.097
t 6 b 4.370 4.390 t 0 . 0 2 0
t 6 c 4.370 4.434 s 0.064
s 7a 6.835 6.458 m -0.377
s 7b 6.835 6.556 m -0.279
s 7c 6.835 6.718 m -0.117
s 8 6.877 - - -
s 9 7.461 - - -
s 1 0 8.772 - - -
s 15 2j% 7 1.254 s -1.573
b,s 14 3.672 - - -
d 13a 6.610 7.180 m 0.570
d 13b 6.610 7.926 d 1.317
t 1 1 a 6.704 7.053 t 0.348
t 1 1 b 6.704 7.280 t 0.576
t 1 1 c 6.704 7.427 t 0.723
t l i d 6.704 7.521 t 0.817
t 1 2 7.187 7.487 t 0.300
- indicates that the peak could not be identified
157
Results & Discussion
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Figure 52 Overlaid NMR spectra in CDCI3 at 298 K of: (a) PA(I), blue; (b) NMA, red 
and (c) PA(I) NMA complex, green
Again due to the apparent conformational changes afforded due to complexation peak 
shifting events were also identified in the carbon-13 spectra, these are given in Figure 52 and 
Table 40.
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Table 40 NMR complexation data for PA(I) NMA, in CDCI3 at 298 K, with significant 
chemical shifts highlighted in bold
Carbon # Control 5 (ppm) Complex 6  (ppm) AÔ (ppm)
i 14.154 14.125 -0.0286
2 22.760 30.495 7.735
3 27.989 30.890 2.901
4 32.146 38216 6.070
5 33.143 40.504 7.360
6 34.169 55.930 21.761
7a 113.764 109.727 -4.036
7b 113.764 112.442 -1.322
7c 113.764 112.534 -1.229
7d 113.764 112.641 -1.122
7e 113.764 114.853 1.090
11 113.764 116.605 2.842
Zg 113.764 118.479 4.715
7h 113.764 122.410 8.646
8 124.106 127.999 3.894
9 125.433 128.673 3.241
1 0 131.389 129.205 -2.184
1 1 137.364 129.393 -7.971
1 2 138.510 129.639 -8.871
13 149.336 152.673 3.337
14 112.406 122.846 10.440
15 129.197 129.089 -0.108
16 117.242 130.986 13.744
17 30.723 29.713 -1.010
Due to the overlap of the spectra in the aromatic region it is difficult to be certain for the 
identification of carbon 7, in which some of these peaks may belong to NMA
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PA(I) NNDMA
[ppm]
Figure 53 Three 'H NMR spectra in CDCI3 at 298 K: (a) NNDMA, green; (b) PA(I), red and
(c) PA(1) NNDMA complex, blue
The complexation o f PA(I) and NNDMA was identified from the initial ’H NMR experiment, 
performed on the complex and compared to the control spectra o f the two compounds 
involved, this is given in Figure 53. The complexation was easily identified as being less 
dramatic than encountered before with aniline and NMA. The proton NMR data was 
tabulated and is presented in Table 41.
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Table 41 NMR complexation data for PA(I) NNDMA, in CDCI3 at 298 K, proton 
numbers with significant chemical shifts highlighted in bold.
Control
multiplicity
Proton
#
Control 8  
(ppm)
Complex 8  
(ppm)
Complex
multiplicity
A8
(ppm)
t 1 0.922 0.922 t 0 . 0 0 0
m 2 - 1.325 1.352 m 0.027
m 4 1.435 1.418 m -0.017
q 5 2.217 2.217 s 0 . 0 0 1
t 6 4.370 4.370 t 0 . 0 0 0
s 7 6.835 7.244 s 0.409
s 8 6.877 - - -
s 9 7.461 7.462 s 0 . 0 0 1
s 1 0 8.772 8.773 s 0 . 0 0 1
s 14 2.937 2.942 s 0.005
d 13 6.711 6.715 d 0.004
d 1 1 6.743 6.750 d 0.007
t 1 2 7.240 0856 d -0.384
- indicates that the peak coulc not be identified
The results here in Table 41 in comparison to the others show a localisation o f the interaction 
in the complex, identified specifically to a shift in the host at the aromatic proton 7. It is 
interesting that 2  of the hydroxyl groups have been identified and are unaltered, the absence 
of the third implies that only one set of hydroxyl groups are taking part in complexation. This 
would explain the variance in solubility as shown in 3.8.4. If the hydroxyls are not involved 
in complexation then it would seem that they are available to affect the solubility o f the 
complex. Overlaying the three respective carbon-13 spectra (in CDCI3 at 298 K) showed no 
variation between the control samples and the complex as depicted in Figure 54. The initial 
conclusion can subsequently be drawn that the complexation of PA(I) with NNDMA does not 
induce the conformational changes that were identified when complexation occurred with 
aniline and NMA.
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Figure 54 Overlaid NMR spectra in CDCI3 at 298 K of: (a) PA(I), blue; (b) NNDMA, red 
and (c) PA(I) NNDMA complex, green
Hot filtration followed by evaporation to dryness of the filtrate from the sample which was 
allowed to boil for 5 minutes did not yield the complex. It is likely that these harsh conditions 
applied to both the guest as solvent and the ligand PA(I) led to degradation which 
subsequently when cooled did not allow for complexation.
The complexation of PA(I) with aniline and derivatives yielded complex formation which 
was quite different to that which had been reported before. Previous encapsulation displayed 
little effect on the structure of the host and an encapsulated species would be identified as an 
additional peak in the spectra with a significant chemical shift when doped with additional 
guest. Comparison with the results confirms that in the case of PA(1) NMA the 
complexation involves the entirety of both molecules as opposed to only the hydroxyls.
These remarkable complexes of PA(1) aniline, PA(1) NMA and PA(1) NNDMA have not 
previously been reported. Nor have such significant interactions with a pyrogallolarene been
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tracked by NMR. Chemical shifts in the carbon-13 spectrum for supramolecular complexes 
also have not been encountered previously. These shifts are caused by complexation induced 
conformational changes and by the shielding which results from complexation, as identified 
by NMR. These are greatest in PA(I) NMA where an indiscreet spectrum of numerous peaks 
was achieved, which is indicative of an extensive break in symmetry caused by complexation 
of the host and guest molecules. It would appear that the complexation produces an intricate 
complex in which the constituent molecules occupy various spatial positions.
3.8.2 (D) Chromatography
Due to the numerous peaks were apparent in the complexes it was concluded that the 
complexes were likely present as mixtures, subsequently attempts were made to separate the 
complexes by column chromatography in DCM, EtOAc and DCM : MeOH (99:1, v/v) . 
However although the samples appeared to separate when analysed by TLC, separation was 
not achieved when the samples were eluted through a column. It is likely that an alternative 
mode of separation is required to separate the complexes and free species in the possibly 
mixed samples. Additional methods have not yet been attempted.
3.8.3 (D) Thermogravimetrie analysis
With the final application for combustion in mind the thermal profiles of the complexes were 
sought by TGA. Early samples produced from hot filtration crystallisation as described in the 
literature showed no difference when compared to control when analysed by NMR and 
identical results were apparent when analysed by TGA. In Figure 55 the control samples and 
mixtures show mass loss at identical temperatures.
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Figure 55 Control TGA data in air to 900 °C for: aniline (grey), NMA (blue), NNDMA (red) 
and PA(I) (purple) and host guest combinations thereof: PA(I) with aniline (green), PA(I) 
with NMA (black) and PA(I) with NNDMA (pink)
In Figure 56 the anilines can be seen to have been removed from the pan before reaching 100 
°C, the pyrogallolarene sample is stable to almost 300 °C then decomposition begins. In the 
case of the mixed materials the quantity of aniline or derivative can be established directly 
from the plot, a slight shoulder is present in each sample, possibly suggestive of a small 
quantity of a complex, perhaps forming in situ. The decomposition of the pyrogallolarene 
then occurs, following the trend o f control. The differences compared to the samples of 
Figure 56 are striking, although a decline in mass is obvious in the case of sample A: PA(I) 
Aniline at 300 °C the decline is much more progressive than identified in any of the control 
samples. Indeed the decline in mass for NNDMA: PA(I) NNDMA is almost a perfect curve, 
with the NMA: PA(I) NMA sample displaying a near linear mass decline from -100  °C 
leading to a shaper decline from -520 °C.
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Figure 56 TGA data in air to 900 °C for the three eomplexes: A (PA(I) aniline), red; NMA 
(PA(I) NMA), blue and NNDMA (PA(I) NNDMA) green
3.8.4 (D) Solubility studies
It was necessary to discover the solubilities of the eomplexes in relevant solvents, in order to 
allow for full investigation o f their properties when employed as fuel additives. Before the 
additives could be introduced into the fuel sample, solutions of the complexes at known 
dilutions in pre-determined solvent systems were required to allow correlation with the 
relevant controls.
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Table 42 Solubility data of the three pyrogallolarene complexes and control 
(pyrogallolarene) at concentrations between 1000 and 10000 ppm in heptane and heptane : 
toluene (1:1) at 298 K
Complex\Solvent H 1000 H 10000 H 5000 H /T 1000 H/T 10000 H/T 5000
PA(1) X X X X X X
PA(1) Aniline X X X V X X
PA(1) NMA X X X X X X
PA(1) NNDMA X X X X X X
H = heptane, H/T = heptane : toluene (1:1, v/v), number refers to ppm.
PA(1) is the control sample and showed no solubility in any of the solvents, a fine dispersion 
was identified. PA(1) Aniline was not soluble in heptane but was found to be soluble in 
heptane/toluene and fully dissolved at 1000 ppm. The sample o f PA(1) NMA showed some 
level of dissolution in both solvent systems but was not entirely dissolved at any o f the 
concentrations investigated; a remnant o f the oil remained present in each ease. Attempts to 
obtain a solid from the oil have as yet been unsuccessful. PA(1) NNDMA showed no 
solubility in heptane and was only very slightly soluble in heptane/toluene with a dispersion 
most prevalent.
Due to the poor solubilities found additional solvent systems were explored, the results o f the 
subsequent solubility studies are outlined in Table 43.
Table 43 Solubility data o f the three pyrogallolarene eomplexes and control 
(pyrogallolarene) at concentrations between 1000 and 10000 ppm in solvent systems: n- 
heptane : toluene (25:75, v/v) A and 1 -methylnaphthalene : «-heptane : toluene (5:20:75) B, 
at 298 K
A A A B B B
Complex\Solvent 1000 ppm 10000 ppm 5000 ppm 1000 ppm 10000 ppm 5000 ppm
PA(1) X X X X X X
PA(1) Aniline V V V V X V
PA(I) ■ NMA V V V V V V
PA(1) NNDM A X X X X X X
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The limit o f solubility has been identified for the PA(I) aniline complex in 1- 
methylnaphthalene : «-heptane ; toluene (5:20:75) as between 5000-10000 ppm and the 
introduction of 1 -methylnaphthalene at the expense of «-heptane reduces the solubility o f this 
complex. The PA(I) NMA sample was found to dissolve in both solvents systems to 10000 
ppm. PA(I) is the control sample and showed no solubility in any of the solvents, a fine 
dispersion was identified. This is to be expected due to the number of hydroxyl group present 
in the molecule and the non-polar solvent systems. It is however surprising that the PA(I) 
NNDMA complex which has shown similarity with the other eomplexes produced but has 
identical properties to the control sample when introduced into non-polar solvent systems.
The trend can be followed that solubility in apolar solvents is improved with increasing guest 
stoichiometry, from PA(I) NMA (1:12) > PA(I) ' aniline (1:10) > PA(I) NNDMA (1:4) ~ 
PA(I). The following conclusions can subsequently be made, the eomplexes of PA(I) NMA 
and PA(I) ‘ aniline are discrete from PA(I) NNDMA and of different superstructure. The 
variations between control (PA(I)) and PA(I) aniline and PA(I) NMA display that the 
presence of aniline or NMA in the complex increases the solubility o f the superstructure in 
non-polar solvents. Thus it can be concluded that multiple hydroxl sites are occupied by 
complexation, what cannot be confirmed is whether these interactions are between 
pyrogallolarene hemispheres, between pyrogallolarene and aniline and NMA respectively or 
a combination of the two.
3.8.5 (D) Complex stability study
An initial study was performed in methanol-d4  and CDCI3 respectively, using the NMR 
instrument to increase the temperatures in the sample tubes from 298 K to 313 K 
progressively at 5 K intervals, where analyses were performed. No alterations in the spectra 
were identified and samples were subsequently subjected to prolonged exposures at increased 
temperatures to assess complex stability. Figures 57-59 display the NMR spectra 
produced from sealed samples of the eomplexes, dissolved in methanol-d4  and incubated at 
313 K between analyses. No changes were apparent in the polar protic solvent over the period 
o f analysis, 68 days.
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Figure 57 Overlaid H NMR spectra in methanol-d4 at 313 K o f PA(I) aniline with 
increasing time, samples incubated between analyses at 313 K
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Figure 58 Overlaid 'H  NMR spectra in methanol-d4  at 313 K of PA(I) NMA with increasing 
time, samples incubated between analyses at 313 K
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Figure 59 Overlaid NMR spectra in methanol-d4 at 313 K of PA(I) NNNDMA with 
increasing time, samples incubated between analyses at 313 K
With the stability of the complexes it may be possible to isolate crystals suitable for 
crystallography from slow evaporation of the second solvent or solvent system, yielding 
crystals o f the pyrogallol[4]arene aniline(s) complexes to enable structural understanding. 
Slight variations were observed in spectra when the experiment was performed in 
chloroform-d, which were not observed in methanol. This would suggest that the complex is 
more stable in polar solvents rather than non-polar solvents; however the situation is likely 
more complicated than this. In the case of PA(I) NMA the increase in a peak at -9.75 ppm is 
likely representative of a hydroxyl of pyrogallolarene this is accompanied by the silencing of 
a peak at -4.40 ppm, proton 6. Because o f the involvement o f proton 6 it is likely that the 
same solvent interaction is identified again here. These spectral deviations were not identified 
for PA(I) NNDMA, displaying further differences between the complexes formed.
169
Results & Discussion
3.8.6 (D) Breaking the complex
The complexes were found broken following dissolution in chloroform-d : methanol-d4 , 1:1 
(v/v) the ease at which the complexes were found to break was of some initial concern. 
Further studies were performed, not least those discussed in 3.8.5, o f note a sample dissolved 
in chloroform was analysed then an equal volume o f methanol-d4  was introduced and the 
sample was re-analysed. The spectra produced were with the exception o f the additional 
methanol representative peaks identical to the previous spectra, indicating no effect had been 
afforded onto the structure of the complexes. The sample was then submitted to sonication 
for 10 hours and then re-analysed, with no variance recorded. An additional portion of 
methanol-d4  to a ratio of 2:1 methanol-d4  : CDCI3 (v/v) the sample was sonicated for a further 
10 hours and re-analysed again with no variance in spectra. Consequently it would appear 
that the reason that the complex was broken with ease was due to the agitation by sonication 
used for dissolution and that in a sample in which the complex is already dissolved it is stable 
as a complex and is not readily broken.
Because o f the alteration to the solvent system necessary to induce the collapse o f the 
supermolecule to work out the stoichiometry involved in complexation it was o f no 
advantage to compare any chemical shifts. Instead the peaks were easily identified as 
identical to control, but with different 5 ppm values associated induced by the solvent 
variation. Integration of the spectra produced stoichiometric ratios for the complexes of: 
PA(I) aniline, 1:10 (Fig. 60); PA(I) NMA, 1:12 (Fig. 61) and PA(I) NNDMA, 1:4 (Fig. 
62). The triplet representative of proton 6  at the bridge of PA(I) was used as reference for the 
calculation and the integration was normalised to 4 (as each PA(I) contains 4 o f this type of 
proton).
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Figure 60 NMR of the broken complex of PA(I) and aniline in CDCI3 and methanol-d4  at 
298 K
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Figure 61 H NMR of the broken complex of PA(I) and NMA in CDCI3 and methanol-d4 at 
298 K
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Figure 62 NMR o f the broken complex of PA(I) and NNDMA in CDCI3 and methanol-d4
at 298 K
It would be advantageous to be able to study these molecules thermodynamically, however 
the right method would need to be devised. Whitesides et a l  offer an insight into the 
thermodynamics o f self-assembly stating that entropy is usually o f secondary importance in 
molecular recognition with AH values usually within the order o f between 4 x 1 0 ^  and 5x10^
3.8.7 (D) PA(I) ‘ anilines sum m ary
It is clear that complexation has been achieved by the dissolution o f PA(I) in aniline, NMA 
and NNDMA respectively (guest as solvent) followed by slow evaporation o f the solvent 
over time. Pilot studies have been performed to increase the speed o f removal o f the solvent 
by rotary evaporation, with promising results. The subsequent effects on the complexes (if 
any) have not yet been investigated. This method would be a valuable upgrade to the method 
because the anilines are o f low volatility (high boiling points, 184-194 °C) as such even when 
placed into watch glasses or oil baths o f sizable diameter (-30 cm), at high solvent volume
172
^ _________________________________________________________________Results & Discussion
(>250 ml) evaporation periods are extensive (>1 month). With the implementation of rotary 
evaporation this period can be reduced to less than 30 minutes, if the system and pump can 
support a consistent vacuum of approximately 10 mbar or less with the flask submerged in a 
water bath at 95 °C. Additionally with a well-maintained or dedicated rotary-evaporator the 
solvent may be reclaimed following formation of the complex, allowing it to be recycled. The 
number o f times this may be performed and the effect on the solvent of thermal 
decomposition would need to be investigated. This is certainly necessary as mentioned in 
earlier experiments as boiling to dryness and reflux treated samples failed to yield complexes. 
It may be that the temperatures induced in this method are (-100 °C) lower than the reflux 
temperature at ambient pressure do not cause thermal degradation of the anilines considered. 
The solubility series for PA(I) in the anilines follows: aniline > NMA > NNDMA, as such the 
greatest yield can be harvested from this complex per solvent aliquot.
The PA(I) NNDMA complex forms a brittle black solid, which has shown poor solubility in 
the required solvents. PA(I) displays poor solubility in NNDMA, yielding 6.3 g o f the 
complex from 10 g of PA(I), the remaining quantity o f PA(I) removed by filtration. At the 
stoichiometry of PA(I) NNDMA of 1:4 which equates to 3.98 g o f PA(I) dissolved in 
NNDMA for complexation. The factor which prohibits implementation of this complex is the 
poor solubility in non-polar solvent systems which conclude that full dissolution at 
efficacious concentrations in a fuel cannot occur.
The PA(I) NMA complex forms a viscous oil which is difficult to handle but has afforded 
the greatest solubility at significant concentrations in the solvent systems investigated. The 
stoichiometry of the complex as calculated by NMR showed the guest at the highest ratio
The presence of the reported pyrogallol[4]arene hexamer has not been confirmed. Due to the
remarkable stability o f the complexes shown in the solvent systems considered, it may be
possible to recrystallise the complexes from a mixture of methanol and chloroform, or other
solvent system to yield crystals suitable for X-ray crystallography to elucidate their
structures. The issue may arise that the structures are of multiple discrete conformations
which are difficult to separate (as found), subsequently analysis by XRD would be difficult.
The stoichiometry calculated for possible hexameric capsules were: PA(I) aniline, 6:60;
PA(I) NMA, 6:72; and PA(I) NNDMA, 6:26. Calculations based on the internal volume of
the hexamer of 1200 conclude that 7 molecules of aniline, 6 of NMA and 5 of NNDMA
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could be encapsulated. Subsequently it must be concluded that no pyrogallolarene hexamers 
were produced. The conclusion was then drawn that complex formation occurred between the 
hydroxyls of PA(I) with aniline, NMA and NNDMA respectively. These structures are 
detailed in Figures 63-65.
Figure 63 Molecular model o f PA(I) aniline presented in ball-stick with hydrogens omitted 
for clarity
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Figure 64 Molecular model of PA(I) NMA presented in ball-stick with hydrogens omitted 
for clarity
Figure 65 Molecular model of PA(I) NNDMA presented in ball-stick with hydrogens 
omitted for clarity
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These structures are in-line with the results with the anilines interacting with the hydroxyls of 
pyrogallolarene leading to occupation of the hydroxyl groups increasing the solubility in non­
polar solvents. The conformational changes associated with the numerous complexation 
events were apparent in Figures 60-61, as were visualised by NMR.
The remarkable stability in polar and non-polar solvents of the complexes affords 
encouragement for implementation. Fuel additives must be stable over extended periods of 
time due to the time-frames between manufacture and ultimate combustion by the end-user in 
their vehicle. These stabilities are surprising given the difficulties encountered and specific 
requirements which are o f prerequisite to formation.
Despite encapsulation seemingly not being achieved the results described by the TGA data 
suggest that significant variations are apparent when the complexes are submitted to 
increasing temperatures. Additionally the complexes may show important variations from 
control in terms of toxicity which may be important for implementation.
At the time of writing the samples were being prepared for analysis in test engines to examine 
the efficacy o f the fuel additives produced. Due to the insoluble nature of pyrogallolarene 
because o f the numerous hydroxyl groups, control analysis cannot be performed against the 
ligand but with the elucidation of the stoichiometric values o f the anilines may be compared 
to the free additives. It is interesting to note that research previously performed has shown the 
advantages of aminated compounds as fuel additives when employed with oxygenates^"^’^ ’^^  ^
this is the case for the complexes outlined.
3.8.8 (D) PA(I) ' aniline and PA(I) ' N M A IQ T  testing
Following the successful dissolution o f the complexes in «-heptane : toluene (25:75, v/v). 
Table 43 it was determined that IQT (ignition quality testing) would be performed o f the 
complexes in this solvent system. Testing is due to be performed at volumes of 1 litre per 
sample at the concentrations noted in the table plus a control o f the solvent system.
As mentioned in 1.7.3 the exciting prospect of an oxygenated alcohol complex with aniline 
and NMA may prove to be an excellent combination for increased efficacy. The mentioned
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drawbacks to implementation o f aniline and NMA as fuel additives were negated by the 
presence of oxygenates in the fuel blend/^ Here the two are present as a complex, the 
question of then how the complex responds to compression. If the complex is broken, the 
possibility arises that PA(I) may precipitate out o f solution. It is likely that the ‘pendant 
groups’ of PA(I) have not been optimised for use as a petrol additive due to the nature o f the 
C5H 11 straight chain under compression. A commonly used alternative: CH2 CH2Ph may show 
improvement but may not be optimal and solubility is also likely to be affected. What is 
certain is that if  an effect is observed it has not yet been optimised.
3.9 (D.A) A ttem pted complexation of PA(I) w ith cetane im provers
Following the results produced from the complexation of aniline and the two aniline 
derivatives with PA(I), without the application of heating, attempts were made to replicate 
the complexation with the cetane improvers as guests.
Following the unsuccessful initial attempt with the cetane improvers alone (see appendix), no 
complexes were apparent. NMR spectroscopy yielded samples with peaks only indicative of 
common NMR sample impurities. PA(I) was found to be insoluble in both 2-EHN and 
DTBP, blocking complexation. Consequently six common laboratory solvents were selected 
to be combined with the additives in an attempt to form complexes. The selected solvents 
were: «-hexane, THF, ethyl acetate, toluene, acetone and diethyl ether. The solvents were 
combined with the cetane improvers separately at 1:1 (v/v), PA(I) was dissolved in them and 
the samples were filtered gravitationally into crucibles and allowed to evaporate in the fume 
hood. Once dryness had been achieved the samples were analysed by NMR in CDCI3 . The 
solvents alone were also analysed as controls. None of the samples (including the control, 
solvent alone) showed complex formation with PA(I) with this method, samples either 
evaporated to dryness or the host remained insoluble in the solvent system («-hexane, 
toluene).
None of the samples when analysed by ^H NMR showed evidence o f complexation or 
deviation from control.
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(D) The complexes achieved with PA(I) 2, 8, 14, 20-tetrapentylpyrogallo 1 [4]arene with 
aniline and NMA, PA(I) ' aniline and PA(I) NMA have shown promise through all of the 
examinations to which they have been subjected. The NMR spectral deviations achieved 
from the combination of two chemicals were extraordinary and confirmed the self-assembly 
o f novel discrete complexes. The alterations identified in the thermal properties of the 
complexes compared to control were amazing. The stoichiometries encountered for these two 
complexes are remarkable, quite exactly how they are arranged is not clear but the solubility 
in apolar solvents suggests that the complexed anilines must be occupying the 
pyrogallolarene hydroxyl groups. It has been confirmed that the pyrogallolarene when 
subjected to the exact conditions for complex formation is able to accommodate interactions 
with multiple guests. The great number of anilines which PA(I) is able to accommodate 
proved that the complexes were not hexameric in nature. Crucially the complexes showed 
excellent stability over time, even at increased temperatures. To the authors knowledge none 
o f the reported complexes of pyrogallolarene or indeed any hemicarceplexes have previously 
displayed such longevity in solution.
The complex achieved with NNDMA did not readily dissolve in the apolar solvent systems, it 
would seem that a great proportion of the macroscopic properties of this complex are inferred 
by the host, due to the low stoichiometric ratio (compared to PA(I) aniline and PA(I) ' NMA) 
o f guest to host. It can be inferred that this is due to the remaining availability of the 
hydroxyls of pyrogallolarene which leaves the complex too similar to the host alone to 
dissolve in the required solvents.
Final analysis of PA(I) aniline and PA(I) NMA as fuel additives however remains pending.
(E) The carcerand 4, 24- 5, 4’- 6, 5’- 10, I I ’- 12, 16- 17, 16’- 18, 17’- 22, 23’- 23, 24’- 6’, 
10’- 18’, 22’-dodecamethylenedioxy, 2, 8, 14, 20, 2 ’, 8’, 14’, 20’-octapentyl-bis- 
calix[4] arene, PP may be an indicator of the future of these types of molecules. With the great 
advantage in terms of speed of production with which it can be synthesised, in only 2 steps.
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Although the yield from the reaction presented was rather low ( ~ 8  mg from 2 g o f PA(I)) it 
may be that these yields could be improved by minor alterations to the synthesis. The self- 
assembly demonstrated in the formation of PP is most significant with the joining together of 
14 molecules: 2 PA(I) and 12 BrCH2 Cl and the formation of 24 new molecular bonds in a 
single step!
(B) The carceplex, 4, 24- 5, 5’- 6 , 10- 11, 11’- 12, 16- 17, 17’- 18, 22- 23, 23’- 4 ’, 24’- 6 ’, 
10’- 12’, 16’- 18’, 22’-dodecamethylenedioxy, 2, 8 , 14, 20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis- 
calix[4]arene aniline, AC produced was obviously not a favourable product from the 
reaction constituents, due to the numerous failures necessitating the application o f pressure to 
facilitate production. The synthesis of carceplexes following a guest centric approach is of 
disadvantage to this approach for these molecules which only have symmetry along a single 
axis because of this for optimal host-guest complementarity the host system should mimic 
this break in symmetry. The ideal host would require the joining o f two different 
hemispheres, complementarity between which would not be difficult to achieve as has been 
demonstrated previously.^^ However exactly how to modify the inner surface o f a cavitand to 
accommodate the head group o f the AK additives (as opposed to the aromatic base) 
respectively escapes the imagination. It may be that these systems cannot be implemented to 
high yield to make products applicable for real-world implementation, especially with the 
current number o f steps required to reach the final product. Also the extreme dilution which 
is required for the encapsulation step requires large volumes of solvent and becomes difficult 
to manage at ligand quantities o f >1 g. There is a finite level to which these may be reduced, 
as they were employed successfully in order to minimise unwanted side reactions. The 
conclusion must regrettably be drawn that although aniline has been found encapsulated, the 
quantity produced was far below that required for initial testing by approximately a factor of 
1000. Until a safe method of scaling up pressure induced encapsulation is found the method 
remains purely in the realm o f academia. This added to the withdrawal from market of 
bromochloromethane will likely mean this is the only report o f the molecule which will be 
produced.
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(C) The synthesis of hemicarcerand, 4, 24- 6 , 10- 12, 16- 18, 22- 4 ’, 24’- 6 ’, 10’- 12’, 16’- 
18’, 22’-octamethylenedioxy, 5, 5’- 11, 11’- 17, 17’- 23, 23’-tetra-met^z-dimethoxybenzene, 
2, 8 , 14, 20, 2 ’, 8 ’, 14’, 20’-octapentyl-bis-calix[4]arene, HD benefits greatly from the 
presence of the excellent template molecule pyrazine for optimisation of the synthesis and 
was produced in relatively high yield. Ultimately the rigidity o f the bridging totm-meta- 
dimethoxybenzenes did not allow passage of the desired guests into the pocket o f the 
hemicarcerand and failed to form any of the desired hemicarceplexes. It is regrettable that no 
encapsulation was achieved in this way as it was of great importance to understand the 
stability and longevity of these complexes to establish if  this route is ultimately viable for the 
production of fuel additives. Access to a library of hemicarceplexes or to a substantial 
quantity of tetrol for the production o f hemicarceplexes would be o f great interest; 
unfortunately neither were available during the research.
The great advantage possessed by previous researchers was that they were able to attempt 
their encapsulation research without the constraint o f the guests which they were required to 
introduce but instead approach the problem as an entirely academic pursuit. This however is 
the nature of research, to push the boundaries, it is not to our knowledge that this guest 
focussed encapsulation has been attempted before.
(A) The dynamic interaction approach as applied in the early stages of the work displayed 
how complexation is possible between neutral species in solution. Molecular sensing has 
been achieved with the new calixarene derivative, 5, 11, 17, 23-tetra-^gr^-butyl, 25, 27- 
bis(oxyethylphenylurea), 26, 28-dihydroxycalix[4]arene with the two cetane improvers 2- 
EHN and DTBP. However the complexation was not strong enough for the application and 
no heats of interaction were produced which subsequently and unfortunately did not allow for 
thermodynamic study. The ligand however displayed some interaction and possible 
selectively and so will likely find application through analysis with other guests.
(F) Very little was achieved with p-cyclodextrin (BCD) due to difficulties encountered in its 
study and the complexities involved in modifying a lead compound for application. However,
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considering that no lead compound has been established for the encapsulation of phenol, the 
route which may offer the best possibility may be that of BCD as inclusion complexes with 
phenol have been reported/"^
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(D) A great deal of work remains for the pyrogallolarene complexes, priority one of which is 
to introduce the complexes to a test engine.
Further study is required into the nature of the complexation which has been identified 
between PA(I) and the anilines. It is crucial to establish a crystal structure for these 
complexes if possible. It was initially thought that these would need to come from the mother 
liquor in order to maintain the complexes, this was attempted and found to be unsuccessful. 
However with the remarkable stability that has been shown in solvents it may be possible to 
achieve suitable crystals from conventional techniques, these would provide far greater 
understanding as to the nature o f complexation.
As mentioned pilot studies have been performed in order to speed up the lengthy 
complexation process, afforded from the slow evaporation of solvent over time. These studies 
require completion to fully understand what effects forced evaporation has on complex 
formation and on the resulting complex.
Further attempts to separate the complexes should also be made, methods for such may 
include reverse phase chromatography and size exclusion chromatography. Additional 
research could be performed into the stability of the complexes. This could begin with 
dissolution into various solvents, enquiries into understanding the effect o f agitation on the 
complexes, by sonication. It could also include the effect on the complex of the introduction 
of acid, base or ionic species into the solution.
It would also be interesting to see what occurs with the complexes and which guests are 
found to be preferable and the differences which would arise from the dissolution o f PA(I) 
into mixed solutions o f anilines, for instance with 1:1 (v/v) aniline : NMA, aniline : 
NNDMA, NMA : NNDMA and 1:1:1 aniline : NMA : NNDMA. Additionally phenol could 
be dissolved in these systems and with each aniline respectively and mixtures thereof to see 
whether complex formation can be achieved. The difficulty which can be envisaged here is 
that phenol is solid at roomi temperature, so experiments may need to be conducted with a
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restricted quantity o f phenol or samples evaporated at increased temperature. These 
experiments may also be assisted by rotary evaporation to retain phenol in the liquid state.
Phenol has proved difficult to manipulate, mainly due to being solid at room temperature. 
This resulted in its application being somewhat more difficult and it may subsequently be 
necessary to investigate a method o f maintaining the temperature above melting point to 
allow for study. However it is likely that the hydroxyl present in its structure will not lend 
itself well to this technique. The fascinating prospect then arises due to the complexation 
already identified between amines and hydroxyls. It is incredibly interesting how these 
complexes have formed and the differing properties o f the amine groups o f the aniline used in 
the study. It would be excellent to continue the work with pyrogallol in this area but to see if 
it would be possible to substitute the hydroxyls for amines in the pyrogallolarene structure, 
forming ‘4, 5, 6 , 10, I I ,  12, 16, 17, 18, 22, 23, 24-dodeca-amine-calix[4]arene’ (see 
appendix). It would then be interesting to see what this (if possible) would do with phenol, 
thus inverting the functional groups o f PA(I) aniline.
The reports in the literature suggest at the versatility o f the pyrogallolarene hexamer, 
especially considering the level of complementarity and the absence of water, it could be 
mixed with any number o f fuel additives, to investigate whether any allow for the formation 
of the self-assembly around them. Also the necessity of the other types of capsules formed 
from resorcarene and pyrogallolarene need not be eliminated as the addition o f an alcohol has 
been shown to assist the self-assembly and bind the ‘seams’. It has been established that the 
presence of alcohols in fuels offer improvements to the compressive nature o f the fuel and 
also assist in the combustion process. Subsequently additional numerous alcohols could be 
blended with fuel additives and resorcarene or pyrogallolarene and the properties o f any 
subsequent supermolecules could then be studied. Following which, the length and nature o f 
the pendant R groups o f pyrogallolarene and resorcarene could be altered and studied. 
Impacts of alterations here are not fully understood but as mentioned inner pore size could be 
affected in the case of hexameric capsules. Solubility and crucially for application additional 
activity could be imparted or improved upon with modification. It is likely that the pentyl 
chain is not the optimum functionality for this section due to the detonative nature o f straight 
chain alkanes in fuels. Modification of this section would aid in the understanding as to the 
role (if any) which it plays the self-assembly process.
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(E) The possibilities for the pyrogallolarene based carcerand, PP should be fully 
investigated. Modifications should be made to the method presented in order to establish an 
optimal procedure for its production. There is a difficulty in this caused by the removal from 
market of bromochloromethane, as such replication and substitution of this reagent will be 
required. It would be interesting to discover if  the carcerand can be produced without 
pyrazine as pyrazine was not identified as a guest. Larger versions of PP with extended 
bridging and spanning groups may be possible with 2-(p-Tolylsulfonyloxy)ethyl 4- 
methylbenzenesulfonate, ED.
It seems likely that the greatest possibilities for the future of this system, indeed the 
production of host molecules from pyrogallolarene would be as hemicarcerands. 
Implementation o f this ethos allows the introduction o f an ‘ideal’ template molecule in the 
synthesis to assist in the formation o f the desired host. For the assembly of such a complex 
system and similar systems the templation molecules will surely prove to be vital. It would 
certainly require some extensive investigation; however with the details from previous 
workers, library compounds could be examined for properties similar to pyrazine with 
increasing size to facilitate the synthesis o f a hemicarcerand from pyrogallolarene if  such 
templates exist.
(B) The significant result for the future was that the application of pressure to the presented 
system was able to overcome factors which did not allow for the reaction to proceed to 
completion when performed under reflux. Future application of the technique however will 
have to proceed in the absence o f bromochloromethane and as it was this reagent which 
triggered its application due to its low boiling point it is perhaps instantly redundant. 
Although a great number of possibilities remain and it may prove to increase the yield of 
other carceplex and hemicarceplex syntheses, in the case of all but the most effective 
templators.
(C) The production o f a useable hemicarcerand remains elusive; however it is certain that an 
appropriate hemicarcerand molecule could be developed for encapsulation of the anilines.
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The requirements for the ‘ideal’ host with the greatest complex stability with portals o f length 
and flexibility necessary to allow the guest access to the void but restraint enough so as to 
afford suitable longevity may exist only in theory. A great library o f hemicarcerands would 
be required along with trial and error in combination with the specific guests. However it may 
be that the correct lengths o f bridges and spanners may afford such a complex without first­
hand knowledge o f the stability o f these guests inside such hosts when exposed to apolar 
media would be necessary to decipher whether they can be appropriate for application.
(A) The novel calixarene derivative CA(III) may find application in the selective interaction 
with other molecules or elemental species. Subsequently studies should be continued to 
include the interaction o f ionic species and organic species o f interest containing hydrogen 
bond accepting moieties in order to assess the full capabilities of this molecule for molecular 
sensing and the functionalisation may find application for the selective extraction of 
pollutants.
It would be interesting to study further the possibilities for complexation with the cetane 
improvers with calix[n]pyrrole (n = 5, 6 ), the results produced with calix[4]pyrrole and 2- 
EHN suggest that complexation may be possible with one of its larger counterparts, the 
synthesis of which have been reported.
(F) It seems unlikely that future work will be performed in this area with unmodified 
cyclodextrins, due to its innate insolubility in apolar solvents. Future work would follow the 
formation of a desired inclusion complex, followed by modification o f the host cyclodextrin 
by capping at either ends, to secure encapsulation. Then would require manipulation o f the 
outer surface to facilitate solubility of the complex in apolar solvents. Due to these 
complications and the fact that cyclodextrin is known to be non-toxic it is likely that its 
application will remain in the realm of the pharmaceutical and food industries.
An interesting observation from the research is that the formation o f complexes can allow for 
dissolution of compounds in solvents in which they were previously insoluble. As such it 
may be possible to form complexes with (3-cyclodextrin with a guest contained within the
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inclusion complex and attached to the exterior to aid solubility. Following the results 
presented it may be possible that this type of complexation may be possible with aniline, 
NMA or NNDMA and as such should be investigated.
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Appendix Figure 39 TGA plot of Aniline in air to 350 °C
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Appendix Figure 40 TGA plot of A-methylaniline in air to 350 °C
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Appendix Figure 42 TGA plot of pyrogallol[4]arene in air to 900 °C
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Appendix Figure 44 TGA of pyrogallol[4]arene (PA(I)) with A-methylaniline in air to 900 
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to 900 °C
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Appendix Figure 46 TGA plot of the pyrogallol[4]arene (PA(I)) aniline complex in air to 
900 °C
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Appendix Figure 49 Overlaid NMR spectra in CDCI3 at 313 K of PA(I) . aniline with
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Appendix Figure 50 Overlaid NMR spectra in CDCI3 at 313 K of PA(I) . NMA with 
increasing time, samples incubated between analyses at 313 K
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Appendix Figure 51 Overlaid NMR spectra in CD3 OD & CDCI3 at 313 K o f PA(I) .
aniline with increasing time, samples incubated between analyses at 313 K
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Appendix Figure 53 Overlaid NMR spectra in CD3 OD & CDCI3 at 313 K o f PA(I)
NNDMA with increasing time, samples incubated between analyses at 313 K
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Appendix Figure 55 Overlaid NMR spectra achieved in CDCI3 at 298 K, of: DTBP 
(green), PA(I) (red) and sample impurities (blue)
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Appendix Figure 56 The TLC plates from the attempted separation of PA(I) aniline (1), 
PA(I) NMA (2) and PA(I) NNDMA (3), in DCM (a), EtOAc (b) and DCM : MeOH (99:1, 
v/v)
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Appendix Figure 57 The proposed structure of 4, 5, 6, 10, 11, 12, 16, 17, 18, 22, 23, 24- 
dodeca-amine-calix[4]arene
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A ppendix Scheme 1 Proposed scheme for expanded cavitand synthesis
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Appendix Scheme 2 Proposed hydroxylation of expanded cavitand to expanded tetrol
232
7. Appendix
2
+ 4
E jçan d ed  tetrol
:oo:
NMP
Guest
:o
E D
Expanded carceplex
Guest
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